Document:

EX-4.6

 Exhibit 4.6 
 FOURTH AMENDED AND RESTATED 
 VOTING AGREEMENT 

This Fourth Amended and Restated Voting Agreement dated as of November 7, 2011 (this “Agreement”) is made by and
among BIND Biosciences, Inc., a Delaware corporation (the “Company”); the persons and entities listed on Schedule A (each a “Purchaser” and collectively, the “Purchasers”); Omid
Farokhzad, Paul Goldenheim and Robert S. Langer, Jr. (each, a “Founder,” and collectively, the “Founders”); the persons listed on Schedule B (collectively, the “Executive
Officers”); and the persons listed on Schedule C (the “Other Stockholders”). The Purchasers, the Founders, the Executive Officers and the Other Stockholders are (together with and any other persons or entities
that become parties to this Agreement after the date hereof in accordance with Section 12.8 or 12.9 hereof) referred to in this Agreement individually as a “Stockholder” and collectively as the
“Stockholders.” 
 WHEREAS, the Company, the Founders, the Executive Officers, the Other Stockholders and
certain of the Purchasers (the “Prior Purchasers”), are parties to a Third Amended and Restated Voting Agreement dated as of June 14, 2010 (the “Former Voting Agreement”); 

WHEREAS, the Company and certain of the Purchasers (the “Series D Investors”) are parties to the Series D Preferred
Stock Investment Agreement and Series BRN Preferred Stock Investment Agreement dated as of October 27, 2011 (the “Purchase Agreement”) pursuant to which the Series D Investors have agreed to purchase shares of the
Company’s Series D Convertible Preferred Stock, $0.0001 par value per share (the “Series D Preferred Stock”) and shares of the Company’s Series BRN Convertible Preferred Stock, $0.0001 par value per share (the
“Series BRN Preferred Stock”); 
 WHEREAS, the Series D Investors have made it a condition precedent to their
purchase of shares of Series D Preferred Stock and Series BRN Preferred Stock pursuant to the Purchase Agreement that the Former Voting Agreement be amended and restated in its entirety as set forth herein; and 

WHEREAS, the Company and the undersigned Prior Purchasers and Founders have the power to amend and restate the Former Voting Agreement as
set forth herein pursuant to Section 9.5 thereof, such amendment and restatement to be binding on all parties to the Former Voting Agreement; 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants set forth herein, the Former Voting Agreement is hereby amended and restated in its entirety as set forth herein. 

1. Voting of Shares. 
 1.1 Board of Directors. In any and all elections of directors of the Company (whether at a meeting or by written consent in lieu of a meeting), each Stockholder shall vote or cause to be voted all
Shares (as defined in Section 2) owned by him or it, or over which he or it has voting control, and otherwise use his or its respective best efforts, so as to: 
 (a) fix the number of directors of the Company at ten (10); 

 (b) elect the following persons as directors: (i) one person designated by Polaris
Venture Partners IV, L.P. or an Affiliated Entity (as defined in Section 8.2) thereof (“Polaris”), who shall initially be Amir Nashat (the “Polaris Director”); (ii) one person designated by Flagship
Ventures Fund 2004, L.P. or an Affiliated Entity thereof (“Flagship”), who shall initially be Noubar Afeyan (the “Flagship Director”); (iii) one person designated by ARCH Venture Fund VII, L.P.
(“ARCH”) or an Affiliated Entity thereof (the “ARCH Director”), which seat shall initially be vacant; (iv) one person designated by DHK Investments, LLC (“DHK”), who may only be David H.
Koch (“Koch”); (v) two directors each designated by a majority of the Founders, who shall initially be Omid Farokhzad and Robert S. Langer, Jr.; (vi) the person who shall serve from time to time as the chief
executive officer of the Company, initially Scott Minick; (vii) one person designated by RUSNANO, an open joint stock company organized and existing under the laws of the Russian Federation (“RUSNANO”), who must be either a
member of RUSNANO’s executive board or an experienced global pharmaceutical executive with predefined qualification requirements consistent with those applied in relation to the other members of the Board of Directors and who shall initially be
Yuriy Udaltsov (the “RUSNANO Director”) and (viii) two persons not otherwise Affiliates of the Company and designated by a majority of the other directors (the “Outside Directors”), one of whom shall initially
be Peter Barton Hutt, and the other of which seats shall initially be vacant; and 
 (c) remove any director at the request of
the party or parties entitled to designate such director. 
 For avoidance of doubt, DHK shall not be obligated to designate
Koch for election as a director. For so long as DHK shall have a right hereunder to designate Koch for election as a director, in the event that DHK shall not have so designated Koch for election, the seat on the Board of Directors of the Company
(the “Board of Directors”) that would otherwise be occupied by Koch shall remain vacant, and neither the Company nor any Stockholder shall take any action to fill such vacancy without the written authorization of DHK. 

For avoidance of doubt, ARCH shall not be obligated to designate a director. For so long as ARCH shall have a right hereunder to
designate a director, in the event that ARCH shall not have so designated any individual, the Board of Directors seat that would otherwise be occupied by an ARCH Director shall remain vacant, and neither the Company nor any Stockholder shall take
any action to fill such vacancy without the written authorization of ARCH. 
 Each director appointed pursuant to
Section 1.1(b)(i), Section 1.1(b)(ii), Section 1.1(b)(iii), Section 1.1(b)(iv) or Section 1.1(b)(vii) shall be referred to herein as a “Preferred Director” and collectively
as the “Preferred Directors.” 
 1.2 Observer Rights. 

(a) As long as NanoDimension L.P. (“NanoDimension”) holds not less than 500,000 shares of Common Stock (as defined
below) (including shares of Common Stock issuable upon conversion of Preferred Stock (as defined below)) subject to appropriate 

  
 2 

 
adjustment for all stock splits, dividends, combinations, recapitalizations and similar events, the Company shall (i) invite a representative of NanoDimension (the “NanoDimension
Observer”) to attend all meetings of its Board of Directors in a nonvoting observer capacity and (ii) shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors;
provided, however, that any such representative shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to
withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or
result in disclosure of trade secrets or a conflict of interest, or if such Stockholder or its representative is a competitor of the Company. 
 (b) If at any time prior to the termination of this Section 1, Polaris, Flagship, ARCH, DHK or RUSNANO shall (i) not have a designation right pursuant to Section 1.1 (or, in
the case of DHK, shall not have or shall not then be exercising its designation right pursuant to Section 1.1), and (ii) hold not less than 500,000 shares (or, in the case of DHK, 165,000 shares) of Common Stock (including shares of
Common Stock issuable upon conversion of Preferred Stock), subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalizations and similar events, the Company shall (A) invite a representative of such Stockholder
to attend all meetings of its Board of Directors in a nonvoting observer capacity and (B) give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that any such
representative shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude
such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or
a conflict of interest, or if such Stockholder or its representative is a competitor of the Company. 
 (c) As long as Peter
Doelger (“Doelger”) and Dimitris J. Bertsimas (“Bertismas”) collectively hold not less than 165,000 shares of Common Stock (including shares of Common Stock issuable upon conversion of Preferred Stock) subject
to appropriate adjustment for all stock splits, dividends, combinations, recapitalizations and similar events, the Company shall (i) invite a representative of such Stockholders to attend all meetings of its Board of Directors in a nonvoting
observer capacity, provided that such representative may only be Peter Doelger, and (ii) shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that any
such representative shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to
exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney­ client privilege between the Company and its counsel or result in disclosure of
trade secrets or a conflict of interest, or if such Stockholder or its representative is a competitor of the Company. 
 (d) As
long as Endeavour II L.P. (“Endeavour”), Gerald W. Blakeley, Jr. and Gerald W. Blakeley, III (collectively, “Blakeley”) and D2 Investment LLC (“D2 Investment”) collectively hold
not less than 165,000 shares of Common Stock (including 

  
 3 

 
shares of Common Stock issuable upon conversion of Preferred Stock) subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalizations and similar events, the
Company shall (i) invite a representative of Endeavour, Blakeley or D2 Investment (such representative to be designated for each meeting by Endeavour, Gerald W. Blakeley, III or D2 Investment in a rotating fashion) to attend each
meeting of its Board of Directors in a nonvoting observer capacity, and (ii) shall give Gerald W. Blakeley, Jr., Gerald W. Blakeley, III and the representatives of each of Endeavour and D2 Investment copies of all notices,
minutes, consents, and other materials that it provides to its directors; provided, however, that each such person shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided;
and provided further, that the Company reserves the right to withhold any information and to exclude any such person from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the
attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Stockholder or its representative is a competitor of the Company. 

1.3 CEO Director. In the event that the person serving pursuant to Section 1.1(b)(vi) above ceases to be Chief
Executive Officer of the Company, such person agrees to resign from the Board of Directors on the date such person ceases to be the Chief Executive Officer. 
 1.4 Compensation Committee. The Board of Directors shall appoint a Compensation Committee consisting of the Polaris Director, the Flagship Director, the ARCH Director, and one Outside Director to
determine compensation for the officers and directors of the Company, including option grants or other equity compensation. 

1.5 Voting Agreement Regarding Certain Other Matters. With respect to any action or failure to act which would require the
consent, affirmative vote, waiver, approval or execution of any instrument or agreement by stockholders or Purchasers holding a minimum specified portion of the outstanding shares of the Company’s Series C Convertible Preferred Stock, $0.0001
par value per share (the “Series C Preferred Stock”) (whether such requirement is set forth in the Certificate of Incorporation or the By-laws of the Company, in one or more agreements to which the Purchasers are parties, under
applicable law or otherwise) (each such specified portion, a “Series C Voting Threshold”), each of Doelger, the Doelger Family 2006 Trust FBO Emily M. Doelger, the Doelger Family 2006 Trust FBO Matthew Doelger and the Hee-Jean
Kim 2007 Trust (collectively, the “Doelger Group”) and Bertsimas agrees as follows: (i) with respect to any such action or failure to act for which affirmative votes, consents, waivers, approvals or executed instruments or
agreements, as the case may be, have been duly provided by Purchasers (excluding the Doelger Group and Bertsimas) holding such number of shares of capital stock as would, but for the fact that the shares of capital stock issued to the Doelger Group
and Bertsimas are issued and outstanding and held by any member of the Doelger Group or Bertsimas (and assuming that such shares of capital stock would not otherwise be outstanding), equal or exceed the applicable Series C Voting Threshold (each, a
“Trigger Amount”), each member of the Doelger Group and Bertsimas hereby agrees to vote its shares in favor of, or execute such consents, waivers, approvals, instruments or agreements, as applicable, as shall be necessary to permit
or effect, such action or failure to act, as the case may be, and (ii) with respect to any such action or failure to act for which the affirmative vote, waiver or approval has not been obtained from Purchasers (excluding the Doelger Group and
Bertsimas) 

  
 4 

 
holding the applicable Trigger Amount, each member of the Doelger Group and Bertsimas hereby agrees to refrain from voting its shares in favor of, and refrain from executing any consents,
waivers, approvals, instruments or agreements, as applicable, that would permit or effect such action or failure to act, as the case maybe. 
 1.6 Board of Directors and Internal Audit Commission of the Project Company. In any and all elections of directors or internal audit commission members of BIND (RUS) LLC, a controlled subsidiary of
the Company (the “Project Company”), whether at a meeting or by written consent in lieu of a meeting, the Company, as the controlling participant of the Project Company, shall vote or cause to be voted all shares of capital stock of
the Project Company owned by it, or over which it has voting control, so as to: 
 (a) fix the number of directors of the
Project Company at five (5). 
 (b) elect the following persons as directors of the Project Company: 

(i) prior to the purchase by a Co-Investor (as defined in the Purchase Agreement) of shares of Series BRN Preferred pursuant to the
Purchase Agreement, two (2) directors designated by RUSNANO, who shall initially be Vasiliy Kostyanovskiy and Leysan Shaydullina; 
 (ii) from and after the purchase by a Co-Investor of shares of Series BRN Preferred pursuant to the Purchase Agreement, one (1) director designated by RUSNANO and, for so long as a Co-Investor holds
and has sole beneficial ownership of all of the shares of Series BRN Preferred Stock purchased by it under the Purchase Agreement, one (1) director designated by the Co-Investor; and 

(iii) three (3) directors designated by the Board of Directors, who shall initially be Jeff Hrkach, Scott Minick and Robert Rosen.

 (c) appoint or cause to be appointed one of the directors designated pursuant to Section 1.6(b)(iii) as the
Chairperson of each board meeting of the Project Company. 
 (d) appoint or cause to be appointed one of the directors
designated by RUSNANO pursuant to Sections 1.6(b)(i) or 1.6(b)(ii) as the Secretary of each board meeting of the Project Company at which an action requiring the unanimous consent of the directors of the Project Company is taken.

 (e) appoint or cause to be appointed to the internal audit commission of the Project Company one (1) nominee designated
by RUSNANO, provided that such nominee shall not be a member of the board of directors of the Project Company. 
 (f) appoint
or cause to be appointed to the internal audit commission of the Project Company two (2) nominees designated by the Board of Directors, provided that such nominees shall not be members of the board of directors of the Project Company.

 (g) remove any director of the Project Company at the request of the party or parties entitled to designate such director
pursuant to Section 1.6(b) above. 

  
 5 

 (h) Notwithstanding anything to the contrary herein, this Section 1.6 shall
terminate and be of no further force and effect on the earliest date on which RUSNANO (or a controlled affiliate that is a permitted transferee pursuant to Section 8.3) no longer holds and has sole beneficial ownership of all of the
shares of Series BRN Preferred Stock purchased by it under the Purchase Agreement, whether as a result of any transfer, sale, conversion or redemption or otherwise. 
 2. Shares. “Shares” shall mean and include any and all shares of (i) the Company’s common stock, $0.0001 par value per share (the “Common Stock”),
(ii) the Company’s Series A Convertible Preferred Stock, $0.0001 par value per share (the “Series A Preferred Stock”), the Company’s Series B Convertible Preferred Stock, $0.0001 par value per share (the
“Series B Preferred Stock”), the Series C Preferred Stock, the Company’s Series C-1 Convertible Preferred Stock, $0.0001 par value per share (the “Series C-1 Preferred Stock”), and the Series D Preferred Stock
(collectively, the “Preferred Stock”), (iii) the Series BRN Preferred Stock and (iv) any other series and classes of capital stock of the Company, by whatever name called, which carry voting rights (including voting rights
which arise by reason of default) and shall include any such shares now owned or subsequently acquired by a Stockholder, however acquired, including in connection with stock splits, stock dividends, and the exercise of options or conversion or
exchange of convertible securities. 
 3. Drag-Along Right. 

3.1 Definitions. A “Sale of the Company” shall mean either: (a) a transaction or series of related
transactions in which a person, or a group of related persons, acquires from stockholders of the Company shares representing more than fifty percent (50%) of the outstanding voting power of the Company (a “Stock Sale”); or
(b) a transaction or series of related transactions regarded as a liquidation, dissolution or winding up of the affairs of the Company under Section 3.2 of Article Fourth of the Company’s Certificate of Incorporation, as may be
amended from time to time (the “Company Charter” and such transaction or series of related transactions, a “Liquidation Event”)). 
 3.2 Actions to be Taken. In the event that: (i) the holders of at least sixty percent (60%) of the shares of Common Stock then issued or issuable upon conversion of the shares of
Preferred Stock, voting together as a single class, and (ii) the holders of at least sixty percent (60%) of the then outstanding shares of Common Stock (collectively, the “Selling Stockholders”) approve a Sale of the
Company in writing, specifying that this Section 3 shall apply to such transaction, then each Stockholder hereby agrees: 
 (a) if such transaction requires stockholder approval, with respect to all Shares that such Stockholder owns or over which such Stockholder otherwise exercises voting power, to vote (in person, by proxy
or by action by written consent, as applicable) all such Shares in favor of, and adopt, such Sale of the Company (together with any related amendment to the Company Charter required in order to implement such Sale of the Company) and to vote in
opposition to any and all other proposals that could reasonably be expected to delay or impair the ability of the Company to consummate such Sale of the Company; 

  
 6 

 (b) if such transaction is a Stock Sale, to sell the same proportion of Shares beneficially
held by such Stockholder as is being sold by the Selling Stockholders to the person to whom the Selling Stockholders propose to sell their Shares, and, except as permitted in Section 3.3 below, on the same terms and conditions as the
Selling Stockholders; 
 (c) to execute and deliver all related documentation and take such other action in support of the Sale
of the Company as shall reasonably be requested by the Company or the Selling Stockholders in order to carry out the terms and provision of this Section 3, including without limitation executing and delivering instruments of conveyance
and transfer, and any purchase agreement, merger agreement, indemnity agreement, escrow agreement, consent, waiver, governmental filing, share certificates duly endorsed for transfer (free and clear of impermissible liens, claims and encumbrances)
and any similar or related documents; 
 (d) not to deposit, and to cause their Affiliated Entities not to deposit, except as
provided in this Agreement, any Shares owned by such party or Affiliate in a voting trust or subject any Shares to any arrangement or agreement with respect to the voting of such Shares, unless specifically requested to do so by the acquiror in
connection with the Sale of the Company; 
 (e) to refrain from exercising any dissenters’ rights or rights of appraisal
under applicable law at any time with respect to such Sale of the Company; and 
 (f) if the consideration to be paid in
exchange for the Shares pursuant to this Section 3 includes any securities and due receipt thereof by any Stockholder would require under applicable law (i) the registration or qualification of such securities or of any person as a
broker or dealer or agent with respect to such securities or (ii) the provision to any Stockholder of any information other than such information as a prudent issuer would generally furnish in an offering made solely to “accredited
investors” as defined in Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”), the Company may cause to be paid to any such Stockholder in lieu thereof, against surrender of the Shares which
would have otherwise been sold by such Stockholder, an amount in cash equal to the fair value (as determined in good faith by the Company) of the securities which such Stockholder would otherwise receive as of the date of the issuance of such
securities in exchange for the Shares. 
 3.3 Exceptions. Notwithstanding the foregoing, a Stockholder will not be
required to comply with Section 3.2 above in connection with any proposed Sale of the Company (the “Proposed Sale”) unless: 
 (a) any representations and warranties to be made by such Stockholder in connection with the Proposed Sale are limited to representations and warranties related to authority, ownership and the ability to
convey title to such Shares, including but not limited to representations and warranties that (i) the Stockholder holds all right, title and interest in and to the Shares such Stockholder purports to hold, free and clear of all liens and
encumbrances, (ii) the obligations of the Stockholder in connection with the transaction have been duly authorized, if applicable, (iii) the documents to be entered into by the Stockholder have been duly executed by the Stockholder and
delivered to the acquirer and are enforceable against the 

  
 7 

 
Stockholder in accordance with their respective terms and (iv) neither the execution and delivery of documents to be entered into in connection with the transaction, nor the performance of
the Stockholder’s obligations thereunder, will cause a breach or violation of the terms of any agreement, law or judgment, order or decree of any court or governmental agency; 

(b) the Stockholder shall not be liable for the inaccuracy of any representation or warranty made by any other person in connection with
the Proposed Sale, other than the Company (except to the extent that funds may be paid out of an escrow established to cover breach of representations, warranties and covenants of the Company as well as breach by any stockholder of any of identical
representations, warranties and covenants provided by all stockholders); 
 (c) the liability for indemnification, if any, of
such Stockholder in the Proposed Sale and for the inaccuracy of any representations and warranties made by the Company in connection with such Proposed Sale, is several and not joint with any other person or entity (except to the extent that funds
may be paid out of an escrow established to cover breach of representations, warranties and covenants of the Company as well as breach by any stockholder of any of identical representations, warranties and covenants provided by all stockholders),
and is pro rata in proportion to the amount of consideration paid to such Stockholder in connection with such Proposed Sale (in accordance with the provisions of the Company Charter); 

(d) liability shall be limited to such Stockholder’s applicable share (determined based on the respective proceeds payable to each
Stockholder in connection with such Proposed Sale in accordance with the provisions of the Company Charter) of a negotiated aggregate indemnification amount that applies equally to all Stockholders but that in no event exceeds the amount of
consideration otherwise payable to such Stockholder in connection with such Proposed Sale, except with respect to claims related to fraud by such Stockholder, the liability for which need not be limited as to such Stockholder; 

(e) upon the consummation of the Proposed Sale, (i) each holder of each class or series of the Company’s stock will receive
the same form of consideration for their shares of such class or series as is received by other holders in respect of their shares of such same class or series of stock, (ii) each holder of a series of Preferred Stock will receive the same
amount of consideration per share of such series of Preferred Stock as is received by other holders in respect of their shares of such same series, (iii) each holder of Series BRN Preferred Stock will receive the same amount of consideration
per share of such series as is received by other holders in respect of their shares of such same series, (iv) each holder of Common Stock will receive the same amount of consideration per share of Common Stock as is received by other holders in
respect of their shares of Common Stock, and (v) the aggregate consideration receivable by all holders of the Preferred Stock and Common Stock shall be allocated among the holders of Preferred Stock and Common Stock on the basis of the relative
liquidation preferences to which the holders of each respective series of Preferred Stock and the holders of Common Stock are entitled in a liquidation, dissolution or winding up of the affairs of the Company (assuming for this purpose that the
Proposed Sale is a liquidation, dissolution or winding up of the affairs of the Company) in accordance with the Company Charter in effect immediately prior to the Proposed Sale; and 

  
 8 

 (f) subject to clause (e) above, requiring the same form of consideration to be
available to the holders of any single class or series of capital stock, and if any holders of any capital stock of the Company are given an option as to the form and amount of consideration to be received as a result of the Proposed Sale, all
holders of such capital stock will be given the same option. 
 4. Manner of Voting. The voting of Shares pursuant to
this Agreement may be effected in person, by proxy, by written consent or in any other manner permitted by applicable law. 
 5.
Termination. Sections 1, 3 and 4 of this Agreement shall terminate in their entirety on the earliest to occur of (i) the closing of the Company’s first public offering pursuant to a registration statement under
the Act (an “IPO”), (ii) the closing of a Sale of the Company, or (iii) such time as less than 2,200,000 shares of Preferred Stock remain outstanding, subject to appropriate adjustment for all stock splits, dividends,
combinations, recapitalizations and similar events. 
 6. No Revocation. The voting agreements contained herein are
coupled with an interest and may not be revoked, except by an amendment, modification or termination effected in accordance with Section 12.5 hereof. Nothing in this Section 6 shall be construed as limiting the provisions of
Section 5 or 12.5 hereof. 
 7. Restrictive Legend. All certificates representing Shares owned or
hereafter acquired by the Stockholders or any transferee of the Stockholders bound by this Agreement shall have affixed thereto a legend substantially in the following form: 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A VOTING AGREEMENT, AS AMENDED FROM TIME TO TIME, BY AND AMONG THE REGISTERED OWNER OF THIS CERTIFICATE, THE COMPANY AND CERTAIN OTHER
STOCKHOLDERS OF THE COMPANY. THE COMPANY WILL FURNISH A COPY OF THIS AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE UPON WRITTEN REQUEST. 
 8. Transfers of Rights. 
 8.1 Any transferee to whom Shares are transferred
by a Stockholder, whether voluntarily or by operation of law, shall be bound by the obligations imposed upon the transferor under this Agreement, to the same extent as if such transferee were a Stockholder hereunder, and no Stockholder shall
transfer any Shares unless the transferee agrees in writing to be bound by this Agreement. 
 8.2 Notwithstanding anything to
the contrary herein, any Purchaser (other than RUSNANO) which is a partnership, limited liability company or joint stock company may transfer rights granted to such Purchaser hereunder to any partner, affiliated fund or member thereof, or to any
entity or person that controls, or is controlled by, or is under common control with, such Purchaser (an “Affiliate” or “Affiliated Entity”) to which Shares are transferred and which delivers to the Company a
written instrument in accordance with Section 8.1. In the event 

  
 9 

 
of such transfer, such Affiliated Entity shall be deemed a Purchaser and may again transfer such rights to any other person or entity that acquires Shares in accordance with, and subject to, the
provisions of this Section 8. 
 8.3 Notwithstanding anything to the contrary herein, RUSNANO may transfer all, but
not less than all, rights granted to RUSNANO hereunder to any entity that is controlled by RUSNANO, an open joint stock company organized and existing under the laws of the Russian Federation, to which all Shares held by RUSNANO are transferred and
which delivers to the Company a written instrument in accordance with Section 8.1; in the event of such transfer, such transferee shall be deemed a “Purchaser” and “RUSNANO” hereunder and may again transfer such
rights to any other entity controlled by RUSNANO, an open joint stock company organized and existing under the laws of the Russian Federation, that acquires all such Shares and rights in accordance with, and subject to, the provisions of this
Section 8. 
 9. Reimbursement of Expenses. The Company shall pay the reasonable out-of-pocket expenses of
all the directors (other than directors who are employees of the Company, who shall be reimbursed in accordance with the Company’s employee travel policies) and any Board of Directors observers appointed pursuant to Section 1.2 in
attending meetings of the Board of Directors and committees thereof (including travel, room and board). 
 10. Call
Option. Provided that there is no unremedied KPI Failure (as defined in the Purchase Agreement) with respect to any Additional Closing (as defined in the Purchase Agreement), the Company shall have the right to require each holder of outstanding
shares of Series BRN Preferred Stock to sell to the Company all (but not less than all) of its shares of Series BRN Preferred Stock (the “Call Option”) under the following terms and conditions: 

10.1 At any time on or after the fourth (4th) anniversary of the Initial Closing Date (as defined in the Purchase Agreement), the Company shall have the right
to exercise the Call Option in the manner set forth in Section 10.3 below at a per share purchase price equal to an amount that would yield a twenty percent (20%) internal rate of return on the original purchase price paid by such
holder for the shares of Series BRN Preferred Stock subject to the Call Option (the “IRR Exercise Price”). For purposes hereof, “internal rate of return” means the discount rate at which the net present value of the
Original Issue Price (as defined in the Company Charter) of the Series BRN Preferred Stock is equal to the net present value of the purchase price to be paid upon exercise of the Call Option and all dividends paid with respect to a share of Series
BRN Preferred from the original date of issuance and shall be calculated using the XIRR function in the most recent version of Microsoft Excel (or if such program is no longer available, such other software program for calculating IRR reasonably
proposed by the Company). 
 10.2 At any time after any holder of Series BRN Preferred Stock: 

(a) fails to purchase the minimum number of shares such holder is required to purchase at any Additional Closing (excluding, for the
avoidance of doubt, any purchase of Second Closing Remaining Shares, Third Closing Remaining Shares or Fourth Closing Remaining Shares (as each such term is defined in the Purchase Agreement)) after the satisfaction or waiver of the conditions set
forth in Section 4.2 of the Purchase Agreement (other than Section 4.2(e) of the Purchase Agreement) in accordance with the Purchase Agreement other than due to (i) a KPI Failure, (ii) an IPO or (iii) the closing of a Sale
of the Company; or 

  
 10 

 (b) breaches any of its material obligations under the Financing Agreements (as defined in
the Purchase Agreement) (including, for example, failing to assign ownership of any inventions made within the Project Company to the Company or failing to convert its shares of Series BRN Preferred Stock in accordance with the Company Charter),
which breach remains uncured for a period of thirty (30) days after such breach and provided, however, that the Company is not then itself in breach of its obligations under the applicable Financing Agreement(s); 

the Company shall have the right to exercise the Call Option at any time within two (2) months of such failure to purchase or breach (provided that
such two (2) month period shall commence on the date of delivery of written notice of such breach) with respect to all of the shares of Series BRN Preferred Stock held by such holder as of immediately prior to such failure to purchase or breach
or as of the date of the Exercise Notice (whichever is greater), at a per share purchase price of $6.00 (as adjusted for all stock splits, dividends, combinations, recapitalizations and the like affecting the Series BRN Preferred Stock) (the
“Minimum Exercise Price” and together with the IRR Exercise Price, the “Exercise Price”). 

10.3 If, at any time after the Initial Closing Date, a statute, rule, regulation, order, or interpretation shall have been enacted,
entered or deemed applicable by any domestic or foreign government or governmental or administrative agency or court which would make the transactions contemplated by the Purchase Agreement or the other Financing Agreements illegal and each of the
conditions to the obligations of RUSNANO and any Co-Investor set forth in Sections 4.2(a), (b), (c) and (d) of the Purchase Agreement, if applicable, have been satisfied, the Company shall have the right to exercise the Call Option in the
manner set forth in Section 10.4 below at a per share purchase price equal to the Minimum Exercise Price 
 10.4 The
Call Option shall be exercisable by the Company only by delivery of a written exercise notice stating the applicable Exercise Price (the “Exercise Notice”) to the holders of the Series BRN Preferred Stock. Upon delivery of an
Exercise Notice, the holders of the Series BRN Preferred Stock shall be obligated to sell all but not less than all of their shares of Series BRN Preferred Stock (and to promptly deliver any certificates representing the same, duly endorsed or
accompanied by an executed stock power) to the Company, and the Company shall be obligated to purchase such shares from the holders of the Series BRN Preferred Stock, in the manner and at the price contemplated in this Section 10. On a
date (the “Settlement Date”) that is within ten (10) business days after receipt of an Exercise Notice, the Company shall pay to the relevant holder the applicable Exercise Price determined in accordance with Sections
10.1, 10.2 or 10.3. Such payment may be effected in cash or by certified or official bank check or wire transfer to an account designated by the holders of the Series BRN Preferred Stock in writing. 

11. Series BRN Preferred Stock Voting Right. For so long as RUSNANO (or a controlled affiliate that is a permitted transferee
pursuant to Section 8.3) owns of record and beneficially all of the shares of Series BRN Preferred Stock purchased by RUSNANO under the Purchase Agreement, with respect to any action or failure to act which would require the consent,
affirmative vote, waiver, approval or execution of any instrument or agreement by the 

  
 11 

 
holders of a minimum specified portion of the outstanding shares of the Company’s Series BRN Preferred Stock (excluding, for the avoidance of doubt, any other shares of capital stock of the
Company), including, for the avoidance of doubt, the exercise of the redemption right set forth in Section 3.5 of the Company Charter, other than with respect to (a) the right to designate a director as set forth in
Section 1.6(b) (whether such requirement is set forth in the Company Charter, in this Agreement or in one or more of the other Financing Agreements), each holder of shares of Series BRN Preferred Stock agrees as follows: (i) with
respect to any such action or failure to act for which affirmative votes, consents, waivers, approvals or executed instruments or agreements, as the case may be, have been duly provided by RUSNANO, each such holder of the Series BRN Preferred Stock
hereby agrees to vote its shares of the Series BRN Preferred Stock in favor of, or execute such consents, waivers, approvals, instruments or agreements, as applicable, as shall be necessary to permit or effect, such action or failure to act, as the
case may be, in the same manner as RUSNANO and (ii) with respect to any such action or failure to act for which the affirmative vote, waiver or approval has not been obtained from RUSNANO, each such holder hereby agrees to refrain from voting
its shares of Series BRN Preferred Stock in favor of, and refrain from executing any consents, waivers, approvals, instruments or agreements, as applicable, that would permit or effect such action or failure to act, as the case may be. For the
avoidance of doubt, this Section 11 shall not apply to any person or entity, other than a holder of shares of Series BRN Preferred Stock. No amendment or modification of, or waiver under, this Section 11 shall be valid unless
in writing and signed by the Company and each Purchaser holding shares of Series BRN Preferred Stock. 
 12. General.

 12.1 Severability. The provisions of this Agreement are severable, so that the invalidity or unenforceability of any
provision of this Agreement shall not affect the validity or enforceability of any other term or provision of this Agreement, which shall remain in full force and effect. 
 12.2 Specific Performance. In addition to any and all other remedies that may be available at law in the event of any breach of this Agreement, each party hereto shall be entitled to specific
performance of the agreements and obligations of any other party hereto hereunder and to such other injunctive or other equitable relief as may be granted by a court of competent jurisdiction. 

12.3 Governing Law. This Agreement shall be governed by, and construed and enforced in accordance with, the General Corporation
Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by, and construed and enforced in accordance with, the internal laws of the State of New York, without regard to conflict of law
principles that would result in the application of any law other than the law of the State of New York. 

  
 12 

 12.4 Notices. All notices, requests, consents, and other communications under this
Agreement shall be in writing and shall be deemed delivered (a) for notices sent by the Company to addressees within the United States, two (2) business days after being sent by registered or certified mail, return receipt requested,
postage prepaid, (b) three (3) business days after being sent via a reputable international courier service with expedited delivery, in each case to the intended recipient as set forth below, or (c) immediately upon being sent by
facsimile, provided that the sender receives electronic confirmation of delivery, or electronic mail: 
 If to the Company:

 BIND Biosciences, Inc. 
 64 Sidney Street 
 Cambridge, Massachusetts 02139 

Attn: President 

Fax: 617-491-0351 
 E-mail: scottminick@bindbio.com 
 with a copy to: 

Peter N. Handrinos, Esquire 
 Latham & Watkins LLP 
 John Hancock Tower 

200 Clarendon Street, 20th Floor 
 Boston, Massachusetts 02116 
 Fax: 617-948-6001 

E-mail: peter.handrinos@lw.com 
 (i) If to a Purchaser, at its address set forth in Schedule A hereto, or at such other address as may have been furnished to the other parties hereto in writing by such Purchaser; 

(ii) If to an Other Stockholder, at its address set forth in Schedule C hereto, or at such other address as may have been
furnished to the other parties hereto in writing by such Other Stockholder; and 
 (iii) If to a Founder or Executive Officer,
at the Company or at such other address or addresses as may have been furnished to the other parties hereto in writing by such Founder. 
 Any party may give any notice, request, consent or other communication under this Agreement using any other means (including, without limitation, personal delivery, messenger service, first class mail or
electronic mail), but no such notice, request, consent or other communication shall be deemed to have been duly given unless and until it is actually received by the party for whom it is intended. Any party may change the address to which notices,
requests, consents or other communications hereunder are to be delivered by giving the other parties notice in the manner set forth in this Section 12.4. 
 12.5 Complete Agreement; Amendments. This Agreement constitutes the entire agreement and understanding of the parties hereto with respect to the subject matter hereof, and supersedes all prior
agreements and understandings relating to such subject matter, including the Former Voting Agreement. No amendment, modification or termination of, or waiver under any provision of this Agreement shall be valid unless in writing and signed by (i)

  
 13 

 
the Company, (ii) the Founders holding shares representing a majority of the voting power of the Shares then held by all of the Founders, provided that, for purposes of this provision, the
Shares held by the trusts listed on Schedule C hereto shall be included in the calculation of Shares held by their respective settlors and (iii) Purchasers holding shares (other than Series BRN Preferred Stock) representing at least
sixty-five percent (65%) of the voting power of the Shares (other than shares of Series BRN Preferred Stock) then held by all of the Purchasers, and any such amendment, modification, termination or waiver shall be binding on all parties hereto;
provided that any such waiver or amendment which materially and adversely affects the rights, privileges, duties or obligations of a Purchaser in a manner materially different than those of all other Purchasers shall not be effective against such
affected Purchaser without the written consent of such affected Purchaser. Notwithstanding anything to the contrary herein, this Agreement may be amended by the Company without the consent of any of the other parties hereto to add as a party hereto
and include information regarding and otherwise accommodate an additional purchaser of shares of Series D Preferred Stock or Series BRN Preferred Stock (including a Co-Investor) pursuant to the Purchase Agreement, as may be amended from time to
time; provided that any such amendment does not materially and adversely affect the rights of any Purchaser under this Agreement (it being agreed that the issuance of additional shares of capital stock in accordance with the Purchase Agreement, as
may be amended or modified from time to time in accordance with its terms, and the other Financing Documents, each as may be amended or modified from time to time in accordance with its respective terms, shall not be deemed to affect the Purchasers
under this Agreement). Notwithstanding the foregoing, no amendment, modification or waiver under this Agreement shall be made: 

(a) affecting the obligation of the Stockholders to elect the Polaris Director without the written consent of Polaris so long as Polaris
holds at least ten percent (10%) of all outstanding shares of the Company’s preferred stock (including Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock, Series D Preferred Stock and
any subsequently issued class or series of preferred stock), other than the Series BRN Preferred Stock or any shares issued in the circumstances specified in Article Fourth, Section 3.3(f)(i)(4)(A)-(I) of the Company Charter, on an
as­converted-to-Common Stock basis (the “10% Threshold”); 
 (b) affecting the obligation of the
Stockholders to elect the Flagship Director without the written consent of Flagship so long as Flagship holds at least the 10% Threshold; 
 (c) affecting the obligation of the Stockholders to elect the ARCH Director without the written consent of ARCH so long as ARCH holds at least the 10% Threshold; 

(d) affecting the obligation of the Stockholders to elect Koch to the Board of Directors without the written consent of DHK so long as
DHK holds at least six percent (6%) of the sum of: the total number of shares of Common Stock then outstanding plus the number of shares of Common Stock issuable upon conversion or exchange of then outstanding Preferred Stock or other
convertible securities or exercise of then outstanding options, rights or warrants (but not including any shares issued in the circumstances specified in Article Fourth, Section 3.3(f)(i)(4)(A)-(I) of the Company Charter) on an
as-converted-to-Common Stock basis (the “Fully Diluted Shares”); 

  
 14 

 (e) affecting NanoDimension’s rights set forth in Section 1.2(a) with
respect to the NanoDimension Observer without the written consent of NanoDimension; 
 (f) affecting DHK’s rights set
forth in Section 1.2(b) without the written consent of DHK; 
 (g) affecting the rights of Doelger and Bertsimas
set forth in Section 1.2(c) without the written consent of Doelger, for so long as such Stockholders collectively hold at least four and two-tenths percent (4.2%) of the Fully Diluted Shares of the Company; 

(h) affecting the rights of Endeavour, Gerald W. Blakeley, Jr., Gerald W. Blakeley, III or D2 Investment set forth
in Section 1.2(d) without the written consent of Endeavour, Blakeley and D2 Investment, for so long as such Stockholders collectively hold at least four and two-tenths percent (4.2%) of the Fully Diluted Shares of the Company;

 (i) affecting the obligation of the Stockholders to elect the RUSNANO Director without the written consent of RUSNANO so
long as RUSNANO (or a controlled affiliate that is a permitted transferee pursuant to Section 8.3) holds at least ten percent (10%) of all outstanding shares of the Company’s preferred stock (including Series A Preferred Stock,
Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock, Series D Preferred Stock, Series BRN Preferred Stock and any subsequently issued class or series of preferred stock), or any shares issued in the circumstances specified
in Article Fourth, Section 3.3(f)(i)(4)(A)-(I) of the Company Charter, on an as-converted-to-Common Stock basis; 
 (j) to Section 11 except as specifically provided therein; or 
 (k)
without the written consent of all of the holders who would be required to exercise the drag-along right in accordance with Section 3.2, if such amendment, modification or waiver would change the voting thresholds set forth in
Section 3.2. 
 12.6 Construction. A reference to a Section or Schedule shall mean a Section in or Schedule
to this Agreement unless otherwise expressly stated. The titles and headings herein are for reference purposes only and shall not in any manner limit the construction of this Agreement which shall be considered as a whole. The words
“include,” “includes” and “including” when used herein shall be deemed in each case to be followed by the words “without limitation.” Whenever the context may require, any pronouns used herein shall include
the corresponding masculine, feminine or neuter forms, and the singular form of names and pronouns shall include the plural and vice-versa. 
 12.7 Counterparts; Facsimile Signatures. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, and all of which together shall constitute
one and the same document. This Agreement may be executed by facsimile signatures. 

  
 15 

 12.8 Additional Purchasers. Notwithstanding Section 12.5, any person or
entity that purchases Series BRN Preferred Stock as a Co-Investor (as defined in the Purchase Agreement) under the Purchase Agreement shall become a party to this Agreement by executing and delivering to the Company a counterpart signature page to
this Agreement, and thereupon shall be deemed a “Purchaser” for all purposes of this Agreement, and the Company shall amend Schedule A hereto to add the name and address of such Purchaser. No such accession instrument shall be
effective unless and until accepted in writing by the Company. Except as required by the preceding sentence, no action or consent by the Purchasers, Founders, Executive Officers or Other Stockholders shall be required for such joinder to this
Agreement by such Co-Investor or any aforesaid amendment of Schedule A, so long as such Co-Investor has agreed in writing to be bound by all of the obligations as an “Purchaser” hereunder. 

12.9 Additional Common Holders. In the event that after the date of this Agreement, the Company issues shares of capital stock to
any employee or consultant, which shares constitute two percent (2%) or more of the Company’s then outstanding capital stock (treating for this purpose all shares of Common Stock issuable upon exercise of or conversion of outstanding
options, warrants or convertible securities, as if exercised or converted), the Company shall use its best efforts to cause such person to execute a counterpart signature page hereto as a “Stockholder”, and such person shall thereby be
bound by, and subject to, all the terms and provisions of this Agreement applicable to a Stockholder. In addition, with the consent of the Company, any other Stockholder may become a party to this Agreement as an “Other Stockholder” by
executing and delivering a counterpart signature page hereto to the Company, and such person shall thereby be bound by, and subject to, all the terms and provisions of this Agreement applicable to an Other Stockholder; provided that no such joinder
shall be effective unless and until accepted in writing by the Company. No action or consent by the other parties to this Agreement shall be required for such joinder to this Agreement by such additional Other Stockholder, and upon any such joinder,
the Company shall update Schedule C hereto to reflect the addition of such Other Stockholder as a party hereto. 
 12.10
Additional Shares. Each Stockholder agrees to vote all of the shares it holds, in whatever manner shall be necessary to authorize an increase in the authorized capital stock of the Company so that there will be sufficient shares of Common
Stock available for conversion of all of the then-outstanding shares of Preferred Stock and Series BRN Preferred Stock at any time that an adjustment to the applicable Conversion Price (as defined in the Company Charter) is made pursuant to
Article Fourth, Section 3.3(f)(iv) of the Company Charter. 
 12.11 Amended and Restated Agreement. All
provisions of, rights granted and covenants made in the Former Voting Agreement are hereby superseded in their entirety and shall have no further force or effect. Each of the Founders and the Prior Purchasers acknowledge and agree that the execution
and delivery by the Company of this Agreement, the Purchase Agreement and the additional Financing Agreements and the performance by the Company of its obligations thereunder do not constitute a default under the provisions of the Former Voting
Agreement. 
 12.12 Dispute Resolution. Any dispute, controversy or claim arising out of or relating to this Agreement,
including its existence, validity, interpretation, performance, non-performance, 

  
 16 

 
breach or termination (collectively, the “Dispute”) shall be finally settled under the Rules of Arbitration of the International Chamber of Commerce (the “ICC
Rules”), except as they may be modified herein or by mutual agreement of the parties. The Dispute shall be resolved by three (3) arbitrators appointed in the following manner: each party shall nominate an arbitrator for
confirmation as provided in the ICC Rules and following their confirmation, the third arbitrator shall be appointed by the International Court of Arbitration of the International Chamber of Commerce; provided, however, that at least one (1) of
such arbitrators shall have substantive expertise in the pharmaceutical industry. The place of arbitration shall be New York, New York. The language of the arbitration shall be English. The tribunal shall determine the proportion of
the costs of the arbitration which each party shall bear. The award shall be final, conclusive and binding upon the parties hereto. Judgment upon the award may be entered by any court having jurisdiction thereof or having jurisdiction over
the relevant party or its assets. 
 [Remainder of page intentionally left blank.] 

  
 17 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated Voting
Agreement as an instrument under seal as of the date first above written. 
  

							
	COMPANY:	 		 	BIND BIOSCIENCES, INC.
				
		 		 	By:	 	 /s/ Scott Minick

		 		 		 	Scott Minick
		 		 		 	President and Chief Executive Officer
			
	FOUNDERS:	 		 	 /s/ Omid Farokhzad

		 		 	Omid Farokhzad
			
		 		 	  

		 		 	Paul Goldenheim
			
		 		 	 /s/ Robert S. Langer, Jr.

		 		 	Robert S. Langer, Jr.
			
	EXECUTIVE OFFICERS:	 		 	 /s/ Scott Minick

		 		 	Scott Minick

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASERS:	 	POLARIS VENTURE PARTNERS V, L.P.
		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
				
		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 	William E. Bilodeau
		 		 		 	Attorney-in-fact
		
		 	POLARIS VENTURE PARTNERS ENTREPRENEURS’ FUND V, L.P.
			
		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
				
		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 	William E. Bilodeau
		 		 		 	Attorney-in-fact
		
		 	POLARIS VENTURE PARTNERS FOUNDERS’ FUND V, L.P.
			
		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
				
		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 	William E. Bilodeau
		 		 		 	Attorney-in-fact
		
		 	POLARIS VENTURE PARTNERS SPECIAL FOUNDERS’ FUND V, L.P.
			
		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
				
		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 	William E. Bilodeau
		 		 		 	Attorney-in-fact

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 	FLAGSHIP VENTURES FUND 2004, L.P.
			
		 	By:	 	FLAGSHIP VENTURES GENERAL PARTNER LLC, its General Partner
				
		 		 	By:	 	 /s/ Noubar Afeyan

		 		 		 	Noubar Afeyan
		 		 		 	Managing Partner and CEO

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	ARCH VENTURE FUND VII, L.P.
				
		 		 	By:	 	ARCH VENTURE PARTNERS VII, L.P.
		 		 	Its:	 	General Partner
				
		 		 	By:	 	ARCH VENTURE PARTNERS VII, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Clinton W. Bybee

		 		 	Its:	 	Managing Director

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	NANODIMENSION, L.P.
				
		 		 	By:	 	NanoDimension Management Limited, its General Partner
				
		 		 	By:	 	 /s/ Jonathan Nicholson

		 		 		 	Jonathan Nicholson, Director

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	DHK INVESTMENTS, LLC
				
		 		 	By:	 	 /s/ David H. Koch

		 		 		 	David H. Koch
		 		 		 	Manager

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	
				
		 		 		 	 /s/ Peter W. Doelger

		 		 		 	Peter W. Doelger

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	DOELGER FAMILY 2006 TRUST
		 		 		 	FBO EMILY M. DOELGER
				
		 		 		 	 /s/ Bruce A. Haverberg

		 		 		 	Bruce A. Haverberg, Trustee
				
		 		 		 	DOELGER FAMILY 2006 TRUST
		 		 		 	FBO MATTHEW DOELGER
				
		 		 		 	 /s/ Bruce A. Haverberg

		 		 		 	Bruce A. Haverberg, Trustee
				
		 		 		 	HEE-JEAN KIM 2007 TRUST
				
		 		 		 	 /s/ Bruce A. Haverberg

		 		 		 	Bruce A. Haverberg, Trustee

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	
				
		 		 		 	 /s/ Dimitris Bertsimas

		 		 		 	Dimitris Bertsimas

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	ENDEAVOUR II L.P.
				
		 		 	By:	 	ENDEAVOUR PARTNERS GP LIMITED
		 		 		 	its General Partner
				
		 		 	By:	 	 /s/ John Bridle

		 		 		 	Name: John Bridle
		 		 		 	Title:   Director

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	
				
		 		 		 	 /s/ Gerald W. Blakeley, Jr.

		 		 		 	Gerald W. Blakeley, Jr.

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	
				
		 		 		 	 /s/ Gerald W. Blakeley, III

		 		 		 	Gerald W. Blakeley, III

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	D2 INVESTMENT LLC
				
		 		 	By:	 	 /s/ Chris Kryder

		 		 		 	Chris Kryder
		 		 		 	Manager

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	
				
		 		 		 	 /s/ Peter T. Scardino

		 		 		 	Peter T. Scardino

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	
				
		 		 		 	 /s/ Edwin Darracott Vaughan, Jr.

		 		 		 	Edwin Darracott Vaughan, Jr.

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	JOHN T. CONNOR JR. AND SUSAN SCHOLLE CONNOR, tenants by the entirety
				
		 		 		 	 /s/ John T. Connor Jr.

		 		 		 	John T. Connor Jr.
				
		 		 		 	 /s/ Susan Scholle Connor

		 		 		 	Susan Scholle Connor

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	
				
		 		 		 	 /s/ Jeffrey B. Larson

		 		 		 	Jeffrey B. Larson

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	
				
		 		 		 	 /s/ Megan Kelleher

		 		 		 	Megan Kelleher

 Signature Page to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	RUSNANO
		 		 	an open joint stock company organized and existing under the laws of the Russian Federation
				
		 		 	By:	 	 /s/ Andrey Malyshev

		 		 	Name:	 	Andrey Malyshev
		 		 	Title:	 	Deputy Chairman of the Management Board

 Signature Page to Fourth Amended and Restated Voting Agreement 

 SCHEDULE A 
 Names and Addresses of Purchasers 

 

	
	Polaris Venture Partners V, L.P.
	1000 Winter Street, Suite 3350
	Waltham, MA 02451
	Attn: Amir H. Nashat
	Fax: 781.290.0880
	  
 Polaris Venture
Partners
Entrepreneurs’ Fund V, L.P.

	1000 Winter Street, Suite 3350
	Waltham, MA 02451
	Attn: Amir H. Nashat
	Fax: 781.290.0880
	  
 Polaris Venture
Partners
Founders’ Fund V, L.P.

	1000 Winter Street, Suite 3350
	Waltham, MA 02451
	Attn: Amir H. Nashat
	Fax: 781.290.0880
	  
 Polaris Venture
Partners
Special Founders’ Fund V, L.P.

	1000 Winter Street, Suite 3350
	Waltham, MA 02451
	Attn: Amir H. Nashat
	Fax: 781.290.0880
	  
 Flagship Ventures Fund 2004, L.P.

	One Memorial Drive, 7th Floor
	Cambridge, MA 02142
	Fax: 617.868.1115
	  
 ARCH Venture Fund VII, L.P.

	c/o ARCH Venture Partners
	8725 W. Higgins Road, Suite 290
	Chicago, IL 60631
	mmcdonnell@archventure.com
	Fax: ++1 773-380-6606
	  
 Alexandria Equities, LLC

	385 E. Colorado Boulevard, Suite 299
	Pasadena, CA 91101
	 Attn: Joel S. Marcus, CEO

investments@labspace.com

 

	
	NanoDimension L.P.
	Attention Jonathan Nicholson
	Governor’s Square, Unit 3-213-6
	P.O. Box 526 WB
	23, Lime Tree Bay Ave
	Grand Cayman, KY1-1302
	Cayman Islands
	Fax: 345 946 5558
	  
 DHK Investments, LLC

	c/o Koch Family Management
	4111 East 37th Street North
	Wichita, KS 67220
	Fax: 816.828.8602
	  
 Copies to (which does not constitute
notice):

	  
 Koch Companies Public Sector,
LLC

	 4111 East 37th
Street North

	 Wichita, KS 67220

	 Attention: Raffaele G. Fazio

	 Fax: 816.828.8602

	  
 and

	  
 Jones Day

	 3161 Michelson Drive, Suite 800

	 Irvine, CA 92612

	 Attention: Craig S. Mordock

	 Fax: 949.553.7539

	  
 Peter W. Doelger

	144 Beacon Street, Apt. 3
	Boston, MA 02116-1449
	  
 Doelger Family 2006 Trust

	FBO Emily M. Doelger
	c/o Bruce A. Haverberg, Trustee
	10 Tremont Street, Suite 200
	Boston, MA 02108

 
 

	
	Doelger Family 2006 Trust
	FBO Matthew Doelger
	c/o Bruce A. Haverberg, Trustee
	10 Tremont Street, Suite 200
	Boston, MA 02108
	  
 Hee-Jean Kim 2007 Trust

	c/o Bruce A. Haverberg, Trustee
	10 Tremont Street, Suite 200
	Boston, MA 02108
	  
 Dimitris Bertsimas

	43 Lantern Rd
	Belmont, MA 02478-1706
	  
 In each case, with a copy to (which does not constitute
notice):

	  
 Paul G. Roberts

	 300 First Avenue

	 Needham, MA. 02494

	 Fax: (781) 707-2551

	  
 Endeavour II L.P.

	PO Box 255 Trafalgar Court
	Les Banques
	St Peter Port, Guernsey GY1 3QL
	Channel Islands
	  
 Copy (which does not constitute notice)
to:

	  
 Endeavour Vision SA

	 6 rue de la Croix d’Or

	 1204 Geneva, Switzerland

	  
 Jeffrey B. Larson

	6 Arlington Street, Unit 5
	Boston, MA 02116
	Fax: 617-849-5910
	jeff@vaksam.com
	  
 Megan Kelleher

	444 Far Reach Road
	Westwood, MA 02090
	Fax: 617-849-5910
	k.megan.kelleher@gmail.com

 

	
	Gerald W. Blakeley, Jr.
	Blakeley Investment Company
	60 State Street – Suite 3400
	Boston, MA 02109
	  
 Gerald W. Blakeley, III

	Oyster Harbors 2057
	250 Windswept Way
	Osterville, MA 02655
	  
 In each case, with a copy to (which does not constitute
notice):

	  
 William S. Abbott, Esq.

	 50 Congress Street, Suite 925

	 Boston, MA 02109

	  
 D2 Investment LLC

	72 Pine Ridge Rd
	Newton, MA 02468
	  
 Peter T. Scardino

	345 E 68th Street
	New York, NY 10065
	Fax: (646) 422-1095
	  
 Edwin Darracott Vaughan, Jr.

	89 Hollow Creek Road
	Sheridan, WY 82801
	Tel: (307) 671-0429
	  
 John T. Connor Jr. and Susan Scholle

	Connor
	PO Box 1916
	Cotuit, MA 02635
	Tel: (508) 428-2050
	  
 RUSNANO

	10A prospect 60-letiya Oktyabrya
	Moscow, Russia 117036
	Attn: Dmitriy Lisenkov
	Fax: +74959885388
	Dmitriy.Lisenkov@rusnano.com
	Attn: Leysan Shaydullina
	Fax: +7495988538
	Leysan.shaydullina@rusnano.com

 
 

 SCHEDULE B 
 Executive Officers 
 Scott Minick 

 SCHEDULE C 
 Other Stockholders 
  

			
	Pamela Basto	  	Rohit Karnik
	125 Liberty Rd #3	  	931 Massachusetts Ave., Apt. 7
	Somerville, MA 02144	  	Cambridge, MA 02139
		
	Chris Canizzaro	  	Alireza Khademhosseini
	413 North Avenue	  	16 Trowbridge Street, #32
	Weston, MA 02493	  	Cambridge, MA 02138
		
	Jianjun Cheng	  	Maria Teresa Peracchia
	2304 Lynwood Drive	  	18 Rue Cuvier
	Champaign, IL 61821	  	75005 Paris, France
		
	Abraham J. Domb	  	Aleksandar Filip Radovic-Moreno
	16 Migdal Eder Street	  	1055 Crabapple Drive
	EFRAT, 90435 Israel	  	State College, PA 16801
		
	Ruxandra Gref	  	Benjamin A. Teply
	14 rue Moulin Fidel, apt G62	  	5109 Nicholas St.,
	92350 Plessis Robinson, France	  	Omaha, NE 68132-1433
		
	Sangyong Jon	  	Liangfang Zhang
	Dept. of Life Science, GIST	  	6191 Blue Dawn Trail
	1-Oryong dong, Bukgu	  	San Diego, CA 92130
	Gwangju 500-71, Republic of Korea	  	
		  	Susan K. Langer Trust u/d/t 12/14/95
	The OCF Irrevocable Trust 2006	  	c/o Stephanie K. Meilman, Trustee
	c/o Shadi K. Aryanpour, Trustee	  	Law Office of Meilman & Costa, P.C.
	490 Beacon Street	  	70 Wells Avenue, Suite 200
	Chestnut Hill, MA 02476	  	Newton, MA 02459
		
	The SAF Irrevocable Trust 2006	  	Samuel A. Langer Trust u/d/t 12/14/95
	c/o Shadi K. Aryanpour, Trustee	  	c/o Stephanie K. Meilman, Trustee
	490 Beacon Street	  	Law Office of Meilman & Costa, P.C.
	Chestnut Hill, MA 02476	  	70 Wells Avenue, Suite 200
		  	Newton, MA 02459
	 Michael D. Langer Trust u/d/t 12/14/95
 c/o Stephanie K. Meilman, Trustee
	  	
	Law Office of Meilman & Costa, P.C.	  	
	70 Wells Avenue, Suite 200	  	
	Newton, MA 02459	  	

 AMENDMENT NO. 1 

TO 

FOURTH AMENDED AND RESTATED VOTING AGREEMENT 
 THIS AMENDMENT NO. 1 TO FOURTH AMENDED AND RESTATED VOTING AGREEMENT (this “Amendment”) is made and entered into as of November 27, 2012, by and between BIND Biosciences,
Inc., a Delaware corporation (the “Company”), and the undersigned stockholders of the Company.  

WHEREAS, the Company and certain stockholders of the Company entered into that certain Fourth Amended and Restated Voting
Agreement, dated as of November 7, 2011 (the “Agreement”); 
 WHEREAS, pursuant to
Section 12.5 of the Agreement, the Agreement may be amended by written agreement of (i) the Company, (ii) the Founders holding shares representing a majority of the voting power of the Shares then held by all of the Founders, provided
that, for purposes of this provision, the Shares held by the trusts listed on Schedule C of the Agreement shall be included in the calculation of Shares held by their respective settlors and (iii) Purchasers holding shares (other than
Series BRN Preferred Stock) representing at least sixty-five percent (65%) of the voting power of the Shares (other than shares of Series BRN Preferred Stock) then held by all of the Purchasers (collectively, the “Requisite
Parties”); 
 WHEREAS, the Company and the undersigned stockholders of the Company constitute the Requisite
Parties; and 
 WHEREAS, the parties hereto desire to amend the Agreement as set forth herein. 

NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto
hereby covenant and agree to be bound as follows: 
 Section 1. Capitalized Terms. Capitalized terms used herein and
not otherwise defined herein shall have the respective meanings assigned to them in the Agreement. 
 Section 2.
Amendments. 
 (a) Section 1.1(a) of the Agreement is hereby amended and restated in its entirety to read as follows:

 “(a) fix the number of directors of the Company at eleven (11);” 

(b) Section 1.1(b) of the Agreement is hereby amended and restated in its entirety to read as follows: 

“(b) elect the following persons as directors: (i) one person designated by Polaris Venture Partners IV, L.P. or an Affiliated
Entity (as defined in Section 8.2) thereof (“Polaris”), who shall initially be Amir Nashat (the “Polaris Director”); (ii) one person designated by Flagship Ventures Fund 2004, L.P. or an Affiliated
Entity thereof (“Flagship”), who shall initially be Noubar Afeyan (the “Flagship Director”); (iii) one person designated by ARCH Venture Fund VII, L.P. (“ARCH”) or an Affiliated Entity thereof
(the “ARCH Director”), which seat shall initially be vacant; (iv) one person designated by DHK Investments, LLC (“DHK”), who may only be David H. Koch (“Koch”); (v) two directors each
designated by a majority of the Founders, who shall 

 
initially be Omid Farokhzad and Robert S. Langer, Jr.; (vi) the person who shall serve from time to time as the chief executive officer of the Company, initially Scott Minick;
(vii) one person designated by RUSNANO, an open joint stock company organized and existing under the laws of the Russian Federation (“RUSNANO”), who must be either a member of RUSNANO’s executive board or an experienced
global pharmaceutical executive with predefined qualification requirements consistent with those applied in relation to the other members of the Board of Directors and who shall initially be Yuriy Udaltsov (the “RUSNANO Director”);
(viii) two persons not otherwise Affiliates of the Company and designated by a majority of the other directors (the “Outside Directors”), one of whom shall initially be Peter Barton Hutt, and the other of which seats shall
initially be vacant; and (ix) one additional person designated by a majority of the other directors, who shall initially be Daniel S. Lynch; and” 
 Section 3. No Other Amendments; Conflicts. No term or provision of the Agreement shall be affected by this Amendment, unless specifically set forth herein and any term or provision not
affected by this Amendment shall remain in full force and effect following the date hereof. In the event of a conflict between the terms of the Agreement and the terms of this Amendment, the terms of this Amendment shall control. 

Section 4. Governing Law. This Amendment shall be governed by, and construed and enforced in accordance with, the General
Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by, and construed and enforced in accordance with, the internal laws of the State of New York, without regard to conflict
of law principles that would result in the application of any law other than the law of the State of New York. 

Section 5. Captions; Pronouns. All articles and section headings or captions contained in this Amendment are inserted only as
a matter of convenience and for reference and in no way define, limit, extend or describe the scope of this Amendment or the intent of any provision thereof. 
 Section 6. Severability. If any provision of this Amendment or application to any party or circumstance shall be determined by any court of competent jurisdiction to be invalid or
unenforceable to any extent, the remainder of this Amendment or the application of such provision to any other party or circumstances shall not be affected thereby, and each provision shall be valid and shall be enforced to the fullest extent
permitted by law. 
 Section 7. Counterparts. This Amendment may be executed in multiple counterparts, each of which
shall be deemed an original, but all of which taken together shall constitute one and the same instrument. The exchange of copies of this Amendment and of signature pages by facsimile transmission or other electronic means shall constitute effective
execution and delivery of this Amendment as to the parties and may be used in lieu of the original Amendment for all purposes. 

[Signature Page Follows] 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as
of the date first written above. 
  

			
	BIND BIOSCIENCES, INC.
		
	By:	 	 /s/ Scott Minick

	Name:	 	Scott Minick
	Title:	 	President and Chief Executive Officer

  

Signature Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

							
	FOUNDERS:	 		 		 	 /s/ Omid Farokhzad

		 		 		 	Omid Farokhzad
				
		 		 		 	  

		 		 		 	Paul Goldenheim
				
		 		 		 	 /s/ Robert S. Langer, Jr.

		 		 		 	Robert S. Langer, Jr.
				
	EXECUTIVE OFFICERS:	 		 		 	 /s/ Scott Minick

		 		 		 	Scott Minick

  

Signature Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

											
	PURCHASERS:	 		 	POLARIS VENTURE PARTNERS V, L.P.
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
						
		 		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	POLARIS VENTURE PARTNERS ENTREPRENEURS’ FUND V, L.P.
				
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
						
		 		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	POLARIS VENTURE PARTNERS FOUNDERS’ FUND V, L.P.
				
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
						
		 		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	POLARIS VENTURE PARTNERS SPECIAL FOUNDERS’ FUND V, L.P.
				
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
						
		 		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

											
	PURCHASER:	 		 	FLAGSHIP VENTURES FUND 2004, L.P.
				
		 		 	By:	 	FLAGSHIP VENTURES GENERAL PARTNER LLC, its General Partner
						
		 		 		 		 	By:	 	 /s/ Noubar Afeyan

		 		 		 		 	Noubar Afeyan
		 		 		 		 	Managing Partner and CEO

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	ARCH VENTURE FUND VII, L.P.
				
		 		 	By:	 	ARCH VENTURE PARTNERS VII, L.P.
		 		 	Its:	 	General Partner
				
		 		 	By:	 	ARCH VENTURE PARTNERS VII, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Clinton W. Bybee

		 		 	Its:	 	Managing Director

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	NANODIMENSION, L.P.
				
		 		 	By:	 	NanoDimension Management Limited, its General Partner
				
		 		 	By:	 	 /s/ Jonathan Nicholson

		 		 		 	Jonathan Nicholson, Director

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	DHK INVESTMENTS, LLC
				
		 		 	By:	 	 /s/ David H. Koch

		 		 		 	David H. Koch
		 		 		 	Manager

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Peter W. Doelger

	Peter W. Doelger

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	DOELGER FAMILY 2006 TRUST
		 		 		 	FBO EMILY M. DOELGER
				
		 		 		 	 /s/ Bruce A. Haverberg

		 		 		 	Bruce A. Haverberg, Trustee
				
		 		 		 	DOELGER FAMILY 2006 TRUST
		 		 		 	FBO MATTHEW DOELGER
				
		 		 		 	 /s/ Bruce A. Haverberg

		 		 		 	Bruce A. Haverberg, Trustee
				
		 		 		 	HEE-JEAN KIM 2007 TRUST
				
		 		 		 	 /s/ Bruce A. Haverberg

		 		 		 	Bruce A. Haverberg, Trustee

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Dimitris Bertsimas

	Dimitris Bertsimas

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

									
	PURCHASER:	 		 	ENDEAVOUR II L.P.
				
		 		 	By:	 	ENDEAVOUR PARTNERS GP LIMITED its General Partner
				
		 		 	By:	 	 /s/ John Bridle

		 		 		 	Name:	 	John Bridle
		 		 		 	Title:	 	Director

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Gerald W. Blakeley, Jr.

	Gerald W. Blakeley, Jr.

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Gerald W. Blakeley, III

	Gerald W. Blakeley, III

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	D2 INVESTMENT LLC
				
		 		 	By:	 	 /s/ Chris Kryder

		 		 		 	Chris Kryder
		 		 		 	Manager

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Peter T. Scardino

	Peter T. Scardino

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Edwin Darracott Vaughan, Jr.

	Edwin Darracott Vaughan, Jr.

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 		 	JOHN T. CONNOR JR. AND SUSAN SCHOLLE CONNOR, tenants by the entirety
				
		 		 		 	  

		 		 		 	John T. Connor Jr.
				
		 		 		 	  

		 		 		 	Susan Scholle Connor

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Jeffrey B. Larson

	Jeffrey B. Larson

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Megan Kelleher

	Megan Kelleher

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

									
	PURCHASER:	 		 		 	RUSNANO
		 		 		 	an open joint stock company organized and existing under the laws of the Russian Federation
					
		 		 		 	By:	 	 /s/ Andrey Malyshev

		 		 		 	Name:	 	Andrey Malyshev
		 		 		 	Title:	 	Deputy Chairman of the Management Board

  
 Signature
Page to Amendment No. 1 to Fourth Amended and Restated Voting Agreement 

 AMENDMENT NO. 2 

TO 

FOURTH AMENDED AND RESTATED VOTING AGREEMENT 
 THIS AMENDMENT NO. 2 TO FOURTH AMENDED AND RESTATED VOTING AGREEMENT (this “Amendment”) is made and entered into as of January 23, 2013, by and among BIND Biosciences, Inc., a
Delaware corporation (the “Company”), and the undersigned stockholders of the Company.  

WHEREAS, the Company and certain stockholders of the Company entered into that certain Fourth Amended and Restated Voting
Agreement, dated as of November 7, 2011 (as amended to date, the “Agreement”); 
 WHEREAS, pursuant
to Section 12.5 of the Agreement, the Agreement may be amended by written agreement of (i) the Company, (ii) the Founders holding shares representing a majority of the voting power of the Shares then held by all of the Founders,
provided that, for purposes of this provision, the Shares held by the trusts listed on Schedule C of the Agreement shall be included in the calculation of Shares held by their respective settlors and (iii) Purchasers holding shares (other
than Series BRN Preferred Stock) representing at least sixty-five percent (65%) of the voting power of the Shares (other than shares of Series BRN Preferred Stock) then held by all of the Purchasers (collectively, the “Requisite
Parties”); 
 WHEREAS, the Company and the undersigned stockholders of the Company constitute the Requisite
Parties; and 
 WHEREAS, the parties hereto desire to amend the Agreement as set forth herein. 

NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto
hereby covenant and agree to be bound as follows: 
 Section 1. Capitalized Terms. Capitalized terms used herein and
not otherwise defined herein shall have the respective meanings assigned to them in the Agreement. 
 Section 2.
Amendments. 
 (a) The following text shall be added as a new paragraph at the end of Section 1.1 of the Agreement:

 “Notwithstanding anything to the contrary herein, if any person or entity (or its Affiliate) has (i) the right to
appoint one or more Preferred Directors pursuant to Section 1.1(b) above and (ii) its respective shares of Preferred Stock converted into Common Stock pursuant to Section 3.3A of Article Fourth of the Company Charter (as
defined below), then such person, entity or Affiliate, as applicable, shall forfeit its respective rights to appoint any Preferred Director pursuant to Section 1.1(b) above.” 

(b) Section 1.2 of the Agreement is hereby amended by adding the following as a new subsection (e) thereto: 

“(e) Notwithstanding anything to the contrary herein, in the event of the conversion into Common Stock of the shares of Preferred
Stock held by any Purchaser or its Affiliates pursuant to Section 3.3A of Article Fourth of the Company Charter (as defined below), the rights of such Purchaser under this Section 1.2 shall terminate automatically.” 

 (c) The following is added as a new sentence at the end of Section 8.1 of the
Agreement: 
 “Following a permitted joinder to this Agreement by such transferee, and upon such joinder, the Company shall
update the Schedules and signature pages hereto as needed to reflect the addition of such Stockholder as a party hereto.” 

(d) The third sentence of Section 12.5 of the Agreement is hereby amended and restated in its entirety to read as follows:

 “Notwithstanding anything to the contrary herein, this Agreement may be amended by the Company without the consent of any
of the other parties hereto to (A) add as a party hereto and include information regarding and otherwise accommodate an additional purchaser of shares of the Series D Preferred Stock or Series BRN Preferred Stock (including a Co-Investor)
pursuant to the Purchase Agreement, as may be amended from time to time; provided that any such amendment does not materially and adversely affect the rights of any Purchaser under this Agreement (it being agreed that the issuance of additional
shares of capital stock in accordance with the Purchase Agreement, as may be amended or modified from time to time in accordance with its terms, and the other Financing Agreements, each as may be amended or modified from time to time in accordance
with its respective terms, shall not be deemed to affect the Purchasers under this Agreement) and (B) add as a party hereto and include information regarding and otherwise accommodate any purchaser of shares of Series D Preferred Stock pursuant
to the Series D Preferred Stock Purchase Agreement dated as of January 23, 2013, among the Company and the purchasers named therein, as may be amended from time to time (the “Series D Preferred Stock Extension Purchase
Agreement”).” 
 (e) Section 12.8 of the Agreement is hereby amended and restated in its entirety to read as
follows: 
 “12.8 Additional Purchasers. Notwithstanding Section 12.5, any person or entity that
purchases (i) Series BRN Preferred Stock as a Co-Investor (as defined in the Purchase Agreement) under the Purchase Agreement or (ii) Series D Preferred Stock under the Series D Preferred Stock Extension Purchase Agreement, unless already
a party to this Agreement, shall become a party to this Agreement by executing and delivering to the Company a counterpart signature page to this Agreement, and thereupon shall be deemed a “Purchaser” for all purposes of this Agreement,
and the Company shall amend Schedule A hereto to add the name and address of such Purchaser. No such accession instrument shall be effective unless and until accepted in writing by the Company. No action or consent by the Purchasers,
Founders, Executive Officers or Other Stockholders shall be required for such joinder to this Agreement by such Co-Investor or such other purchaser or any aforesaid amendment of Schedule A, so long as such Co-Investor or such other purchaser
has agreed in writing to be bound by all of the obligations as a “Purchaser” hereunder.” 
 (f) Schedule C of the
Agreement is hereby amended and restated in its entirety to read as set forth on Schedule C of this Amendment. 

 Section 3. No Other Amendments; Conflicts. No term or provision of the Agreement
shall be affected by this Amendment, unless specifically set forth herein and any term or provision not affected by this Amendment shall remain in full force and effect following the date hereof. In the event of a conflict between the terms of the
Agreement and the terms of this Amendment, the terms of this Amendment shall control. 
 Section 4. Governing Law.
This Amendment shall be governed by, and construed and enforced in accordance with, the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by, and construed and
enforced in accordance with, the internal laws of the State of New York, without regard to conflict of law principles that would result in the application of any law other than the law of the State of New York. 

Section 5. Captions; Pronouns. All articles and section headings or captions contained in this Amendment are inserted only as
a matter of convenience and for reference and in no way define, limit, extend or describe the scope of this Amendment or the intent of any provision thereof. 
 Section 6. Severability. If any provision of this Amendment or application to any party or circumstance shall be determined by any court of competent jurisdiction to be invalid or
unenforceable to any extent, the remainder of this Amendment or the application of such provision to any other party or circumstances shall not be affected thereby, and each provision shall be valid and shall be enforced to the fullest extent
permitted by law. 
 Section 7. Counterparts. This Amendment may be executed in multiple counterparts, each of which
shall be deemed an original, but all of which taken together shall constitute one and the same instrument. The exchange of copies of this Amendment and of signature pages by facsimile transmission or other electronic means shall constitute effective
execution and delivery of this Amendment as to the parties and may be used in lieu of the original Amendment for all purposes. 

[Signature Page Follows] 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as
of the date first written above. 
  

			
	BIND BIOSCIENCES, INC.
		
	By:	 	 /s/ Scott Minick

	Name:	 	Scott Minick
	Title:	 	President & Chief Executive Officer

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

							
	FOUNDERS:	 		 		 	 /s/ Omid Farokhzad

		 		 		 	Omid Farokhzad
				
		 		 		 	  

		 		 		 	Paul Goldenheim
				
		 		 		 	 /s/ Robert S. Langer, Jr.

		 		 		 	Robert S. Langer, Jr.
				
	EXECUTIVE OFFICERS:	 		 		 	 /s/ Scott Minick

		 		 		 	Scott Minick

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 OTHER STOCKHOLDERS: 

 

			
	SHADI K. ARYANPOUR AS TRUSTEE OF SAF-BND TRUST
		
	By:	 	 /s/ Shadi K. Aryanpour

	Shadi K. Aryanpour, Trustee
	
	REZA ARYANPOUR AS TRUSTEE OF OCF-BND TRUST
		
	By:	 	 /s/ Reza Aryanpour

	Reza Aryanpour, Trustee
	
	 /s/ Shoku Ordukhani Kashi

	Shoku Ordukhani Kashi

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

											
	PURCHASERS:	 		 	POLARIS VENTURE PARTNERS V, L.P.
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
						
		 		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	POLARIS VENTURE PARTNERS ENTREPRENEURS’ FUND V, L.P.
				
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
						
		 		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	POLARIS VENTURE PARTNERS FOUNDERS’ FUND V, L.P.
				
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
						
		 		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	POLARIS VENTURE PARTNERS SPECIAL FOUNDERS’ FUND V, L.P.
				
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
						
		 		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

											
	PURCHASER:	 		 	FLAGSHIP VENTURES FUND 2004, L.P.
				
		 		 	By:	 	FLAGSHIP VENTURES GENERAL PARTNER LLC, its General Partner
						
		 		 		 		 	By:	 	 /s/ Noubar Afeyan

		 		 		 		 	Noubar Afeyan
		 		 		 		 	Managing Partner and CEO

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	ARCH VENTURE FUND VII, L.P.
				
		 		 	By:	 	ARCH VENTURE PARTNERS VII, L.P.
		 		 	Its:	 	General Partner
				
		 		 	By:	 	ARCH VENTURE PARTNERS VII, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Keith L. Crandell

		 		 	Its:	 	Managing Director

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	NANODIMENSION, L.P.
				
		 		 	By:	 	NanoDimension Management Limited, its General Partner
				
		 		 	By:	 	 /s/ Jonathan Nicholson

		 		 		 	Jonathan Nicholson, Director

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	DHK INVESTMENTS, LLC
				
		 		 	By:	 	 /s/ David H. Koch

		 		 		 	David H. Koch
		 		 		 	Manager

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Peter W. Doelger

	Peter W. Doelger

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

					
	PURCHASER:	 		 	DOELGER FAMILY 2006 TRUST
		 		 	FBO EMILY M. DOELGER
			
		 		 	 /s/ Bruce A. Haverberg

		 		 	Bruce A. Haverberg, Trustee
			
		 		 	DOELGER FAMILY 2006 TRUST
		 		 	FBO MATTHEW DOELGER
			
		 		 	 /s/ Bruce A. Haverberg

		 		 	Bruce A. Haverberg, Trustee
			
		 		 	HEE-JEAN KIM 2007 TRUST
			
		 		 	 /s/ Bruce A. Haverberg

		 		 	Bruce A. Haverberg, Trustee

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Dimitris Bertsimas

	Dimitris Bertsimas

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

									
	PURCHASER:	 		 	ENDEAVOUR II L.P.
				
		 		 	By:	 	ENDEAVOUR PARTNERS GP LIMITED
		 		 		 	its General Partner
				
		 		 	By:	 	 /s/ John Bridle

		 		 		 	Name:	 	John Bridle
		 		 		 	Title:	 	Director

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Gerald W. Blakeley, Jr.

	Gerald W. Blakeley, Jr.

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Gerald W. Blakeley, III

	Gerald W. Blakeley, III

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	D2 INVESTMENT LLC
				
		 		 	By:	 	 /s/ Chris Kryder

		 		 		 	Chris Kryder
		 		 		 	Manager

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Peter T. Scardino

	Peter T. Scardino

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Edwin Darracott Vaughan, Jr.

	Edwin Darracott Vaughan, Jr.

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

					
	PURCHASER:	 		 	JOHN T. CONNOR JR. AND SUSAN SCHOLLE CONNOR, tenants by the entirety
			
		 		 	 /s/ John T. Connor Jr.

		 		 	John T. Connor Jr.
			
		 		 	 /s/ Susan Scholle Connor

		 		 	Susan Scholle Connor

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Jeffrey B. Larson

	Jeffrey B. Larson

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 PURCHASER: 

 

	
	 /s/ Megan Kelleher

	Megan Kelleher

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	RUSNANO
		 		 	an open joint stock company organized and existing under the laws of the Russian Federation
				
		 		 	By:	 	 /s/ Andrey Rappoport

		 		 	Name:	 	Andrey Rappoport
		 		 	Title:	 	First Deputy Chairman of the Management Board

  
 Signature
Page to Amendment No. 2 to Fourth Amended and Restated Voting Agreement 

 SCHEDULE C 
 Other Stockholders 
 Pamela Basto 
 125 Liberty Rd #3 
 Somerville, MA 02144 
 Chris Cannizzaro 
 413 North Avenue 
 Weston, MA 02493 
 Jianjun Cheng 
 2304 Lynwood Drive 
 Champaign, IL 61821 

Abraham J. Domb 
 16 Migdal Eder
Street 
 EFRAT, 90435 Israel 

Ruxandra Gref 
 14 rue Moulin Fidel,
apt G62 
 92350 Plessis Robinson, France 
 Sangyong Jon 
 Dept. of Life Science, GIST 
 1-Oryong dong, Bukgu 
 Gwangju 500-71, Republic of Korea 

Shoku Ordukhani Kashi 
 OCF-BND TRUST

 c/o Reza Aryanpour, Trustee 
 19
Heron Drive 
 Mill Valley, CA 94941 

SAF-BND TRUST 
 c/o Shadi K. Aryanpour,
Trustee 
 15 Laura Road 
 Waban, MA
02468 
 Michael D. Langer Trust u/d/t 12/14/95 
 c/o Stephanie K. Meilman, Trustee 
 Law Office of Meilman & Costa, P.C. 

70 Wells Avenue, Suite 200 
 Newton, MA
02459 

 Rohit Karnik 
 931 Massachusetts Ave., Apt. 7 
 Cambridge, MA 02139 

Alireza Khademhosseini 
 16 Trowbridge
Street, #32 
 Cambridge, MA 02138 

Maria Teresa Peracchia 
 18 Rue Cuvier

 75005 Paris, France 
 Aleksandar
Filip Radovic-Moreno 
 1055 Crabapple Drive 
 State College, PA 16801 
 Benjamin A. Teply 

5109 Nicholas St., 
 Omaha, NE 68132-1433

 Liangfang Zhang 
 6191 Blue
Dawn Trail 
 San Diego, CA 92130 

Susan K. Langer Trust u/d/t 12/14/95 
 c/o
Stephanie K. Meilman, Trustee 
 Law Office of Meilman & Costa, P.C. 
 70 Wells Avenue, Suite 200 
 Newton, MA 02459 

Samuel A. Langer Trust u/d/t 12/14/95 
 c/o
Stephanie K. Meilman, Trustee 
 Law Office of Meilman & Costa, P.C. 
 70 Wells Avenue, Suite 200 
 Newton, MA 02459 

 AMENDMENT NO. 3 

TO 

FOURTH AMENDED AND RESTATED VOTING AGREEMENT 
 THIS AMENDMENT NO. 3 TO FOURTH AMENDED AND RESTATED VOTING AGREEMENT (this “Amendment”) is made and entered into as of August 28, 2013, by and among BIND Therapeutics, Inc., a
Delaware corporation (the “Company”), and the undersigned stockholders of the Company. 
 WHEREAS, the
Company and certain stockholders of the Company entered into that certain Fourth Amended and Restated Voting Agreement, dated as of November 7, 2011 (as amended to date, the “Agreement”); 

WHEREAS, pursuant to Section 12.5 of the Agreement, the Agreement may be amended by written agreement of (i) the
Company, (ii) the Founders holding shares representing a majority of the voting power of the Shares then held by all of the Founders, provided that, for purposes of this provision, the Shares held by the trusts listed on Schedule C of the
Agreement shall be included in the calculation of Shares held by their respective settlors and (iii) Purchasers holding shares (other than Series BRN Preferred Stock) representing at least sixty-five percent (65%) of the voting power of
the Shares (other than shares of Series BRN Preferred Stock) then held by all of the Purchasers (collectively, the “Requisite Parties”); 
 WHEREAS, the Company and the undersigned stockholders of the Company constitute the Requisite Parties; and 
 WHEREAS, the parties hereto desire to amend the Agreement as set forth herein. 
 NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto hereby covenant and agree to be bound as follows: 

Section 1. Capitalized Terms. Capitalized terms used herein and not otherwise defined herein shall have the respective
meanings assigned to them in the Agreement. 
 Section 2. Amendments. Section 5 of the Agreement is hereby
amended and restated in its entirety to read as follows: 
 “5. Termination. This Agreement shall terminate in its
entirety on the earliest to occur of (i) the closing of the Company’s first public offering pursuant to a registration statement under the Act (an “IPO”), (ii) the closing of a Sale of the Company, or (iii) such
time as less than 2,200,000 shares of Preferred Stock remain outstanding, subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalizations and similar events.” 

Section 3. No Other Amendments; Conflicts. No term or provision of the Agreement shall be affected by this Amendment, unless
specifically set forth herein and any term or provision not affected by this Amendment shall remain in full force and effect following the date hereof. In the event of a conflict between the terms of the Agreement and the terms of this Amendment,
the terms of this Amendment shall control. 

 Section 4. Governing Law. This Amendment shall be governed by, and construed and
enforced in accordance with, the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by, and construed and enforced in accordance with, the internal laws of the State
of New York, without regard to conflict of law principles that would result in the application of any law other than the law of the State of New York. 
 Section 5. Captions; Pronouns. All articles and section headings or captions contained in this Amendment are inserted only as a matter of convenience and for reference and in no way define,
limit, extend or describe the scope of this Amendment or the intent of any provision thereof. 
 Section 6.
Severability. If any provision of this Amendment or application to any party or circumstance shall be determined by any court of competent jurisdiction to be invalid or unenforceable to any extent, the remainder of this Amendment or the
application of such provision to any other party or circumstances shall not be affected thereby, and each provision shall be valid and shall be enforced to the fullest extent permitted by law. 

Section 7. Counterparts. This Amendment may be executed in multiple counterparts, each of which shall be deemed an original,
but all of which taken together shall constitute one and the same instrument. The exchange of copies of this Amendment and of signature pages by facsimile transmission or other electronic means shall constitute effective execution and delivery of
this Amendment as to the parties and may be used in lieu of the original Amendment for all purposes. 
 [Signature Page
Follows] 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as
of the date first written above. 
  

			
	BIND THERAPEUTICS, INC.
		
	By:	 	/s/ Scott Minick
	Name: Scott Minick
	Title: President & CEO

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
			
	FOUNDERS:	 		 	 /s/ Omid Farokhzad

		 		 	Omid Farokhzad
			
		 		 	  

		 		 	Paul Goldenheim
			
		 		 	 /s/ Robert S. Langer, Jr.

		 		 	Robert S. Langer, Jr.
			
		 		 	SHADI K. ARYANPOUR AS TRUSTEE OF SAF-BND TRUST
				
		 		 	By:	 	/s/ Shadi K. Aryanpour
		 		 	Shadi K. Aryanpour, Trustee
			
		 		 	REZA ARYANPOUR AS TRUSTEE OF OCF-BND TRUST
				
		 		 	By:	 	/s/ Reza Aryanpour
		 		 	Reza Aryanpour, Trustee
			
		 		 	 MICHAEL D. LANGER TRUST U/D/T 12/14/95
 SUSAN K. LANGER TRUST U/D/T 12/14/1995, and
 SAMUEL A. LANGER TRUST U/D/T
12/14/1995

				
		 		 	By:	 	/s/ Aimee Hamilton
		 		 	Aimee Hamilton, Trustee
			
	EXECUTIVE OFFICERS:	 		 	 /s/ Scott Minick

		 		 	Scott Minick

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

									
	PURCHASERS: 	 		 	POLARIS VENTURE PARTNERS V, L.P.
				
		 		 	By:	 	 POLARIS VENTURE MANAGEMENT CO. V, L.L.C.,
 its General Partner

					
		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	 POLARIS VENTURE PARTNERS
 ENTREPRENEURS’ FUND V, L.P.

				
		 		 	By:	 	 POLARIS VENTURE MANAGEMENT CO. V, L.L.C.,
 its General Partner

					
		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	POLARIS VENTURE PARTNERS FOUNDERS’ FUND V, L.P.
				
		 		 	By:	 	 POLARIS VENTURE MANAGEMENT CO. V, L.L.C.,
 its General Partner

					
		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact
			
		 		 	POLARIS VENTURE PARTNERS SPECIAL FOUNDERS’ FUND V, L.P.
				
		 		 	By:	 	POLARIS VENTURE MANAGEMENT CO. V, L.L.C., its General Partner
					
		 		 		 	By:	 	 /s/ William E. Bilodeau

		 		 		 		 	William E. Bilodeau
		 		 		 		 	Attorney-in-fact

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

									
	PURCHASER:	 		 	FLAGSHIP VENTURES FUND 2004, L.P.
				
		 		 	By:	 	 FLAGSHIP VENTURES GENERAL PARTNER LLC,
 its General Partner

					
		 		 		 	By:	 	 /s/ Noubar Afeyan

		 		 		 		 	Noubar Afeyan
		 		 		 		 	Managing Partner and CEO

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

									
	PURCHASER:	 		 	ARCH VENTURE FUND VII, L.P.
				
		 		 	By:	 	ARCH VENTURE PARTNERS VII, L.P.
		 		 	Its:	 	General Partner
				
		 		 	By:	 	ARCH VENTURE PARTNERS VII, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Keith L. Crandell

		 		 	Its:	 	Managing Director, Keith L. Crandell

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	NANODIMENSION, L.P.
				
		 		 	By:	 	NanoDimension Management Limited,
		 		 		 	its General Partner
				
		 		 	By:	 	 /s/ Jonathan Nicholson

		 		 		 	Jonathan Nicholson, Director
		 		 		 	

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	
			
		 		 	 /s/ Peter W. Doelger

		 		 	Peter W. Doelger

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	 DOELGER FAMILY 2006 TRUST
 FBO EMILY M. DOELGER

			
		 		 	 /s/ Bruce A. Haverberg

		 		 	Bruce A. Haverberg, Trustee
		 		 	
		 		 	DOELGER FAMILY 2006 TRUST
		 		 	FBO MATTHEW DOELGER
			
		 		 	 /s/ Bruce A. Haverberg

		 		 	Bruce A. Haverberg, Trustee
			
		 		 	HEE-JEAN KIM 2007 TRUST
			
		 		 	 /s/ Bruce A. Haverberg

		 		 	Bruce A. Haverberg, Trustee

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	
			
		 		 	 /s/ Dimitris Bertsimas

		 		 	Dimitris Bertsimas

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	ENDEAVOUR II L.P.
				
		 		 	By:	 	ENDEAVOUR PARTNERS GP LIMITED
		 		 		 	its General Partner
				
		 		 	By:	 	 /s/ Nigel Carey

		 		 		 	Name:  Nigel Carey
		 		 		 	Title:    Director

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	
			
		 		 	 /s/ Gerald W. Blakeley, Jr.

		 		 	Gerald W. Blakeley, Jr.

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	
			
		 		 	 /s/ Gerald W. Blakeley, III

		 		 	Gerald W. Blakeley, III

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	D2 INVESTMENT LLC
				
		 		 	By:	 	 /s/ Chris Kryder

		 		 		 	Chris Kryder
		 		 		 	Manager

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	
			
		 		 	 /s/ Edwin Darracott Vaughan, Jr.

		 		 	Edwin Darracott Vaughan, Jr.

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	JOHN T. CONNOR JR. AND SUSAN SCHOLLE CONNOR, tenants by the entirety
			
		 		 	 /s/ John T. Connor Jr.

		 		 	John T. Connor Jr.
			
		 		 	 /s/ Susan Scholle Connor

		 		 	Susan Scholle Connor

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	
			
		 		 	 /s/ Jeffrey B. Larson

		 		 	Jeffrey B. Larson

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting Agreement 

							
	PURCHASER:	 		 	
			
		 		 	 /s/ Megan Kelleher

		 		 	Megan Kelleher

  
 Signature
Page to Amendment No. 3 to Fourth Amended and Restated Voting AgreementEX-10.2

 Exhibit 10.2 
 BIND THERAPEUTICS, INC. 
 2013 INCENTIVE AWARD PLAN 

ARTICLE 1. 

PURPOSE 

The purpose of the BIND Therapeutics, Inc. 2013 Incentive Award Plan (as it may be amended or restated from time to time, the
“Plan”) is to promote the success and enhance the value of BIND Therapeutics, Inc. (the “Company”) by linking the individual interests of the members of the Board, Employees, and Consultants to those of Company
stockholders and by providing such individuals with an incentive for outstanding performance to generate superior returns to Company stockholders. The Plan is further intended to provide flexibility to the Company in its ability to motivate,
attract, and retain the services of members of the Board, Employees, and Consultants upon whose judgment, interest, and special effort the successful conduct of the Company’s operation is largely dependent. 

ARTICLE 2. 

DEFINITIONS AND CONSTRUCTION 
 Wherever the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates otherwise. The singular pronoun shall include the plural where the
context so indicates. 
 2.1 “Administrator” shall mean the entity that conducts the general administration of
the Plan as provided in Article 11. With reference to the duties of the Committee under the Plan which have been delegated to one or more persons pursuant to Section 11.6, or as to which the Board has assumed, the term “Administrator”
shall refer to such person(s) unless the Committee or the Board has revoked such delegation or the Board has terminated the assumption of such duties. 
 2.2 “Applicable Accounting Standards” shall mean Generally Accepted Accounting Principles in the United States, International Financial Reporting Standards or such other accounting
principles or standards as may apply to the Company’s financial statements under United States federal securities laws from time to time. 
 2.3 “Applicable Law” shall mean any applicable law, including without limitation: (i) provisions of the Code, the Securities Act, the Exchange Act and any rules or regulations
thereunder; (ii) corporate, securities, tax or other laws, statutes, rules, requirements or regulations, whether federal, state, local or foreign; and (iii) rules of any securities exchange or automated quotation system on which the Shares
are listed, quoted or traded. 
 2.4 “Automatic Exercise Date” shall mean, with respect to an Option or a Stock
Appreciation Right, the last business day of the applicable Option Term or Stock Appreciation Right Term that was established by the Administrator for such Option or Stock Appreciation Right (e.g., the last business day prior to the tenth
anniversary of the date of grant of such 

 
Option or Stock Appreciation Right if the Option or Stock Appreciation Right initially had a ten-year Option Term or Stock Appreciation Right Term, as applicable); provided that with respect to
an Option or Stock Appreciation Right that has been amended pursuant to this Plan so as to alter the applicable Option Term or Stock Appreciation Right Term, “Automatic Exercise Date” shall mean the last business day of the applicable
Option Term or Stock Appreciation Right Term that was established by the Administrator for such Option or Stock Appreciation Right as amended. 
 2.5 “Award” shall mean an Option, a Restricted Stock award, a Restricted Stock Unit award, a Performance Award, a Dividend Equivalents award, a Stock Payment award or a Stock Appreciation
Right, which may be awarded or granted under the Plan (collectively, “Awards”). 
 2.6 “Award
Agreement” shall mean any written notice, agreement, terms and conditions, contract or other instrument or document evidencing an Award, including through electronic medium, which shall contain such terms and conditions with respect to an
Award as the Administrator shall determine consistent with the Plan. 
 2.7 “Board” shall mean the Board of
Directors of the Company. 
 2.8 “Change in Control” shall mean and includes each of the following: 

(a) A transaction or series of transactions (other than an offering of Common Stock to the general public through a registration statement
filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act) (other than the Company, any of its
Subsidiaries, an employee benefit plan maintained by the Company or any of its Subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company)
directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50% of the total combined voting power of the Company’s securities outstanding
immediately after such acquisition; or 
 (b) During any period of two consecutive years, individuals who, at the beginning of
such period, constitute the Board together with any new Director(s) (other than a Director designated by a person who shall have entered into an agreement with the Company to effect a transaction described in Section 2.8(a) or
Section 2.8(c)) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the Directors then still in office who either were Directors at the beginning of the
two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or 
 (c) The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation, reorganization, or
business combination or (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (z) the acquisition of assets or stock of another entity, in
each case other than a transaction: 

  
 2 

 (i) which results in the Company’s voting securities outstanding immediately before
the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly
or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the Company or such person, the “Successor Entity”)) directly or indirectly, at least a majority of the
combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and 

(ii) after which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the
Successor Entity; provided, however, that no person or group shall be treated for purposes of this Section 2.8(c)(ii) as beneficially owning 50% or more of the combined voting power of the Successor Entity solely as a
result of the voting power held in the Company prior to the consummation of the transaction; or 
 (d) The Company’s
stockholders approve a liquidation or dissolution of the Company. 
 In addition, if a Change in Control constitutes a payment event with
respect to any portion of an Award that provides for the deferral of compensation and is subject to Section 409A of the Code, the transaction or event described in subsection (a), (b), (c) or (d) with respect to such Award (or portion
thereof) must also constitute a “change in control event,” as defined in Treasury Regulation Section 1.409A-3(i)(5) to the extent required by Section 409A. 
 The Committee shall have full and final authority, which shall be exercised in its discretion, to determine conclusively whether a Change in Control of the Company has occurred pursuant to the above
definition, and the date of the occurrence of such Change in Control and any incidental matters relating thereto; provided that any exercise of authority in conjunction with a determination of whether a Change in Control is a “change in control
event” as defined in Treasury Regulation Section 1.409A-3(i)(5) shall be consistent with such regulation. 
 2.9
“Code” shall mean the Internal Revenue Code of 1986, as amended from time to time, together with the regulations and official guidance promulgated thereunder. 
 2.10 “Committee” shall mean the Compensation Committee of the Board, or another committee or subcommittee of the Board or the Compensation Committee, appointed as provided in
Section 11.1. 
 2.11 “Common Stock” shall mean the common stock of the Company, par value $0.0001 per
share. 
 2.12 “Company” shall have the meaning set forth in Article 1. 

  
 3 

 2.13 “Consultant” shall mean any consultant or adviser engaged to provide
services to the Company or any Subsidiary that qualifies as a consultant under the applicable rules of the Securities and Exchange Commission for registration of shares on a Form S-8 Registration Statement. 

2.14 “Director” shall mean a member of the Board, as constituted from time to time. 

2.15 “Dividend Equivalent” shall mean a right to receive the equivalent value (in cash or Shares) of dividends paid on
Shares, awarded under Section 8.2. 
 2.16 “DRO” shall mean a domestic relations order as defined by the
Code or Title I of the Employee Retirement Income Security Act of 1974, as amended from time to time, or the rules thereunder. 

2.17 “Effective Date” shall mean the day prior to the Public Trading Date. 

2.18 “Eligible Individual” shall mean any person who is an Employee, a Consultant or a Non-Employee Director, as
determined by the Committee. 
 2.19 “Employee” shall mean any officer or other employee (as determined in
accordance with Section 3401(c) of the Code) of the Company or of any Subsidiary. 
 2.20 “Equity
Restructuring” shall mean a nonreciprocal transaction between the Company and its stockholders, such as a stock dividend, stock split, spin-off, rights offering or recapitalization through a large, nonrecurring cash dividend, that affects
the number or kind of Shares (or other securities of the Company) or the share price of Common Stock (or other securities) and causes a change in the per share value of the Common Stock underlying outstanding Awards. 

2.21 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended from time to time. 

2.22 “Expiration Date” shall have the meaning given to such term in Section 12.1. 

2.23 “Fair Market Value” shall mean, as of any given date, the value of a Share determined as follows: 

(a) If the Common Stock is listed on any (i) established securities exchange (such as the New York Stock Exchange, the NASDAQ Global
Market and the NASDAQ Global Select Market), (ii) national market system or (iii) automated quotation system, its Fair Market Value shall be the closing sales price for a Share as quoted on such exchange or system for such date or, if
there is no closing sales price for a Share on the date in question, the closing sales price for a Share on the last preceding date for which such quotation exists, as reported in The Wall Street Journal or such other source as the Administrator
deems reliable; 
 (b) If the Common Stock is not listed on an established securities exchange, national market system or
automated quotation system, but the Common Stock is regularly quoted by a recognized securities dealer, its Fair Market Value shall be the mean of the high bid 

  
 4 

 
and low asked prices for such date or, if there are no high bid and low asked prices for a Share on such date, the high bid and low asked prices for a Share on the last preceding date for which
such information exists, as reported in The Wall Street Journal or such other source as the Administrator deems reliable; or 
 (c) If the Common Stock is neither listed on an established securities exchange, national market system or automated quotation system nor regularly quoted by a recognized securities dealer, its Fair
Market Value shall be established by the Administrator in good faith. 
 Notwithstanding the foregoing, with respect to any
Award granted after the effectiveness of the Company’s registration statement relating to its initial public offering and prior to the Public Trading Date, the Fair Market Value shall mean the initial public offering price of a Share as set
forth in the Company’s final prospectus relating to its initial public offering filed with the Securities and Exchange Commission. 
 2.24 “Greater Than 10% Stockholder” shall mean an individual then owning (within the meaning of Section 424(d) of the Code) more than 10% of the total combined voting power of all
classes of stock of the Company or any subsidiary corporation (as defined in Section 424(f) of the Code) or parent corporation thereof (as defined in Section 424(e) of the Code). 

2.25 “Holder” shall mean a person who has been granted an Award. 

2.26 “Incentive Stock Option” shall mean an Option that is intended to qualify as an incentive stock option and conforms
to the applicable provisions of Section 422 of the Code. 
 2.27 “Non-Employee Director” shall mean a
Director of the Company who is not an Employee. 
 2.28 “Non-Employee Director Equity Compensation Policy”
shall have the meaning set forth in Section 4.5. 
 2.29 “Non-Qualified Stock Option” shall mean an Option
that is not an Incentive Stock Option. 
 2.30 “Option” shall mean a right to purchase Shares at a specified
exercise price, granted under Article 5. An Option shall be either a Non-Qualified Stock Option or an Incentive Stock Option; provided, however, that Options granted to Non-Employee Directors and Consultants shall only be Non-Qualified
Stock Options. 
 2.31 “Option Term” shall have the meaning set forth in Section 5.6. 

2.32 “Parent” shall mean any entity (other than the Company), whether domestic or foreign, in an unbroken chain of
entities ending with the Company if each of the entities other than the Company beneficially owns, at the time of the determination, securities or interests representing at least fifty percent (50%) of the total combined voting power of all
classes of securities or interests in one of the other entities in such chain. 

  
 5 

 2.33 “Performance Award” shall mean a cash bonus award, stock bonus award,
performance award or other incentive award that is paid in cash, Shares or a combination of both, awarded under Section 8.1. 
 2.34 “Performance Criteria” shall mean the criteria (and adjustments) that the Committee selects for an Award for purposes of establishing the Performance Goal or Performance Goals for a
Performance Period, determined as follows: 
 (a) The Performance Criteria that shall be used to establish Performance Goals may
include but are not limited to: (i) net earnings (either before or after one or more of (A) interest, (B) taxes, (C) depreciation and (D) amortization); (ii) gross or net sales or revenue; (iii) net income (either
before or after taxes); (iv) adjusted net income; (v) operating earnings or profit; (vi) cash flow (including, but not limited to, operating cash flow and free cash flow); (vii) return on assets; (viii) return on capital;
(ix) return on stockholders’ equity; (x) total stockholder return; (xi) return on sales; (xii) gross or net profit or operating margin; (xiii) costs; (xiv) expenses; (xv) working capital; (xvi) earnings
per share; (xvii) adjusted earnings per share; (xviii) price per share; (xix) regulatory body approval for commercialization of a product; (xx) implementation, completion or attainment of objectives relating to research,
development, regulatory, commercial, or strategic milestones or developments; (xxi) market share; (xxii) economic value; (xxiii) revenue; (xxiv) revenue growth; and (xxv) operational and organizational metrics, any of which
may be measured either in absolute terms or as compared to any incremental increase or decrease or as compared to results of a peer group or to market performance indicators or indices. 

(b) The Administrator, in its discretion, may adjust the Performance Criteria for any Performance Period for such factors as the
Administrator may determine, including, without limitation, in recognition of unusual or non-recurring events affecting the Company or changes in Applicable Law or Applicable Accounting Standards. 

2.35 “Performance Goals” shall mean, for a Performance Period, one or more goals established in writing by the
Administrator for the Performance Period based upon one or more Performance Criteria. Depending on the Performance Criteria used to establish Performance Goals, Performance Goals may be expressed in terms of overall Company performance or the
performance of a Subsidiary, division, business unit, or an individual. The achievement of each Performance Goal shall be determined, to the extent applicable, with reference to Applicable Accounting Standards. 

2.36 “Performance Period” shall mean one or more periods of time, which may be of varying and overlapping durations, as
the Administrator may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Holder’s right to, and the payment of, an Award. 

2.37 “Performance Stock Unit” shall mean a Performance Award awarded under Section 8.1 which is denominated in
units of value including dollar value of Shares. 
 2.38 “Permitted Transferee” shall mean, with respect to a
Holder, any “family member” of the Holder, as defined in the instructions to use the Form S-8 Registration Statement under the Securities Act, or any other transferee specifically approved by the Administrator after taking into account
Applicable Law. 

  
 6 

 2.39 “Plan” shall have the meaning set forth in Article 1. 

2.40 “Prior Plan” shall mean the BIND Biosciences, Inc. 2006 Stock Incentive Plan, as such plan may be amended from time
to time. 
 2.41 “Public Trading Date” shall mean the first date upon which Common Stock is listed (or approved
for listing) upon notice of issuance on any securities exchange or designated (or approved for designation) upon notice of issuance as a national market security on an interdealer quotation system. 

2.42 “Restricted Stock” shall mean Common Stock awarded under Article 6 that is subject to certain restrictions and
may be subject to risk of forfeiture or repurchase. 
 2.43 “Restricted Stock Unit” shall mean the right to
receive Shares awarded under Article 7. 
 2.44 “Securities Act” shall mean the Securities Act of 1933, as
amended. 
 2.45 “Shares” shall mean shares of Common Stock. 

2.46 “Stock Appreciation Right” shall mean a stock appreciation right granted under Article 9. 

2.47 “Stock Appreciation Right Term” shall have the meaning set forth in Section 9.4. 

2.48 “Stock Payment” shall mean (a) a payment in the form of Shares, or (b) an option or other right to
purchase Shares, as part of a bonus, deferred compensation or other arrangement, awarded under Section 8.3. 
 2.49
“Subsidiary” shall mean any entity (other than the Company), whether domestic or foreign, in an unbroken chain of entities beginning with the Company if each of the entities other than the last entity in the unbroken chain
beneficially owns, at the time of the determination, securities or interests representing at least 50% of the total combined voting power of all classes of securities or interests in one of the other entities in such chain. 

2.50 “Substitute Award” shall mean an Award granted under the Plan upon the assumption of, or in substitution for,
outstanding equity awards granted by a company or other entity in connection with a corporate transaction, such as a merger, combination, consolidation or acquisition of property or stock; provided, however, that in no event shall the
term “Substitute Award” be construed to refer to an award made in connection with the cancellation and repricing of an Option or Stock Appreciation Right. 

  
 7 

 2.51 “Termination of Service” shall mean: 

(a) As to a Consultant, the time when the engagement of a Holder as a Consultant to the Company or a Subsidiary is terminated for any
reason, with or without cause, including, without limitation, by resignation, discharge, death, disability or retirement, but excluding terminations where the Consultant simultaneously commences or remains in employment or service with the Company
or any Subsidiary. 
 (b) As to a Non-Employee Director, the time when a Holder who is a Non-Employee Director ceases to be a
Director for any reason, including, without limitation, a termination by resignation, failure to be elected, death, disability or retirement, but excluding terminations where the Holder simultaneously commences or remains in employment or service
with the Company or any Subsidiary. 
 (c) As to an Employee, the time when the employee-employer relationship between a Holder
and the Company or any Subsidiary is terminated for any reason, including, without limitation, a termination by resignation, discharge, death, disability or retirement; but excluding terminations where the Holder simultaneously commences or remains
in employment or service with the Company or any Subsidiary. 
 The Administrator, in its discretion, shall determine the effect
of all matters and questions relating to any Termination of Service, including, without limitation, the question of whether a Termination of Service resulted from a discharge for cause and all questions of whether particular leaves of absence
constitute a Termination of Service; provided, however, that, with respect to Incentive Stock Options, unless the Administrator otherwise provides in the terms of the Award Agreement or otherwise, or as otherwise required by Applicable
Law, a leave of absence, change in status from an employee to an independent contractor or other change in the employee-employer relationship shall constitute a Termination of Service only if, and to the extent that, such leave of absence, change in
status or other change interrupts employment for the purposes of Section 422(a)(2) of the Code. For purposes of the Plan, a Holder’s employee-employer relationship or consultancy relations shall be deemed to be terminated in the event that
the Subsidiary employing or contracting with such Holder ceases to remain an Subsidiary following any merger, sale of stock or other corporate transaction or event (including, without limitation, a spin-off). 

ARTICLE 3. 

SHARES SUBJECT TO THE PLAN 
 3.1 Number of Shares. 
 (a) Subject to Sections 3.1(b) and 12.2, the
aggregate number of Shares which may be issued or transferred pursuant to Awards under the Plan is the sum of: (i) 1,335,877 Shares, (ii) any Shares which as of the Effective Date are subject to awards granted under the Prior Plan which
are forfeited, lapse unexercised or are settled in cash and which following the Effective Date are not issued under the Prior Plan; and (iii) an annual increase on the first day of each calendar year beginning January 1, 2014 and ending on
and including January 1, 2023, 

  
 8 

 
equal to the lesser of (A) 1,335,877 Shares, (B) 4% of the Shares outstanding (on an as-converted basis) on the final day of the immediately preceding calendar year and (C) such
smaller number of Shares as determined by the Board; provided, however, no more than 10,000,000 Shares may be issued upon the exercise of Incentive Stock Options. From and after the Effective Date, no awards shall be granted
under the Prior Plan. Any award outstanding under the Prior Plan as of the Effective Date shall continue to be subject to the terms and conditions of the Prior Plan. 
 (b) To the extent all or a portion of an Award is forfeited, expires, lapses for any reason, or is settled for cash without the delivery of Shares to the Holder, any Shares subject to such Award or
portion thereof shall, to the extent of such forfeiture, expiration, lapse or cash settlement, again be available for the grant of an Award under the Plan. Any Shares repurchased by or surrendered to the Company under Section 6.4 so that such
Shares are returned to the Company shall again be available for the grant of an Award under the Plan. The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards shall not be counted against the Shares available for
issuance under the Plan. Notwithstanding the provisions of this Section 3.1(b), no Shares may again be optioned, granted or awarded if such action would cause an Incentive Stock Option to fail to qualify as an incentive stock option under
Section 422 of the Code. 
 (c) To the extent permitted by Applicable Law, Substitute Awards shall not reduce the Shares
authorized for grant under the Plan. 
 3.2 Stock Distributed. Any Shares distributed pursuant to an Award may consist,
in whole or in part, of authorized and unissued Common Stock, treasury Common Stock or Common Stock purchased on the open market. 
 3.3 Limitation on Awards to Non-Employee Directors. Notwithstanding any provision in the Plan to the contrary, and subject to Section 12.2, no Non-Employee Director shall be granted Awards
under the Plan for services as a Non-Employee Director for any one year covering more than 250,000 Shares, provided that a Non-Employee Director may be granted Awards under the Plan for services as a Non-Employee Director for any one year in
excess of such amount if the total Awards granted to such Non-Employee Director under the Plan for services as a Non-Employee Director in such year do not have a grant date fair value, as determined in accordance with Financial Accounting Standards
Board Accounting Standards Codification Topic 718, or any successor thereto, in excess of $1,000,000. 
 ARTICLE 4.

 GRANTING OF AWARDS 
 4.1 Participation. The Administrator may, from time to time, select from among all Eligible Individuals, those to whom an Award shall be granted and shall determine the nature and amount of each
Award, which shall not be inconsistent with the requirements of the Plan. Except as provided in Section 4.5 regarding the grant of Awards pursuant to the Non-Employee Director Equity Compensation Policy, no Eligible Individual shall have any
right to be granted an Award pursuant to the Plan. 

  
 9 

 4.2 Award Agreement. Each Award shall be evidenced by an Award Agreement that sets
forth the terms, conditions and limitations for such Award, which may include the term of the Award, the provisions applicable in the event of the Holder’s Termination of Service, and the Company’s authority to unilaterally or bilaterally
amend, modify, suspend, cancel or rescind an Award. Award Agreements evidencing Incentive Stock Options shall contain such terms and conditions as may be necessary to meet the applicable provisions of Section 422 of the Code. 

4.3 Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan, the Plan, and any Award
granted or awarded to any individual who is then subject to Section 16 of the Exchange Act, shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including Rule 16b-3 of the Exchange Act and any amendments thereto) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, the Plan and Awards granted or awarded hereunder
shall be deemed amended to the extent necessary to conform to such applicable exemptive rule. 
 4.4 At-Will Employment;
Voluntary Participation. Nothing in the Plan or Award Agreement shall confer upon any Holder any right to continue in the employ of, or as a Director or Consultant for, the Company or any Subsidiary, or shall interfere with or restrict in any
way the rights of the Company and any Subsidiary, which rights are hereby expressly reserved, to discharge any Holder at any time for any reason whatsoever, with or without cause, and with or without notice, or to terminate or change all other terms
and conditions of employment or engagement, except to the extent expressly provided otherwise in a written agreement between the Holder and the Company or any Subsidiary. Participation by each Holder in the Plan shall be voluntary and nothing in the
Plan shall be construed as mandating that any Eligible Individual shall participate in the Plan. 
 4.5 Non-Employee Director
Awards. The Administrator, in its discretion, may provide that Awards granted to Non-Employee Directors shall be granted pursuant to a written nondiscretionary formula established by the Administrator (the “Non-Employee Director Equity
Compensation Policy”), subject to the limitations of the Plan. The Non-Employee Director Equity Compensation Policy shall set forth the type of Award(s) to be granted to Non-Employee Directors, the number of Shares to be subject to
Non-Employee Director Awards, the conditions on which such Awards shall be granted, become exercisable and/or payable and expire, and such other terms and conditions as the Administrator shall determine in its discretion. The Non-Employee Director
Equity Compensation Policy may be modified by the Administrator from time to time in its discretion. 
 4.6 Stand-Alone and
Tandem Awards. Awards granted pursuant to the Plan may, in the discretion of the Administrator, be granted either alone, in addition to, or in tandem with, any other Award granted pursuant to the Plan. Awards granted in addition to or in tandem
with other Awards may be granted either at the same time as or at a different time from the grant of such other Awards. 

  
 10 

 ARTICLE 5. 
 OPTIONS 
 5.1 Granting of Options to Eligible Individuals. The
Administrator is authorized to grant Options to Eligible Individuals from time to time, in its discretion, on such terms and conditions as it may determine, which shall not be inconsistent with the Plan. 

5.2 Option Exercise Price. The exercise price per Share subject to each Option shall be set by the Administrator, but shall not be
less than 100% of the Fair Market Value of a Share on the date the Option is granted (or, as to Incentive Stock Options, on the date the Option is modified, extended or renewed for purposes of Section 424(h) of the Code) unless otherwise
determined by the Administrator. In addition, in the case of Incentive Stock Options granted to a Greater Than 10% Stockholder, such price shall not be less than 110% of the Fair Market Value of a Share on the date the Option is granted (or the date
the Option is modified, extended or renewed for purposes of Section 424(h) of the Code). 
 5.3 Option Vesting.

 (a) The period during which the right to exercise, in whole or in part, an Option vests in the Holder shall be set by the
Administrator and the Administrator may determine that an Option may not be exercised in whole or in part for a specified period after it is granted. Such vesting may be based on service with the Company or any Subsidiary or any other criteria
selected by the Administrator, including Performance Goals or Performance Criteria. At any time after the grant of an Option, the Administrator, in its discretion and subject to whatever terms and conditions it selects, may accelerate the period
during which an Option vests. 
 (b) No portion of an Option which is unexercisable at a Holder’s Termination of Service
shall thereafter become exercisable, except as may be otherwise provided by the Administrator either in the Award Agreement evidencing the grant of an Option or by action of the Administrator following the grant of the Option. Unless otherwise
determined by the Administrator in the Award Agreement or by action of the Administrator following the grant of the Option, the portion of an Option that is unexercisable at a Holder’s Termination of Service shall automatically expire thirty
(30) days following such Termination of Service. 
 5.4 Manner of Exercise. All or a portion of an exercisable
Option shall be deemed exercised upon delivery of all of the following to the Secretary of the Company, the stock administrator of the Company or such other person or entity designated by the Administrator, or his, her or its office, as applicable:

 (a) A written or electronic notice complying with the applicable rules established by the Administrator stating that the
Option, or a portion thereof, is exercised. The notice shall be signed by the Holder or other person then entitled to exercise the Option or such portion of the Option. 

  
 11 

 (b) Such representations and documents as the Administrator, in its discretion, deems
necessary or advisable to effect compliance with Applicable Law. The Administrator may, in its discretion, also take whatever additional actions it deems appropriate to effect such compliance including, without limitation, placing legends on share
certificates and issuing stop-transfer notices to agents and registrars. 
 (c) In the event that the Option shall be exercised
by any person or persons other than the Holder, appropriate proof of the right of such person or persons to exercise the Option, as determined in the discretion of the Administrator. 

(d) Full payment of the exercise price and applicable withholding taxes for the shares with respect to which the Option, or portion
thereof, is exercised, in a manner permitted by Section 10.1 and Section 10.2. 
 5.5 Partial Exercise. An
exercisable Option may be exercised in whole or in part. However, an Option shall not be exercisable with respect to fractional Shares unless otherwise determined by the Administrator and the Administrator may require that, by the terms of the
Option, a partial exercise must be with respect to a minimum number of shares. 
 5.6 Option Term. The term of each
Option (the “Option Term”) shall be set by the Administrator in its discretion; provided, however, that the Option Term shall not be more than ten (10) years from the date the Option is granted, or five
(5) years from the date an Incentive Stock Option is granted to a Greater Than 10% Stockholder. The Administrator shall determine the time period, including the time period following a Termination of Service, during which the Holder has the
right to exercise the vested Options, which time period may not extend beyond the last day of the Option Term. Except as limited by the requirements of Section 409A of the Code or the first sentence of this Section 5.6, the Administrator
may extend the Option Term of any outstanding Option, and may extend the time period during which vested Options may be exercised, in connection with any Termination of Service of the Holder, and may amend, subject to Section 12.1, any other
term or condition of such Option relating to such a Termination of Service. 
 5.7 Expiration of Option Term: Automatic
Exercise of In-The-Money Options. Unless otherwise provided by the Administrator (in an Award Agreement or otherwise) or as otherwise directed by an Option Holder in writing to the Company, each Option outstanding on the Automatic Exercise Date
with an exercise price per share that is less than the Fair Market Value per share of Common Stock as of such date shall automatically and without further action by the Option Holder or the Company be exercised on the Automatic Exercise Date. In the
discretion of the Administrator, payment of the exercise price of any such Option shall be made pursuant to Section 10.1(b) or Section 10.1(c) and the Company or any Subsidiary shall deduct or withhold an amount sufficient to satisfy all
taxes associated with such exercise in accordance with Section 10.2. Unless otherwise determined by the Administrator, this Section 5.7 shall not apply to an Option if the Holder of such Option incurs a Termination of Service on or before
the Automatic Exercise Date. For the avoidance of doubt, no Option with an exercise price per share that is equal to or greater than the Fair Market Value per share of Common Stock on the Automatic Exercise Date shall be exercised pursuant to this
Section 5.7. 

  
 12 

 5.8 Notification Regarding Disposition. The Holder shall give the Company prompt
written or electronic notice of any disposition of Shares acquired by exercise of an Incentive Stock Option which occurs within (a) two years from the date of granting (including the date the Option is modified, extended or renewed for purposes
of Section 424(h) of the Code) such Option to such Holder, or (b) one year after the transfer of such Shares to such Holder. 
 ARTICLE 6. 
 RESTRICTED STOCK 

6.1 Award of Restricted Stock. 
 (a) The Administrator is authorized to grant Restricted Stock to Eligible Individuals, and shall determine the terms and conditions, including the restrictions applicable to each award of Restricted
Stock, which terms and conditions shall not be inconsistent with the Plan, and may impose such conditions on the issuance of such Restricted Stock as it deems appropriate. 
 (b) The Administrator shall establish the purchase price, if any, and form of payment for Restricted Stock; provided, however, that if a purchase price is charged, such purchase price shall
be no less than the par value, if any, of the Shares to be purchased, unless otherwise permitted by Applicable Law. In all cases, legal consideration shall be required for each issuance of Restricted Stock. 

6.2 Rights as Stockholders. Subject to Section 6.4, upon issuance of Restricted Stock, the Holder shall have, unless
otherwise provided by the Administrator, all the rights of a stockholder with respect to said Shares, subject to the restrictions in each individual Award Agreement, including the right to receive all dividends and other distributions paid or made
with respect to the Shares; provided, however, that, in the discretion of the Administrator, any extraordinary distributions with respect to the Shares shall be subject to the restrictions set forth in Section 6.3. 

6.3 Restrictions. All shares of Restricted Stock (including any shares received by Holders thereof with respect to shares of
Restricted Stock as a result of stock dividends, stock splits or any other form of recapitalization) shall, in the terms of each individual Award Agreement, be subject to such restrictions and vesting requirements as the Administrator shall provide.
Such restrictions may include, without limitation, restrictions concerning voting rights and transferability and such restrictions may lapse separately or in combination at such times and pursuant to such circumstances or based on such criteria as
selected by the Administrator, including, without limitation, criteria based on the Holder’s duration of employment, directorship or consultancy with the Company, Performance Goals, Performance Criteria, Company performance, individual
performance or other criteria selected by the Administrator. By action taken after the Restricted Stock is issued, the Administrator may, on such terms and conditions as it may determine to be appropriate, accelerate the vesting of such Restricted
Stock by removing any or all of the restrictions imposed by the terms of the applicable Award Agreement. Unless otherwise determined by the Administrator, Restricted Stock may not be sold or encumbered until all restrictions are terminated or
expire. 

  
 13 

 6.4 Repurchase or Forfeiture of Restricted Stock. Except as otherwise determined by
the Administrator at the time of the grant of the Award or thereafter, (a) if no price was paid by the Holder for the Restricted Stock, upon a Termination of Service during the applicable restriction period, the Holder’s rights in unvested
Restricted Stock then subject to restrictions shall lapse, and such Restricted Stock shall be surrendered to the Company and cancelled without consideration, and (b) if a price was paid by the Holder for the Restricted Stock, upon a Termination
of Service during the applicable restriction period, the Company shall have the right to repurchase from the Holder the unvested Restricted Stock then subject to restrictions at a cash price per share equal to the price paid by the Holder for such
Restricted Stock or such other amount as may be specified in the applicable Award Agreement. 
 6.5 Certificates for
Restricted Stock. Restricted Stock granted pursuant to the Plan may be evidenced in such manner as the Administrator shall determine. Certificates or book entries evidencing shares of Restricted Stock shall include an appropriate legend
referring to the terms, conditions, and restrictions applicable to such Restricted Stock. The Company, in its discretion, may (a) retain physical possession of any stock certificate evidencing shares of Restricted Stock until the restrictions
thereon shall have lapsed and/or (b) require that the stock certificates evidencing shares of Restricted Stock be held in custody by a designated escrow agent (which may but need not be the Company) until the restrictions thereon shall have
lapsed and that the Holder deliver a stock power, endorsed in blank, relating to such Restricted Stock. 
 6.6
Section 83(b) Election. If a Holder makes an election under Section 83(b) of the Code to be taxed with respect to the Restricted Stock as of the date of transfer of the Restricted Stock rather than as of the date or dates upon which
the Holder would otherwise be taxable under Section 83(a) of the Code, the Holder shall be required to deliver a copy of such election to the Company promptly after filing such election with the Internal Revenue Service. 

ARTICLE 7. 

RESTRICTED STOCK UNITS 
 7.1 Grant of Restricted Stock Units. The Administrator is authorized to grant Awards of Restricted Stock Units to any Eligible Individual selected by the Administrator in such amounts and subject
to such terms and conditions as determined by the Administrator. 
 7.2 Purchase Price. The Administrator shall specify
the purchase price, if any, to be paid by the Holder to the Company with respect to any Restricted Stock Unit award; provided, however, that value of the consideration shall not be less than the par value of a Share, unless otherwise
permitted by Applicable Law. 
 7.3 Vesting of Restricted Stock Units. At the time of grant, the Administrator shall
specify the date or dates on which the Restricted Stock Units shall become fully vested and nonforfeitable, and may specify such conditions to vesting as it deems appropriate, including, without limitation, vesting based upon the Holder’s
duration of service to the Company or any Subsidiary, Company performance, individual performance or other specific criteria, in each case on a specified date or dates or over any period or periods, as determined by the Administrator. 

  
 14 

 7.4 Maturity and Payment. At the time of grant, the
Administrator shall specify the maturity date applicable to each grant of Restricted Stock Units, which shall be no earlier than the vesting date or dates of the Award and may be determined at the election of the Holder (if permitted by the
applicable Award Agreement); provided that, except as otherwise set forth in an applicable Award Agreement, the maturity date relating to each Restricted Stock Unit shall not occur following the later of (a) the 15th day of the third month following the end of the calendar year in
which the applicable portion of the Restricted Stock Unit vests; or (b) the 15th day of the third month following the end of the Company’s fiscal year in which the applicable portion of the Restricted Stock Unit vests. On the maturity date, the Company shall, subject to
Section 10.4, transfer to the Holder one unrestricted, fully transferable Share for each Restricted Stock Unit scheduled to be paid out on such date and not previously forfeited, or in the discretion of the Administrator, an amount in cash
equal to the Fair Market Value of such Shares on the maturity date or a combination of cash and Common Stock as determined by the Administrator. 
 7.5 No Rights as a Stockholder. Unless otherwise determined by the Administrator, a Holder of Restricted Stock Units shall possess no incidents of ownership with respect to the Shares represented
by such Restricted Stock Units, unless and until such Shares are transferred to the Holder pursuant to the terms of this Plan and the Award Agreement. 
 ARTICLE 8. 
 PERFORMANCE AWARDS, DIVIDEND EQUIVALENTS, STOCK PAYMENTS

 8.1 Performance Awards. The Administrator is authorized to grant Performance Awards, including Awards of
Performance Stock Units and other Awards determined in the Administrator’s discretion from time to time, to any Eligible Individual. The value of Performance Awards, including Performance Stock Units, may be linked to the attainment of the
Performance Goals or other specific criteria, whether or not objective, determined by the Administrator, in each case on a specified date or dates or over any period or periods and in such amounts as may be determined by the Administrator.

 8.2 Dividend Equivalents. 
 (a) Dividend Equivalents may be granted by the Administrator based on dividends declared on the Common Stock, to be credited as of dividend payment dates with respect to dividends with record dates that
occur during the period between the date an Award is granted to a Holder and the date such Award vests, is exercised, is distributed or expires, as determined by the Administrator. Such Dividend Equivalents shall be converted to cash or additional
Shares by such formula and at such time and subject to such restrictions and limitations as may be determined by the Administrator. 
 8.3 Stock Payments. The Administrator is authorized to make Stock Payments to any Eligible Individual. The number or value of Shares of any Stock Payment shall be determined by the Administrator
and may be based upon one or more Performance Goals or any other specific criteria, including service to the Company or any Subsidiary, determined by the Administrator. Shares underlying a Stock Payment which is subject to a vesting schedule or
other conditions or criteria set by the Administrator shall not be issued until those conditions 

  
 15 

 
have been satisfied. Unless otherwise provided by the Administrator, a Holder of a Stock Payment shall have no rights as a Company stockholder with respect to such Stock Payment until such time
as the Stock Payment has vested and the Shares underlying the Award have been issued to the Holder. Stock Payments may, but are not required to, be made in lieu of base salary, bonus, fees or other cash compensation otherwise payable to such
Eligible Individual. 
 8.4 Purchase Price. The Administrator may establish the purchase price of a Performance Award or
Shares distributed as a Stock Payment award; provided, however, that value of the consideration shall not be less than the par value of a Share, unless otherwise permitted by Applicable Law. 

ARTICLE 9. 

STOCK APPRECIATION RIGHTS 
 9.1 Grant of Stock Appreciation Rights. 
 (a) The Administrator is
authorized to grant Stock Appreciation Rights to Eligible Individuals from time to time, in its discretion, on such terms and conditions as it may determine, which shall not be inconsistent with the Plan. 

(b) A Stock Appreciation Right shall entitle the Holder (or other person entitled to exercise the Stock Appreciation Right pursuant to
the Plan) to exercise all or a specified portion of the Stock Appreciation Right (to the extent then exercisable pursuant to its terms) and to receive from the Company an amount determined by multiplying the difference obtained by subtracting the
exercise price per share of the Stock Appreciation Right from the Fair Market Value on the date of exercise of the Stock Appreciation Right by the number of Shares with respect to which the Stock Appreciation Right shall have been exercised, subject
to any limitations the Administrator may impose. Unless otherwise determined by the Administrator, the exercise price per Share subject to each Stock Appreciation Right shall be set by the Administrator, but shall not be less than 100% of the Fair
Market Value on the date the Stock Appreciation Right is granted. 
 9.2 Stock Appreciation Right Vesting. 

(a) The period during which the right to exercise, in whole or in part, a Stock Appreciation Right vests in the Holder shall be set by
the Administrator, and the Administrator may determine that a Stock Appreciation Right may not be exercised in whole or in part for a specified period after it is granted. Such vesting may be based on service with the Company or any Subsidiary,
Performance Criteria, Performance Goals or any other criteria selected by the Administrator. At any time after grant of a Stock Appreciation Right, the Administrator, in its discretion and subject to whatever terms and conditions it selects, may
accelerate the period during which a Stock Appreciation Right vests. 
 (b) No portion of a Stock Appreciation Right which is
unexercisable at a Holder’s Termination of Service shall thereafter become exercisable, except as may be otherwise provided by the Administrator in an Award Agreement or by action of the Administrator following the grant of the Stock
Appreciation Right. Unless otherwise determined by the 

  
 16 

 
Administrator in the Award Agreement or by action of the Administrator following the grant of the Stock Appreciation Right, the portion of a Stock Appreciation Right which is unexercisable at a
Holder’s Termination of Service shall automatically expire thirty (30) days following such Termination of Service. 

9.3 Manner of Exercise. All or a portion of an exercisable Stock Appreciation Right shall be deemed exercised upon delivery of all
of the following to the Secretary of the Company, the stock administrator of the Company, or such other person or entity designated by the Administrator, or his, her or its office, as applicable: 

(a) A written or electronic notice complying with the applicable rules established by the Administrator stating that the Stock
Appreciation Right, or a portion thereof, is exercised. The notice shall be signed by the Holder or other person then entitled to exercise the Stock Appreciation Right or such portion of the Stock Appreciation Right. 

(b) Such representations and documents as the Administrator, in its discretion, deems necessary or advisable to effect compliance with
Applicable Law. The Administrator, in its discretion, may also take whatever additional actions it deems appropriate to effect such compliance, including, without limitation, placing legends on share certificates and issuing stop-transfer notices to
agents and registrars. 
 (c) In the event that the Stock Appreciation Right shall be exercised by any person or persons other
than the Holder, appropriate proof of the right of such person or persons to exercise the Stock Appreciation Right, as determined in the discretion of the Administrator. 
 (d) Full payment of the exercise price and applicable withholding taxes for the Shares with respect to which the Stock Appreciation Right, or portion thereof, is exercised, in a manner permitted by
Section 10.1 and Section 10.2. 
 9.4 Stock Appreciation Right Term. The term of each Stock Appreciation Right
(the “Stock Appreciation Right Term”) shall be set by the Administrator in its discretion; provided, however, that the Stock Appreciation Right Term shall not be more than ten (10) years from the date the Stock
Appreciation Right is granted. The Administrator shall determine the time period, including the time period following a Termination of Service, during which the Holder has the right to exercise the vested Stock Appreciation Rights, which time period
may not extend beyond the last day of the Stock Appreciation Right Term applicable to such Stock Appreciation Right. Except as limited by the requirements of Section 409A of the Code or the first sentence of this Section 9.4, the
Administrator may extend the Stock Appreciation Right Term of any outstanding Stock Appreciation Right, and may extend the time period during which vested Stock Appreciation Rights may be exercised, in connection with any Termination of Service of
the Holder, and may amend, subject to Section 14.1, any other term or condition of such Stock Appreciation Right relating to such a Termination of Service. 
 9.5 Payment. Payment of the amounts payable with respect to Stock Appreciation Rights pursuant to this Article 9 shall be in cash, Shares (based on Fair Market Value as of the date the Stock
Appreciation Right is exercised), or a combination of both, as determined by the Administrator. 

  
 17 

 9.6 Expiration of Stock Appreciation Right Term: Automatic Exercise of In-The-Money Stock
Appreciation Rights. Unless otherwise provided by the Administrator (in an Award Agreement or otherwise) or as otherwise directed by a Stock Appreciation Right Holder in writing to the Company, each Stock Appreciation Right outstanding on the
Automatic Exercise Date with an exercise price per share that is less than the Fair Market Value per share of Common Stock as of such date shall automatically and without further action by the Stock Appreciation Right Holder or the Company be
exercised on the Automatic Exercise Date. In the discretion of the Administrator, the Company or any Subsidiary shall deduct or withhold an amount sufficient to satisfy all taxes associated with such exercise in accordance with Section 10.2.
Unless otherwise determined by the Administrator, this Section 9.6 shall not apply to a Stock Appreciation Right if the Holder of such Stock Appreciation Right incurs a Termination of Service on or before the Automatic Exercise Date. For the
avoidance of doubt, no Stock Appreciation Right with an exercise price per share that is equal to or greater than the Fair Market Value per share of Common Stock on the Automatic Exercise Date shall be exercised pursuant to this Section 9.6.

 ARTICLE 10. 
 ADDITIONAL TERMS OF AWARDS 
 10.1 Payment. The Administrator shall
determine the methods by which payments by any Holder with respect to any Awards granted under the Plan shall be made, including, without limitation: (a) cash or check, (b) Shares (including, in the case of payment of the exercise price of
an Award, Shares issuable pursuant to the exercise of the Award) held for such period of time as may be required by the Administrator in order to avoid adverse accounting consequences, in each case, having a Fair Market Value on the date of delivery
equal to the aggregate payments required, (c) delivery of a written or electronic notice that the Holder has placed a market sell order with a broker acceptable to the Company with respect to Shares then issuable upon exercise or vesting of an
Award, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the aggregate payments required; provided that payment of such proceeds is then made to the Company
upon settlement of such sale, or (d) any other form of legal consideration acceptable to the Administrator in its discretion. The Administrator shall also determine the methods by which Shares shall be delivered or deemed to be delivered to
Holders. Notwithstanding any other provision of the Plan to the contrary, no Holder who is a Director or an “executive officer” of the Company within the meaning of Section 13(k) of the Exchange Act shall be permitted to make payment
with respect to any Awards granted under the Plan, or continue any extension of credit with respect to such payment, with a loan from the Company or a loan arranged by the Company in violation of Section 13(k) of the Exchange Act. 

10.2 Tax Withholding. The Company or any Subsidiary shall have the authority and the right to deduct or withhold, or require a
Holder to remit to the Company, an amount sufficient to satisfy federal, state, local and foreign taxes (including the Holder’s FICA, employment tax or other social security contribution obligation) required by law to be withheld with respect
to any taxable event concerning a Holder arising as a result of the Plan. The Administrator, in its discretion and in satisfaction of the foregoing requirement, may withhold, or allow a Holder to elect to have the Company withhold, Shares otherwise
issuable under an 

  
 18 

 
Award (or allow the surrender of Shares). Unless otherwise determined by the Administrator, the number of Shares which may be so withheld or surrendered shall be limited to the number of Shares
which have a Fair Market Value on the date of withholding or repurchase equal to the aggregate amount of such liabilities based on the minimum statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes that
are applicable to such supplemental taxable income. The Administrator shall determine the fair market value of the Shares, consistent with applicable provisions of the Code, for tax withholding obligations due in connection with a broker-assisted
cashless Option or Stock Appreciation Right exercise involving the sale of Shares to pay the Option or Stock Appreciation Right exercise price or any tax withholding obligation. 

10.3 Transferability of Awards. 
 (a) Except as otherwise provided in Section 10.3(b): 
 (i) No Award under the
Plan may be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution or, subject to the consent of the Administrator, pursuant to a DRO, unless and until such Award has been exercised, or the
Shares underlying such Award have been issued, and all restrictions applicable to such Shares have lapsed; 
 (ii) No Award or
interest or right therein shall be liable for the debts, contracts or engagements of the Holder or the Holder’s successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, hypothecation, encumbrance,
assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition
thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by Section 10.3(a)(i); and 
 (iii) During the lifetime of the Holder, only the Holder may exercise an Award (or any portion thereof) granted to such Holder under the Plan, unless it has been disposed of pursuant to a DRO; after the
death of the Holder, any exercisable portion of an Award may, prior to the time when such portion becomes unexercisable under the Plan or the Award Agreement, be exercised by the Holder’s personal representative or by any person empowered to do
so under the deceased Holder’s will or under the then-applicable laws of descent and distribution. 
 (b) Notwithstanding
Section 10.3(a), the Administrator, in its discretion, may determine to permit a Holder to transfer an Award other than an Incentive Stock Option to any one or more Permitted Transferees, subject to the following terms and conditions:
(i) an Award transferred to a Permitted Transferee shall not be assignable or transferable by the Permitted Transferee other than by will or the laws of descent and distribution; (ii) an Award transferred to a Permitted Transferee shall
continue to be subject to all the terms and conditions of the Award as applicable to the original Holder (other than the ability to further transfer the Award); and (iii) the Holder and the Permitted Transferee shall execute any and all
documents requested by the Administrator, including, without limitation documents to (A) confirm the status of the transferee as a Permitted Transferee, (B) satisfy any requirements for an exemption for the transfer under Applicable Law
and (C) evidence the transfer. 

  
 19 

 (c) Notwithstanding Section 10.3(a), a Holder may, in the manner determined by the
Administrator, designate a beneficiary to exercise the rights of the Holder and to receive any distribution with respect to any Award upon the Holder’s death. A beneficiary, legal guardian, legal representative, or other person claiming any
rights pursuant to the Plan is subject to all terms and conditions of the Plan and any Award Agreement applicable to the Holder, except to the extent the Plan and Award Agreement otherwise provide, and to any additional restrictions deemed necessary
or appropriate by the Administrator. If the Holder is married or a domestic partner in a domestic partnership qualified under Applicable Law and resides in a community property state, a designation of a person other than the Holder’s spouse or
domestic partner, as applicable, as the Holder’s beneficiary with respect to more than 50% of the Holder’s interest in the Award shall not be effective without the prior written or electronic consent of the Holder’s spouse or domestic
partner. If no beneficiary has been designated or survives the Holder, payment shall be made to the person entitled thereto pursuant to the Holder’s will or the laws of descent and distribution. Subject to the foregoing, a beneficiary
designation may be changed or revoked by a Holder at any time; provided that the change or revocation is filed with the Administrator prior to the Holder’s death. 
 10.4 Conditions to Issuance of Shares. 
 (a) Notwithstanding anything
herein to the contrary, the Company shall not be required to issue or deliver any certificates or make any book entries evidencing Shares issuable pursuant to any Award, unless and until the Board or the Committee has determined, with advice of
counsel, that the issuance of such Shares is in compliance with Applicable Law and the Shares are covered by an effective registration statement or applicable exemption from registration. In addition to the terms and conditions provided herein, the
Board or the Committee may require that a Holder make such reasonable covenants, agreements and representations as the Board or the Committee, in its discretion, deems advisable in order to comply with Applicable Law. 

(b) All Share certificates delivered pursuant to the Plan and all Shares issued pursuant to book entry procedures are subject to any
stop-transfer orders and other restrictions as the Administrator deems necessary or advisable to comply with Applicable Law. The Administrator may place legends on any Share certificate or book entry to reference restrictions applicable to the
Shares. 
 (c) The Administrator shall have the right to require any Holder to comply with any timing or other restrictions with
respect to the settlement, distribution or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Administrator. 
 (d) No fractional Shares shall be issued and the Administrator, in its discretion, shall determine whether cash shall be given in lieu of fractional Shares or whether such fractional Shares shall be
eliminated by rounding down. 

  
 20 

 (e) Notwithstanding any other provision of the Plan, unless otherwise determined by the
Administrator or required by Applicable Law, the Company shall not deliver to any Holder certificates evidencing Shares issued in connection with any Award and instead such Shares shall be recorded in the books of the Company (or, as applicable, its
transfer agent or stock plan administrator). 
 10.5 Forfeiture and Claw-Back Provisions. Pursuant to its general
authority to determine the terms and conditions applicable to Awards under the Plan, the Administrator shall have the right to provide, in an Award Agreement or otherwise, or to require a Holder to agree by separate written or electronic instrument,
that: 
 (a) (i) Any proceeds, gains or other economic benefit actually or constructively received by the Holder upon any receipt
or exercise of the Award, or upon the receipt or resale of any Shares underlying the Award, shall be paid to the Company, and (ii) the Award shall terminate and any unexercised portion of the Award (whether or not vested) shall be forfeited, if
(x) a Termination of Service occurs prior to a specified date, or within a specified time period following receipt or exercise of the Award, or (y) the Holder at any time, or during a specified time period, engages in any activity in
competition with the Company, or which is inimical, contrary or harmful to the interests of the Company, as further defined by the Administrator or (z) the Holder incurs a Termination of Service for “cause” (as such term is defined in
the discretion of the Administrator, or as set forth in a written agreement relating to such Award between the Company and the Holder); and 
 (b) All Awards (including any proceeds, gains or other economic benefit actually or constructively received by the Holder upon any receipt or exercise of any Award or upon the receipt or resale of any
Shares underlying the Award) shall be subject to the provisions of any claw-back policy implemented by the Company, including, without limitation, any claw-back policy adopted to comply with the Dodd-Frank Wall Street Reform and Consumer Protection
Act and any rules or regulations promulgated thereunder, to the extent set forth in such claw-back policy and/or in the applicable Award Agreement. 
 10.6 Repricing. Subject to Section 12.2, the Administrator shall have the authority, without the approval of the stockholders of the Company, to amend any outstanding Option or Stock
Appreciation Right to reduce its price per share or cancel any Option or Stock Appreciation Right in exchange for cash or another Award when the Option or Stock Appreciation Right price per share exceeds the Fair Market Value of the underlying
Shares. 
 ARTICLE 11. 
 ADMINISTRATION 
 11.1 Administrator. The Committee (or another
committee or a subcommittee of the Board assuming the functions of the Committee under the Plan) shall administer the Plan (except as otherwise permitted herein) and, unless otherwise determined by the Board, shall consist solely of two or more
Non-Employee Directors appointed by and holding office at the pleasure of the Board, each of whom is intended to qualify as both a “non-employee director” as defined by Rule 16b-3 of the Exchange Act or any successor rule and an
“independent director” under 

  
 21 

 
the rules of any securities exchange or automated quotation system on which the Shares are listed, quoted or traded. Notwithstanding the foregoing, any action taken by the Committee shall be
valid and effective, whether or not members of the Committee at the time of such action are later determined not to have satisfied the requirements for membership set forth in this Section 11.1 or otherwise provided in any charter of the
Committee. Except as may otherwise be provided in any charter of the Committee, appointment of Committee members shall be effective upon acceptance of appointment. Committee members may resign at any time by delivering written or electronic notice
to the Board. Vacancies in the Committee may only be filled by the Board. Notwithstanding the foregoing, (a) the full Board, acting by a majority of its members in office, shall conduct the general administration of the Plan with respect to
Awards granted to Non-Employee Directors and, with respect to such Awards, the terms “Administrator” and “Committee” as used in the Plan shall be deemed to refer to the Board and (b) the Board or Committee may delegate its
authority hereunder to the extent permitted by Section 11.6. 
 11.2 Duties and Powers of Committee. It shall be the
duty of the Committee to conduct the general administration of the Plan in accordance with its provisions. The Committee shall have the power to interpret the Plan and Award Agreements, and to adopt such rules for the administration, interpretation
and application of the Plan as are not inconsistent therewith, to interpret, amend or revoke any such rules and to amend any Award Agreement; provided that the rights or obligations of the Holder of the Award that is the subject of any such
Award Agreement are not affected adversely by such amendment, unless the consent of the Holder is obtained or such amendment is otherwise permitted under Section 10.5 or Section 12.10. Any such grant or award under the Plan need not be the
same with respect to each Holder. Any such interpretations and rules with respect to Incentive Stock Options shall be consistent with the provisions of Section 422 of the Code. In its discretion, the Board may at any time and from time to time
exercise any and all rights and duties of the Committee under the Plan except with respect to matters which under Rule 16b-3 under the Exchange Act or any successor rule, or any regulations or rules issued
thereunder, or the rules of any securities exchange or automated quotation system on which the Shares are listed, quoted or traded are required to be determined in the discretion of the Committee. 

11.3 Action by the Committee. Unless otherwise established by the Board or in any charter of the Committee, a majority of the
Committee shall constitute a quorum and the acts of a majority of the members present at any meeting at which a quorum is present, and acts approved in writing by all members of the Committee in lieu of a meeting, shall be deemed the acts of the
Committee. Each member of the Committee is entitled to, in good faith, rely or act upon any report or other information furnished to that member by any officer or other employee of the Company or any Subsidiary, the Company’s independent
certified public accountants, or any executive compensation consultant or other professional retained by the Company to assist in the administration of the Plan. 
 11.4 Authority of Administrator. Subject to the Company’s Bylaws, the Committee’s Charter and any specific designation in the Plan, the Administrator has the exclusive power, authority
and sole discretion to: 
 (a) Designate Eligible Individuals to receive Awards; 

  
 22 

 (b) Determine the type or types of Awards to be granted to Eligible Individuals; 

(c) Determine the number of Awards to be granted and the number of Shares to which an Award will relate; 

(d) Determine the terms and conditions of any Award granted pursuant to the Plan, including, but not limited to, the exercise price,
grant price, purchase price, any Performance Goals or Performance Criteria, any reload provision, any restrictions or limitations on the Award, any schedule for vesting, lapse of forfeiture restrictions or restrictions on the exercisability of an
Award, and accelerations or waivers thereof, and any provisions related to non-competition and recapture of gain on an Award, based in each case on such considerations as the Administrator in its sole discretion determines; 

(e) Determine whether, to what extent, and pursuant to what circumstances an Award may be settled in, or the exercise price of an Award
may be paid in cash, Shares, other Awards, or other property, or an Award may be canceled, forfeited, or surrendered; 
 (f)
Prescribe the form of each Award Agreement, which need not be identical for each Holder; 
 (g) Decide all other matters that
must be determined in connection with an Award; 
 (h) Establish, adopt or revise any rules and regulations as it may deem
necessary or advisable to administer the Plan; 
 (i) Interpret the terms of, and any matter arising pursuant to, the Plan or
any Award Agreement; 
 (j) Make all other decisions and determinations that may be required pursuant to the Plan or as the
Administrator deems necessary or advisable to administer the Plan; and 
 (k) Accelerate wholly or partially the vesting or
lapse of restrictions of any Award or portion thereof at any time after the grant of an Award, subject to whatever terms and conditions it selects and Section 12.2(d). 
 11.5 Decisions Binding. The Administrator’s interpretation of the Plan, any Awards granted pursuant to the Plan, and any Award Agreement and all decisions and determinations by the
Administrator with respect to the Plan are final, binding and conclusive on all parties. 
 11.6 Delegation of Authority.
To the extent permitted by Applicable Law, the Board or Committee may from time to time delegate to a committee of one or more members of the Board or one or more officers of the Company the authority to grant or amend Awards or to take other
administrative actions pursuant to this Article 11; provided, however, that in no event shall an officer of the Company be delegated the authority to grant awards to, or amend awards held by, the following individuals:
(a) individuals who are subject to Section 16 of the Exchange Act or (b) officers of the Company (or Directors) to whom authority to grant or amend Awards has 

  
 23 

 
been delegated hereunder; provided, further, that any delegation of administrative authority shall only be permitted to the extent it is permissible under Applicable Law. Any
delegation hereunder shall be subject to the restrictions and limits that the Board or Committee specifies at the time of such delegation, and the Board may at any time rescind the authority so delegated or appoint a new delegatee. At all times, the
delegatee appointed under this Section 11.6 shall serve in such capacity at the pleasure of the Board and the Committee. 

ARTICLE 12. 

MISCELLANEOUS PROVISIONS 
 12.1 Amendment, Suspension or Termination of the Plan. Except as otherwise provided in this Section 12.1, the Plan may be wholly or partially amended or otherwise modified, suspended or
terminated at any time or from time to time by the Board or the Committee. However, without approval of the Company’s stockholders given within twelve (12) months before or after the action by the Administrator, no action of the
Administrator may, except as provided in Section 12.2, increase the limits imposed in Section 3.1 on the maximum number of Shares which may be issued under the Plan. Except as provided in Section 12.10, no amendment, suspension or
termination of the Plan shall, without the consent of the Holder, impair any rights or obligations under any Award theretofore granted or awarded, unless the Award itself otherwise expressly so provides. No Awards may be granted or awarded during
any period of suspension or after termination of the Plan, and in no event may any Award be granted under the Plan after the tenth (10th) anniversary of the date the Plan is first adopted by the Board (the “Expiration Date”). Any
Awards that are outstanding on the Expiration Date shall remain in force according to the terms of the Plan and the applicable Award Agreement. 
 12.2 Changes in Common Stock or Assets of the Company, Acquisition or Liquidation of the Company and Other Corporate Events. 

(a) In the event of any stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution
(other than normal cash dividends) of Company assets to stockholders, or any other change affecting the shares of the Company’s stock or the share price of the Company’s stock other than an Equity Restructuring, the Administrator may make
equitable adjustments, if any, to reflect such change with respect to: (i) the aggregate number and kind of shares that may be issued under the Plan (including, but not limited to, adjustments of the limitations in Sections 3.1 and 3.3 on the
maximum number and kind of shares which may be issued under the Plan); (ii) the number and kind of Shares (or other securities or property) subject to outstanding Awards; (iii) the number and kind of Shares (or other securities or
property) for which automatic grants are subsequently to be made to new and continuing Non-Employee Directors pursuant to Section 4.5; (iv) the terms and conditions of any outstanding Awards (including, without limitation, any applicable
performance targets or criteria with respect thereto); and (v) the grant or exercise price per share for any outstanding Awards under the Plan. 
 (b) In the event of any transaction or event described in Section 12.2(a) or any unusual or nonrecurring transactions or events affecting the Company, any Subsidiary of the Company, or the financial
statements of the Company or any Subsidiary, or of changes in 

  
 24 

 
Applicable Law or accounting principles, the Administrator, in its discretion, and on such terms and conditions as it deems appropriate, either by the terms of the Award or by action taken prior
to the occurrence of such transaction or event and either automatically or upon the Holder’s request, is hereby authorized to take any one or more of the following actions whenever the Administrator determines that such action is appropriate in
order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan or with respect to any Award under the Plan, to facilitate such transactions or events or to give effect to such changes in
laws, regulations or principles: 
 (i) To provide for either (A) termination of any such Award in exchange for an amount
of cash, if any, equal to the amount that would have been attained upon the exercise of such Award or realization of the Holder’s rights (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction or event described
in this Section 12.2 the Administrator determines in good faith that no amount would have been attained upon the exercise of such Award or realization of the Holder’s rights, then such Award may be terminated by the Company without
payment) or (B) the replacement of such Award with other rights or property selected by the Administrator, in its discretion, having an aggregate value not exceeding the amount that could have been attained upon the exercise of such Award or
realization of the Holder’s rights had such Award been currently exercisable or payable or fully vested; 
 (ii) To
provide that such Award be assumed by the successor or survivor corporation, or a parent or subsidiary thereof, or shall be substituted for by similar options, rights or awards covering the stock of the successor or survivor corporation, or a parent
or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and prices; 
 (iii) To make
adjustments in the number and type of shares of the Company’s stock (or other securities or property) subject to outstanding Awards, and in the number and kind of outstanding Restricted Stock and/or in the terms and conditions of (including the
grant or exercise price), and the criteria included in, outstanding Awards and Awards which may be granted in the future; 

(iv) To provide that such Award shall be exercisable or payable or fully vested with respect to all shares covered thereby,
notwithstanding anything to the contrary in the Plan or the applicable Award Agreement; and 
 (v) To provide that the Award
cannot vest, be exercised or become payable after such event. 
 (c) In connection with the occurrence of any Equity
Restructuring, and notwithstanding anything to the contrary in Section 12.2(a) and 12.2(b), the Administrator shall equitably adjust each outstanding Award, which adjustments may include adjustments to the number and type of securities subject
to each outstanding Award and/or the exercise price or grant price thereof, if applicable, the grant of new Awards to Participants, and/or the making of a cash payment to Participants, as the Administrator deems appropriate to reflect such Equity
Restructuring. The adjustments provided under this Section 12.2(c) shall be nondiscretionary and shall be final and binding on the affected Holder and the Company; provided that whether an adjustment is equitable shall be determined in the
discretion of the Administrator. 

  
 25 

 (d) Unless otherwise determined by the Administrator, in the event of a Change in Control,
each outstanding Award shall continue in effect or be assumed or an equivalent Award substituted by the successor corporation or a parent or subsidiary of the successor corporation. 

(e) In the event that the Administrator or the successor corporation in a Change in Control refuses to assume or substitute for an Award,
the Administrator may cause all or any portion of such Award to become fully exercisable immediately prior to the consummation of such transaction and all forfeiture restrictions on all or any portion of such Award to lapse. If an Award is
exercisable in lieu of assumption or substitution in the event of a Change in Control, the Administrator shall notify the Holder that the Award shall be fully exercisable for a period of fifteen (15) days from the date of such notice,
contingent upon the occurrence of the Change in Control, and the Award shall terminate upon the expiration of such period. 

(f) For the purposes of this Section 12.2, an Award shall be considered assumed if, following the Change in Control, the Award
confers the right to purchase or receive, for each Share subject to the Award immediately prior to the Change in Control, the consideration (whether stock, cash, or other securities or property) received in the Change in Control by holders of Common
Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however,
that if such consideration received in the Change in Control was not solely common stock of the successor corporation or its parent, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received
upon the exercise of the Award, for each Share subject to an Award, to be solely common stock of the successor corporation or its parent equal in fair market value to the per-share consideration received by holders of Common Stock in the Change in
Control. 
 (g) The Administrator, in its discretion, may include such further provisions and limitations in any Award,
agreement or certificate, as it may deem equitable and in the best interests of the Company that are not inconsistent with the provisions of the Plan. 
 (h) No adjustment or action described in this Section 12.2 or in any other provision of the Plan shall be authorized to the extent that such adjustment or action would cause the Plan to violate
Section 422(b)(1) of the Code. Furthermore, no such adjustment or action shall be authorized to the extent such adjustment or action would result in short-swing profits liability under Section 16 or violate the exemptive conditions of Rule
16b-3 unless the Administrator determines that the Award is not to comply with such exemptive conditions. 
 (i) The existence
of the Plan, the Award Agreement and the Awards granted hereunder shall not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or
other change in the Company’s capital structure or its business, any merger or consolidation of the Company, any issue of stock or of options, warrants or rights to purchase 

  
 26 

 
stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the rights thereof or which are convertible into or exchangeable for
Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise. 

(j) No action shall be taken under this Section 12.2 which shall cause an Award to fail to comply with Section 409A of the
Code, to the extent applicable the Award. 
 (k) In the event of any pending stock dividend, stock split, combination or
exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the Shares or the share price of the Common Stock including any Equity Restructuring,
for reasons of administrative convenience, the Company, in its discretion, may refuse to permit the exercise of any Award during a period of up to thirty (30) days prior to the consummation of any such transaction. 

12.3 Approval of Plan by Stockholders. The Plan shall be submitted for the approval of the Company’s stockholders within
twelve (12) months after the date of the Board’s initial adoption of the Plan. 
 12.4 No Stockholders Rights.
Except as otherwise provided herein, a Holder shall have none of the rights of a stockholder with respect to Shares covered by any Award until the Holder becomes the record owner of such Shares. 

12.5 Paperless Administration. In the event that the Company establishes, for itself or using the services of a third party, an
automated system for the documentation, granting or exercise of Awards, such as a system using an internet website or interactive voice response, then the paperless documentation, granting or exercise of Awards by a Holder may be permitted through
the use of such an automated system. 
 12.6 Effect of Plan upon Other Compensation Plans. The adoption of the Plan shall
not affect any other compensation or incentive plans in effect for the Company or any Subsidiary. Nothing in the Plan shall be construed to limit the right of the Company or any Subsidiary: (a) to establish any other forms of incentives or
compensation for Employees, Directors or Consultants of the Company or any Subsidiary, or (b) except as otherwise provided in the penultimate sentence of Section 3.1(a), to grant or assume options or other rights or awards otherwise than
under the Plan in connection with any proper corporate purpose including without limitation, the grant or assumption of options in connection with the acquisition by purchase, lease, merger, consolidation or otherwise, of the business, stock or
assets of any corporation, partnership, limited liability company, firm or association. 
 12.7 Compliance with Laws. The
Plan, the granting and vesting of Awards under the Plan and the issuance and delivery of Shares and the payment of money under the Plan or under Awards granted or awarded hereunder are subject to compliance with all Applicable Law (including but not
limited to state, federal and foreign securities law and margin requirements), and to such approvals by any listing, regulatory or governmental authority as may, in the opinion 

  
 27 

 
of counsel for the Company, be necessary or advisable in connection therewith. Any securities delivered under the Plan shall be subject to such restrictions, and the person acquiring such
securities shall, if requested by the Company, provide such assurances and representations to the Company as the Company may deem necessary or desirable to assure compliance with all Applicable Law. To the extent permitted by Applicable Law, the
Plan and Awards granted or awarded hereunder shall be deemed amended to the extent necessary to conform to Applicable Law. 

12.8 Titles and Headings, References to Sections of the Code or Exchange Act. The titles and headings of the Sections in the Plan
are for convenience of reference only and, in the event of any conflict, the text of the Plan, rather than such titles or headings, shall control. References to sections of the Code or the Exchange Act shall include any amendment or successor
thereto. 
 12.9 Governing Law. The Plan and any agreements hereunder shall be administered, interpreted and enforced
under the internal laws of the State of Delaware without regard to conflicts of laws thereof or of any other jurisdiction. 

12.10 Section 409A. To the extent that the Administrator determines that any Award granted under the Plan is subject to
Section 409A of the Code, the Award Agreement evidencing such Award shall incorporate the terms and conditions required by Section 409A of the Code. To the extent applicable, the Plan and any Award Agreements shall be interpreted in
accordance with Section 409A of the Code, including without limitation any such regulations or other guidance that may be issued after the Effective Date. Notwithstanding any provision of the Plan to the contrary, in the event that following
the Effective Date the Administrator determines that any Award may be subject to Section 409A of the Code (including Department of Treasury guidance as may be issued after the Effective Date), the Administrator may adopt such amendments to the
Plan and the applicable Award Agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Administrator determines are necessary or appropriate to
(a) exempt the Award from Section 409A of the Code and/or preserve the intended tax treatment of the benefits provided with respect to the Award, or (b) comply with the requirements of Section 409A of the Code and thereby avoid
the application of any penalty taxes under such Section. 
 12.11 No Rights to Awards. No Eligible Individual or other
person shall have any claim to be granted any Award pursuant to the Plan, and neither the Company nor the Administrator is obligated to treat Eligible Individuals, Holders or any other persons uniformly. 

12.12 Unfunded Status of Awards. The Plan is intended to be an “unfunded” plan for incentive compensation. With respect
to any payments not yet made to a Holder pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give the Holder any rights that are greater than those of a general creditor of the Company or any Subsidiary. 

12.13 Indemnification. To the extent allowable pursuant to Applicable Law, each member of the Committee or of the Board shall be
indemnified and held harmless by the Company from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by such member in connection with or resulting from any claim, action, suit, or

  
 28 

 
proceeding to which he or she may be a party or in which he or she may be involved by reason of any action or failure to act pursuant to the Plan and against and from any and all amounts paid by
him or her in satisfaction of judgment in such action, suit, or proceeding against him or her; provided he or she gives the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and
defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled pursuant to the Company’s Certificate of Incorporation or Bylaws, as
a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 
 12.14
Relationship to other Benefits. No payment pursuant to the Plan shall be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company or
any Subsidiary except to the extent otherwise expressly provided in writing in such other plan or an agreement thereunder. 

12.15 Expenses. The expenses of administering the Plan shall be borne by the Company and its Subsidiaries. 

* * * * * 

  
 29 

 BIND THERAPEUTICS, INC. 

2013 INCENTIVE AWARD PLAN 
 STOCK OPTION GRANT NOTICE 
 BIND Therapeutics, Inc., a Delaware corporation
(the “Company”), pursuant to its 2013 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”), an option to purchase the number of
shares of Common Stock (“Stock”) set forth below (the “Option”). The Option is subject to the terms and conditions set forth in this Stock Option Grant Notice (the “Grant Notice”) and the Stock
Option Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in
the Grant Notice and the Agreement. 
  

			
	 Participant:
	  	
		
	 Grant Date:
	  	
		
	
Exercise Price per Share:            
	  	$
		
	 Total Exercise Price:
	  	$
		
	 Total Number of Shares

Subject to the Option:
	  	            shares
		
	 Expiration Date:
	  	
		
	 Vesting Schedule:
	  	[To be specified in individual agreements]
		
	 Type of Option:
	  	 ̈  Incentive Stock
Option       ̈  Non-Qualified Stock Option

 By Participant’s signature below, Participant agrees to be bound by the terms and conditions of the
Plan, the Agreement and the Grant Notice. Participant has reviewed the Agreement, the Plan and the Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Grant Notice and fully understands all
provisions of the Grant Notice, the Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Grant Notice or the
Agreement. 
  

									
	BIND THERAPEUTICS, INC.	 		 	PARTICIPANT
					
	 By:
	 	 	 		 	By:	 	 
	 Print Name: 
	 	 	 		 	Print Name: 	 	 
	 Title:
	 	 	 		 		 	

 EXHIBIT A 
 TO STOCK OPTION GRANT NOTICE 
 STOCK OPTION AGREEMENT 

Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to Participant an Option under the Plan to
purchase the number of shares of Stock set forth in the Grant Notice. 
 ARTICLE 1. 

GENERAL 

1.1 Defined Terms. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan or the Grant
Notice. 
 1.2 Incorporation of Terms of Plan. The Option is subject to the terms and conditions set forth in this
Agreement and the Plan, which is incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. 
 ARTICLE 2. 
 GRANT OF OPTION 

2.1 Grant of Option. In consideration of Participant’s past and/or continued employment with or service to the Company or a
Subsidiary and for other good and valuable consideration, effective as of the grant date set forth in the Grant Notice (the “Grant Date”), the Company has granted to Participant the Option to purchase any part or all of an aggregate
of the number of shares of Stock set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice, the Plan and this Agreement, subject to adjustments as provided in Section 12.2 of the Plan. 

2.2 Exercise Price. The exercise price per share of the shares of Stock subject to the Option (the “Exercise
Price”) shall be as set forth in the Grant Notice. 
 2.3 Consideration to the Company. In consideration of the
grant of the Option by the Company, Participant agrees to render faithful and efficient services to the Company or any Subsidiary. Nothing in the Plan, the Grant Notice or this Agreement shall confer upon Participant any right to continue in the
employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at
any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant. 

ARTICLE 3. 

PERIOD OF EXERCISABILITY 
 3.1 Commencement of Exercisability. 
 (a) Subject to Sections 3.2, 3.3, 5.9
and 5.14 hereof, the Option shall become vested and exercisable in such amounts and at such times as are set forth in the Grant Notice. 

 (b) Unless otherwise determined by the Administrator, any portion of the Option that has not
become vested and exercisable on or prior to the date of the Participant’s Termination of Service shall be forfeited on the date of the Participant’s Termination of Service and shall not thereafter become vested or exercisable. 

3.2 Duration of Exercisability. The installments provided for in the vesting schedule set forth in the Grant Notice are
cumulative. Each such installment which becomes vested and exercisable pursuant to the vesting schedule set forth in the Grant Notice shall remain vested and exercisable until it becomes unexercisable under Section 3.3 hereof. Once the Option
becomes unexercisable, it shall be forfeited immediately. 
 3.3 Expiration of Option. The Option may not be exercised to
any extent by anyone after the first to occur of the following events: 
 (a) The expiration date set forth in the Grant Notice;

 (b) Except as the Administrator may otherwise approve, in the event of Participant’s Termination of Service other than
for Cause or by reason of Participant’s death or Disability, the expiration of three (3) months from the date of Participant’s Termination of Service; 
 (c) Except as the Administrator may otherwise approve, the expiration of one (1) year from the date of Participant’s Termination of Service by reason of Participant’s death or disability;
or 
 (d) Except as the Administrator may otherwise approve, upon Participant’s Termination of Service for Cause.

 As used in this Agreement, “Cause” shall mean (a) the Board’s determination that Participant failed to
substantially perform Participant’s duties (other than any such failure resulting from Participant’s Disability); (b) the Board’s determination that Participant failed to carry out, or comply with any lawful and reasonable
directive of the Board or Participant’s immediate supervisor; (c) Participant’s conviction, plea of no contest, plea of nolo contendere, or imposition of unadjudicated probation for any felony, indictable offense or crime involving
moral turpitude; (d) Participant’s unlawful use (including being under the influence) or possession of illegal drugs on the premises of the Company or any of its Subsidiaries or while performing Participant’s duties and
responsibilities; or (e) Participant’s commission of an act of fraud, embezzlement, misappropriation, misconduct, or breach of fiduciary duty against the Company of any of its Subsidiaries. Notwithstanding the foregoing, if Participant is
a party to a written employment or consulting agreement with the Company (or its Subsidiary) in which the term “cause” is defined, then “Cause” shall be as such term is defined in the applicable written employment or consulting
agreement. 
 3.4 Tax Withholding. Notwithstanding any other provision of this Agreement: 

(a) The Company and its Subsidiaries have the authority to deduct or withhold, or require Participant to remit to the Company or the
applicable Subsidiary, an amount sufficient to satisfy applicable federal, state, local and foreign taxes (including the employee portion of any FICA obligation) required by law to be withheld with respect to any taxable event arising pursuant to
this Agreement. The Company and its Subsidiaries may withhold or Participant may make such payment in one or more of the forms specified below: 
 (i) by cash or check made payable to the Company or the Subsidiary with respect to which the withholding obligation arises; 

  
 A-2

 (ii) by the deduction of such amount from other compensation payable to Participant;

 (iii) with respect to any withholding taxes arising in connection with the exercise of the Option, with the consent of the
Administrator, by requesting that the Company withhold a net number of shares of Stock issuable upon the exercise of the Option having a then current Fair Market Value not exceeding the amount necessary to satisfy the withholding obligation of the
Company and its Subsidiaries based on the minimum applicable statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes; 
 (iv) with respect to any withholding taxes arising in connection with the exercise of the Option, with the consent of the Administrator, by tendering to the Company shares of Stock having a then current
Fair Market Value not exceeding the amount necessary to satisfy the withholding obligation of the Company and its Subsidiaries based on the minimum applicable statutory withholding rates for federal, state, local and foreign income tax and payroll
tax purposes; 
 (v) with respect to any withholding taxes arising in connection with the exercise of the Option, through the
delivery of a notice that Participant has placed a market sell order with a broker acceptable to the Company with respect to shares of Stock then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion
of the net proceeds of the sale to the Company or the Subsidiary with respect to which the withholding obligation arises in satisfaction of such withholding taxes; provided that payment of such proceeds is then made to the Company or the
applicable Subsidiary at such time as may be required by the Administrator, but in any event not later than the settlement of such sale; or 
 (vi) in any combination of the foregoing. 
 (b) With respect to any withholding
taxes arising in connection with the Option, in the event Participant fails to provide timely payment of all sums required pursuant to Section 3.4(a), the Company shall have the right and option, but not the obligation, to treat such failure as
an election by Participant to satisfy all or any portion of Participant’s required payment obligation pursuant to Section 3.4(a)(ii) or Section 3.4(a)(iii) above, or any combination of the foregoing as the Company may determine to be
appropriate. The Company shall not be obligated to deliver any certificate representing shares of Stock issuable with respect to the exercise of the Option to Participant or his or her legal representative unless and until Participant or his or her
legal representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable with respect to the taxable income of Participant resulting from the exercise of the Option or any other taxable
event related to the Option. 
 (c) In the event any tax withholding obligation arising in connection with the Option will be
satisfied under Section 3.4(a)(iii) above, then the Company may elect to instruct any brokerage firm determined acceptable to the Company for such purpose to sell on Participant’s behalf a whole number of shares from those shares of Stock
that are issuable upon exercise of the Option as the Company determines to be appropriate to generate cash proceeds sufficient to satisfy the tax withholding obligation and to remit the proceeds of such sale to the Company or the Subsidiary with
respect to which the withholding obligation arises. Participant’s acceptance of this Award constitutes Participant’s instruction and authorization to the Company and such brokerage firm to complete the transactions described in this
Section 3.4(c), including the transactions described in the previous sentence, as applicable. The Company may refuse to issue any shares of Stock to Participant until the foregoing tax withholding obligations are satisfied. 

  
 A-3

 (d) Participant is ultimately liable and responsible for all taxes owed in connection with
the Option, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise in connection with the Option. Neither the Company nor any Subsidiary makes any representation or undertaking
regarding the treatment of any tax withholding in connection with the awarding, vesting or exercise of the Option or the subsequent sale of Stock. The Company and the Subsidiaries do not commit and are under no obligation to structure the Option to
reduce or eliminate Participant’s tax liability. 
 ARTICLE 4. 

EXERCISE OF OPTION 
 4.1 Person Eligible to Exercise. During the lifetime of Participant, only Participant may exercise the Option or any portion thereof. After the death of Participant, any exercisable portion of the
Option may, prior to the time when the Option becomes unexercisable under Section 3.3 hereof, be exercised by Participant’s personal representative or by any person empowered to do so under the deceased Participant’s will or under the
then applicable laws of descent and distribution. 
 4.2 Partial Exercise. Subject to Section 5.2, any exercisable
portion of the Option or the entire Option, if then wholly exercisable, may be exercised in whole or in part at any time prior to the time when the Option or portion thereof becomes unexercisable under Section 3.3 hereof. 

4.3 Manner of Exercise. The Option, or any exercisable portion thereof, may be exercised solely by delivery to the Secretary of
the Company (or any third party administrator or other person or entity designated by the Company), during regular business hours, of all of the following prior to the time when the Option or such portion thereof becomes unexercisable under
Section 3.3 hereof. 
 (a) An exercise notice in a form specified by the Administrator, stating that the Option or portion
thereof is thereby exercised, such notice complying with all applicable rules established by the Administrator; 
 (b) The
receipt by the Company of full payment for the shares of Stock with respect to which the Option or portion thereof is exercised, in such form of consideration permitted under Section 4.4 hereof that is acceptable to the Administrator;

 (c) The payment of any applicable withholding tax in accordance with Section 3.4; 

(d) Any other written representations or documents as may be required in the Administrator’s sole discretion to effect compliance
with Applicable Law; and 
 (e) In the event the Option or portion thereof shall be exercised pursuant to Section 4.1
hereof by any person or persons other than Participant, appropriate proof of the right of such person or persons to exercise the Option. 

Notwithstanding any of the foregoing, the Administrator shall have the right to specify all conditions of the manner of exercise, which conditions may
vary by country and which may be subject to change from time to time. 

  
 A-4

 4.4 Method of Payment. Payment of the exercise price shall be by any of the
following, or a combination thereof, at the election of Participant: 
 (a) Cash or check; 

(b) With the consent of the Administrator, surrender of shares of Stock (including, without limitation, shares of Stock otherwise
issuable upon exercise of the Option) held for such period of time as may be required by the Administrator in order to avoid adverse accounting consequences and having a Fair Market Value on the date of delivery equal to the aggregate exercise price
of the Option or exercised portion thereof; 
 (c) Through the delivery of a notice that Participant has placed a market sell
order with a broker acceptable to the Company with respect to shares of Stock then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction
of the Option exercise price; provided that payment of such proceeds is then made to the Company at such time as may be required by the Administrator, but in any event not later than the settlement of such sale; or 

(d) Any other form of legal consideration acceptable to the Administrator. 

4.5 Conditions to Issuance of Stock. The Company shall not be required to issue or deliver any shares of Stock purchased upon the
exercise of the Option or portion thereof prior to fulfillment of all of the following conditions: (A) the admission of such shares of Stock to listing on all stock exchanges on which such Stock is then listed, (B) the completion of any
registration or other qualification of such shares of Stock under any state or federal law or under rulings or regulations of the Securities and Exchange Commission or other governmental regulatory body, which the Administrator shall, in its
absolute discretion, deem necessary or advisable, (C) the obtaining of any approval or other clearance from any state or federal governmental agency which the Administrator shall, in its absolute discretion, determine to be necessary or
advisable, (D) the receipt by the Company of full payment for such shares of Stock, which may be in one or more of the forms of consideration permitted under Section 4.4 hereof, and (E) the receipt of full payment of any applicable
withholding tax in accordance with Section 3.4 by the Company or its Subsidiary with respect to which the applicable withholding obligation arises. 
 4.6 Rights as Stockholder. Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any
shares of Stock purchasable upon the exercise of any part of the Option unless and until certificates representing such shares of Stock (which may be in book-entry form) will have been issued and recorded on the records of the Company or its
transfer agents or registrars and delivered to Participant (including through electronic delivery to a brokerage account). No adjustment will be made for a dividend or other right for which the record date is prior to the date of such issuance,
recordation and delivery, except as provided in Section 12.2 of the Plan. Except as otherwise provided herein, after such issuance, recordation and delivery, Participant will have all the rights of a stockholder of the Company with respect to
such shares of Stock, including, without limitation, the right to receipt of dividends and distributions on such shares. 

ARTICLE 5. 

OTHER PROVISIONS 
 5.1 Administration. The Administrator shall have the power to interpret the Plan, the Grant Notice and this Agreement and to adopt such rules for the administration, interpretation and application
of the Plan, the Grant Notice and this Agreement as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator will be final and binding upon
Participant, the Company and all other interested persons. To the extent allowable pursuant to Applicable Law, no member of the Committee or the Board will be personally liable for any action, determination or interpretation made with respect to the
Plan, the Grant Notice or this Agreement. 

  
 A-5

 5.2 Whole Shares. The Option may only be exercised for whole shares of Stock.

 5.3 Option Not Transferable. Subject to Section 4.1 hereof, the Option may not be sold, pledged, assigned or
transferred in any manner other than by will or the laws of descent and distribution, unless and until the shares of Stock underlying the Option have been issued, and all restrictions applicable to such shares of Stock have lapsed. Neither the
Option nor any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge,
encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted
disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. 
 5.4 Adjustments. The Administrator may accelerate the vesting of all or a portion of the Option in such circumstances as it, in its sole discretion, may determine. In addition, upon the occurrence
of certain events relating to the Stock contemplated by Section 12.2 of the Plan (including, without limitation, an extraordinary cash dividend on such Stock), the Administrator may make such adjustments as the Administrator deems appropriate
in the number of shares of Stock subject to the Option, the exercise price of the Option and the kind of securities that may be issued upon exercise of the Option. Participant acknowledges that the Option is subject to adjustment, modification and
termination in certain events as provided in this Agreement and the Plan, including Section 12.2 of the Plan. 
 5.5
Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company’s principal office, and any notice to be given to Participant shall
be addressed to Participant (or, if Participant is then deceased, to the person entitled to exercise the Option pursuant to Section 4.1) at Participant’s last address reflected on the Company’s records. By a notice given pursuant to
this Section 5.5, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited
(with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. 
 5.6
Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. 
 5.7 Governing Law. The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that
might be applied under principles of conflicts of laws. 
 5.8 Conformity to Securities Laws. Participant acknowledges
that the Plan, the Grant Notice and this Agreement are intended to conform to the extent necessary with all Applicable Laws, including, without limitation, the provisions of the Securities Act and the Exchange Act and any and all regulations and
rules promulgated thereunder by the Securities and Exchange Commission and state securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Option is granted and may be exercised, only
in such a manner as to conform to Applicable Law. To the extent permitted by Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to Applicable Law. 

  
 A-6

 5.9 Amendment, Suspension and Termination. To the extent permitted by the Plan, this
Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board, provided that, except as may otherwise be provided by the Plan, no amendment,
modification, suspension or termination of this Agreement shall adversely affect the Option in any material way without the prior written consent of Participant. 
 5.10 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and
assigns of the Company. Subject to the restrictions on transfer set forth in Section 5.3 and the Plan, this Agreement shall be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the
parties hereto. 
 5.11 Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the
Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the Option, the Grant Notice and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under
Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, this Agreement shall be deemed amended to
the extent necessary to conform to such applicable exemptive rule. 
 5.12 Not a Contract of Employment. Nothing in this
Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its
Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement
between the Company or a Subsidiary and Participant. 
 5.13 Entire Agreement. The Plan, the Grant Notice and this
Agreement (including any exhibit hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof. 

5.14 Section 409A. This Award is not intended to constitute “nonqualified deferred compensation” within the meaning
of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof,
“Section 409A”). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines that this Award (or any portion thereof) may be subject to Section 409A,
the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt
other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for this Award either to be exempt from the application of
Section 409A or to comply with the requirements of Section 409A. 
 5.15 Agreement Severable. In the event that
any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of the Grant
Notice or this Agreement. 

  
 A-7

 5.16 Limitation on Participant’s Rights. Participation in the Plan confers no
rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in
and of itself, has any assets. Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Option, and rights no greater than the right to
receive the Stock as a general unsecured creditor with respect to options, as and when exercised pursuant to the terms hereof. 

5.17 Counterparts. The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature,
subject to Applicable Law, each of which shall be deemed an original and all of which together shall constitute one instrument. 

5.18 Broker-Assisted Sales. In the event of any broker-assisted sale of shares of Stock in connection with the payment of
withholding taxes as provided in Section 3.4(a)(v) or Section 3.4(c) or the payment of the exercise price as provided in Section 4.4(c): (A) any shares of Stock to be sold through a broker-assisted sale will be sold on the day
the tax withholding obligation or exercise of the Option, as applicable, occurs or arises, or as soon thereafter as practicable; (B) such shares of Stock may be sold as part of a block trade with other participants in the Plan in which all
participants receive an average price; (C) Participant will be responsible for all broker’s fees and other costs of sale, and Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses
relating to any such sale; (D) to the extent the proceeds of such sale exceed the applicable tax withholding obligation or exercise price, the Company agrees to pay such excess in cash to Participant as soon as reasonably practicable;
(E) Participant acknowledges that the Company or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale may not be sufficient to satisfy the applicable tax withholding
obligation or exercise price; and (F) in the event the proceeds of such sale are insufficient to satisfy the applicable tax withholding obligation, Participant agrees to pay immediately upon demand to the Company or its Subsidiary with respect
to which the withholding obligation arises, an amount sufficient to satisfy any remaining portion of the Company’s or the applicable Subsidiary’s withholding obligation. 

5.19 Incentive Stock Options. Participant acknowledges that to the extent the aggregate Fair Market Value of shares of Stock
(determined as of the time the option with respect to the shares is granted) with respect to which Incentive Stock Options, including this Option (if applicable), are exercisable for the first time by Participant during any calendar year exceeds
$100,000 or if for any other reason such Incentive Stock Options do not qualify or cease to qualify for treatment as “incentive stock options” under Section 422 of the Code, such Incentive Stock Options shall be treated as
Non-Qualified Stock Options. Participant further acknowledges that the rule set forth in the preceding sentence shall be applied by taking the Option and other stock options into account in the order in which they were granted, as determined under
Section 422(d) of the Code and the Treasury Regulations thereunder. Participant also acknowledges that an Incentive Stock Option exercised more than three (3) months after Participant’s Termination of Service, other than by reason of
death or disability, will be taxed as a Non-Qualified Stock Option. 
 5.20 Notification of Disposition. If this Option
is designated as an Incentive Stock Option, Participant shall give prompt written notice to the Company of any disposition or other transfer of any shares of Stock acquired under this Agreement if such disposition or transfer is made (a) within
two (2) years from the Grant Date or (b) within one (1) year after the transfer of such shares of Stock to Participant. Such notice shall specify the date of such disposition or other transfer and the amount realized, in cash, other
property, assumption of indebtedness or other consideration, by Participant in such disposition or other transfer. 
 * * * * *

  
 A-8

 BIND THERAPEUTICS, INC. 

2013 INCENTIVE AWARD PLAN 
 RESTRICTED STOCK GRANT NOTICE 
 BIND Therapeutics, Inc., a Delaware
corporation (the “Company”), pursuant to its 2013 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”) the number of shares of
Restricted Stock (the “Shares”) set forth below. The Shares are subject to the terms and conditions set forth in this Restricted Stock Grant Notice (the “Grant Notice”) and the Restricted Stock Agreement attached
hereto as Exhibit A (the “Agreement”) and the Plan, which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in the Grant Notice and the
Agreement. 
  

			
	 Participant:
	  	
		
	 Grant Date:
	  	
		
	 Total Number of Shares
of            
 Restricted
Stock:
	  	
		
	 Vesting Schedule:
	  	[To be specified in individual agreements]

 By Participant’s signature below, Participant agrees to be bound by the terms and conditions of the
Plan, the Agreement and the Grant Notice. Participant has reviewed the Agreement, the Plan and the Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Grant Notice and fully understands all
provisions of the Grant Notice, the Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Grant Notice or the
Agreement. 
  

									
	BIND THERAPEUTICS, INC.	 		 	PARTICIPANT
					
	 By:
	 	 	 		 	By:	 	 
	 Print Name: 
	 	 	 		 	Print Name: 	 	 
	 Title:
	 	 	 		 		 	

 EXHIBIT A 
 TO RESTRICTED STOCK GRANT NOTICE 
 RESTRICTED STOCK AGREEMENT

 Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to Participant the number of
Shares set forth in the Grant Notice. 
 ARTICLE I. 

GENERAL 

1.1 Defined Terms. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan or the Grant
Notice. 
 1.2 Incorporation of Terms of Plan. The Shares issued to Participant pursuant to the Grant Notice are subject
to the terms and conditions set forth in this Agreement and the Plan, which is incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. 

ARTICLE II. 

ISSUANCE OF SHARES 
 2.1 Issuance of Shares. In consideration of Participant’s past and/or continued employment with or service to the Company or a Subsidiary and for other good and valuable consideration,
effective as of the grant date set forth in the Grant Notice (the “Grant Date”), the Company has granted to Participant the number of Shares set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice,
this Agreement and the Plan. 
 2.2 Issuance Mechanics. As of the Grant Date, the Company shall issue the Shares in the
form of Common Stock (“Stock”) to Participant and shall (a) cause a stock certificate or certificates representing such shares of Stock to be registered in the name of Participant, or (b) cause such shares of Stock to be
held in book-entry form. If a stock certificate is issued, it shall be delivered to and held in custody by the Company and shall bear the restrictive legends required by Section 5.1. If the shares of Stock are held in book-entry form, then such
entry will reflect that the shares are subject to the restrictions of this Agreement. 
 ARTICLE III. 

FORFEITURE AND TRANSFER RESTRICTIONS 
 3.1 Forfeiture Restriction. Subject to the provisions of Section 3.2 below, in the event of Participant’s Termination of Service for any reason, including as a result of
Participant’s death or Disability, all of the Unreleased Shares (as defined below) shall thereupon be forfeited immediately and without any further action by the Company (the “Forfeiture Restriction”), except as otherwise
provided in a written agreement between Participant and the Company. Upon the occurrence of such forfeiture, the Company shall become the legal and beneficial owner of the Unreleased Shares and all rights and interests therein or relating thereto,
and the Company shall have the right to retain and transfer to its own name the number of Unreleased Shares being forfeited by Participant. The Unreleased Shares shall be held by the Company in accordance with Section 3.3 until the Shares are
forfeited as provided in this Section 3.1, until such Unreleased Shares are fully released from the Forfeiture Restriction as provided in 

  
 A-1

 
Section 3.2 or until such time as this Agreement is no longer in effect. Participant hereby authorizes and directs the Secretary of the Company, or such other person designated by the
Administrator, to transfer any Unreleased Shares that are forfeited pursuant to this Section 3.1 from Participant to the Company. 
 3.2 Release of Shares from Forfeiture Restriction. The Shares shall be released from the Forfeiture Restriction in accordance with the vesting schedule set forth in the Grant Notice. Any of the
Shares which, from time to time, have not yet been released from the Forfeiture Restriction are referred to herein as “Unreleased Shares.” In the event any of the Unreleased Shares are released from the Forfeiture Restriction, any
Retained Distributions (as defined below) paid on such Unreleased Shares shall be promptly paid by the Company to Participant. As soon as administratively practicable following the release of any Shares from the Forfeiture Restriction, the Company
shall, as applicable, either deliver to Participant the certificate or certificates representing such Shares in the Company’s possession belonging to Participant, or, if the Shares are held in book-entry form, then the Company shall remove the
notations indicating that the shares are subject to the restrictions of this Agreement. Participant (or the beneficiary or personal representative of Participant in the event of Participant’s death or incapacity, as the case may be) shall
deliver to the Company any representations or other documents or assurances as the Company or its representatives deem necessary or advisable in connection with any such delivery. 

3.3 Escrow. 
 (a) The Unreleased Shares shall be held by the Company until such Unreleased Shares are forfeited as provided in Section 3.1, until such Unreleased Shares are fully released from the Forfeiture
Restriction as provided in Section 3.2 or until such time as this Agreement is no longer in effect. Participant shall not retain physical custody of any certificates representing Unreleased Shares issued to Participant. Participant, by
acceptance of this Award, shall be deemed to appoint, and does so appoint, the Company and each of its authorized representatives as Participant’s attorney(s)-in-fact to effect any transfer of forfeited Unreleased Shares (and Retained
Distributions, if any, paid on such forfeited Unreleased Shares) to the Company as may be required pursuant to the Plan or this Agreement, and to execute such representations or other documents or assurances as the Company or such representatives
deem necessary or advisable in connection with any such transfer. To the extent allowable by Applicable Law, the Company, or its designee, shall not be liable for any act it may do or omit to do with respect to holding the Shares in escrow and while
acting in good faith and in the exercise of its judgment. 
 (b) The Company will retain custody of all cash dividends and other
distributions (“Retained Distributions”) made or declared with respect to Unreleased Shares (and such Retained Distributions will be subject to the Forfeiture Restriction and the other terms and conditions under this Agreement that
are applicable to the Shares) until such time, if ever, as the Unreleased Shares with respect to which such Retained Distributions shall have been made, paid or declared shall have become vested pursuant to the Grant Notice. Retained Distributions
that were made or declared in cash will be deemed reinvested in notional shares of Stock such that upon release and distribution of such Retained Distributions to Participant as set forth in the immediately preceding sentence, Participant shall be
entitled to receive on the date of such distribution or release an amount of cash or the number of whole shares of Stock or a combination thereof, as determined by the Administrator, the aggregate fair value of which shall be equal to the Fair
Market Value of the notional shares of Stock to which such released Retained Distributions relate. Any Retained Distributions with respect to Unreleased Shares shall be forfeited in the event such Unreleased Shares are forfeited. 

3.4 Rights as Stockholder. Except as otherwise provided herein, upon issuance of the Shares by the Company, Participant shall have
all the rights of a stockholder with respect to said Shares, subject to the restrictions herein, including the right to vote the Shares and to receive all dividends or other distributions paid or made with respect to the Shares. 

  
 A-2

 ARTICLE IV. 
 TAXATION AND TAX WITHHOLDING 
 4.1 Representation. Participant
represents to the Company that Participant has reviewed with his or her own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. Participant is relying solely on
such advisors and not on any statements or representations of the Company or any of its agents. 
 4.2 Section 83(b)
Election. If Participant makes an election under Section 83(b) of the Internal Revenue Code of 1986, as amended (the “Code”), to be taxed with respect to the Shares as of the date of transfer of the Shares rather than as of
the date or dates upon which Participant would otherwise be taxable under Section 83(a) of the Code, Participant shall deliver a copy of such election to the Company promptly upon filing such election with the Internal Revenue Service.

 4.3 Tax Withholding. Notwithstanding any other provision of this Agreement: 

(a) The Company and its Subsidiaries have the authority to deduct or withhold, or require Participant to remit to the Company or the
applicable Subsidiary, an amount sufficient to satisfy applicable federal, state, local and foreign taxes (including the employee portion of any FICA obligation) required by law to be withheld with respect to any taxable event arising pursuant to
this Agreement. The Company and its Subsidiaries may withhold or Participant may make such payment in one or more of the forms specified below: 
 (i) by cash or check made payable to the Company or the Subsidiary with respect to which the withholding obligation arises; 
 (ii) by the deduction of such amount from other compensation payable to Participant; 
 (iii) with respect to any withholding taxes arising in connection with the vesting of the Shares, with the consent of the Administrator, by requesting that the Company and its Subsidiaries withhold a net
number of vested Shares having a then current Fair Market Value not exceeding the amount necessary to satisfy the withholding obligation of the Company and its Subsidiaries based on the minimum applicable statutory withholding rates for federal,
state, local and foreign income tax and payroll tax purposes; 
 (iv) with respect to any withholding taxes arising in
connection with the vesting of the Shares, with the consent of the Administrator, by tendering to the Company vested shares of Stock having a then current Fair Market Value not exceeding the amount necessary to satisfy the withholding obligation of
the Company and its Subsidiaries based on the minimum applicable statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes; 
 (v) with respect to any withholding taxes arising in connection with the vesting of the Shares, through the delivery of a notice that Participant has placed a market sell order with a broker acceptable to
the Company with respect to those Shares that are then becoming vested and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company or the Subsidiary with respect to which the withholding
obligation arises in satisfaction of such withholding taxes; provided that payment of such proceeds is then made to the Company or the applicable Subsidiary at such time as may be required by the Administrator, but in any event not later the
settlement of such sale; or 

  
 A-3

 (vi) in any combination of the foregoing. 

(b) With respect to any withholding taxes arising in connection with the Shares, in the event Participant fails to provide timely payment
of all sums required pursuant to Section 4.3(a), the Company shall have the right and option, but not the obligation, to treat such failure as an election by Participant to satisfy all or any portion of Participant’s required payment
obligation pursuant to Section 4.3(a)(ii) or Section 4.3(a)(iii) above, or any combination of the foregoing as the Company may determine to be appropriate. The Company shall not be obligated to deliver any certificate representing the
Shares to Participant or his or her legal representative unless and until Participant or his or her legal representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable with respect
to the taxable income of Participant resulting from the vesting of the Shares or any other taxable event related to the Shares. 

(c) In the event any tax withholding obligation arising in connection with the Shares will be satisfied under Section 4.3(a)(iii),
then the Company may elect to instruct any brokerage firm determined acceptable to the Company for such purpose to sell on Participant’s behalf a whole number of shares of Stock from those Shares that are then becoming vested as the Company
determines to be appropriate to generate cash proceeds sufficient to satisfy the tax withholding obligation and to remit the proceeds of such sale to the Company or the Subsidiary with respect to which the withholding obligation arises.
Participant’s acceptance of this Award constitutes Participant’s instruction and authorization to the Company and such brokerage firm to complete the transactions described in this Section 4.3(c), including the transactions described
in the previous sentence, as applicable. The Company may refuse to deliver any certificate representing the Shares to Participant or his or her legal representative until the foregoing tax withholding obligations are satisfied. 

(d) Participant is ultimately liable and responsible for all taxes owed in connection with the Shares, regardless of any action the
Company or any Subsidiary takes with respect to any tax withholding obligations that arise in connection with the Shares. Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment of any tax withholding
in connection with the awarding, vesting or payment of the Shares or the subsequent sale of the Shares. The Company and the Subsidiaries do not commit and are under no obligation to structure this Award to reduce or eliminate Participant’s tax
liability. 
 ARTICLE V. 
 RESTRICTIVE LEGENDS AND STOP-TRANSFER ORDERS 
 5.1 Legends. The
certificate or certificates representing the Shares, if any, shall bear the following legend (as well as any legends required by the Company’s charter and Applicable Law): 
 THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO FORFEITURE IN FAVOR OF THE COMPANY AND MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF A RESTRICTED STOCK AGREEMENT BETWEEN THE COMPANY
AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 

  
 A-4

 5.2 Refusal to Transfer; Stop-Transfer Notices. The Company shall not be required
(a) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (b) to treat as owner of such Shares or to accord the right to vote or pay dividends to any
purchaser or other transferee to whom such Shares shall have been so transferred. Participant agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate “stop transfer”
instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. 
 5.3 Removal of Legend. After such time as the Forfeiture Restriction shall have lapsed with respect to the Shares, and upon Participant’s request, a new certificate or certificates
representing such Shares shall be issued without the legend referred to in Section 5.1 and delivered to Participant. If the Shares are held in book entry form, the Company shall cause any restrictions noted on the book form to be removed.

 ARTICLE VI. 
 OTHER PROVISIONS 
 6.1 Administration. The Administrator shall have
the power to interpret the Plan, the Grant Notice and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan, the Grant Notice and this Agreement as are consistent therewith and to interpret, amend
or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator will be final and binding upon Participant, the Company and all other interested persons. To the extent allowable pursuant to Applicable
Law, no member of the Committee or the Board will be personally liable for any action, determination or interpretation made with respect to the Plan, the Grant Notice or this Agreement. 

6.2 Shares Not Transferable. The Shares and Retained Distributions may not be sold, pledged, assigned or transferred in any manner
unless and until the Forfeiture Restrictions have lapsed. No Unreleased Shares or Retained Distributions or any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of Participant or his or her successors
in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment,
garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect. 
 6.3 Adjustments. The Administrator may accelerate the vesting of all or a portion of the Unreleased Shares in such circumstances as it, in its sole discretion, may determine. Participant
acknowledges that the Shares are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan, including Section 12.2 of the Plan. 

6.4 Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of
the Secretary of the Company at the Company’s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant’s last address reflected on the Company’s records. By a notice given pursuant
to this Section 6.4, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and
deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. 

  
 A-5

 6.5 Titles. Titles are provided herein for convenience only and are not to serve as a
basis for interpretation or construction of this Agreement. 
 6.6 Governing Law. The laws of the State of Delaware shall
govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. 

6.7 Conformity to Securities Laws. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to
conform to the extent necessary with all Applicable Law, including, without limitation, the provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated thereunder by the Securities and Exchange
Commission, and state securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Shares are granted, only in such a manner as to conform to Applicable Law. To the extent permitted by
Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to Applicable Law. 
 6.8
Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the
Board, provided that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Shares in any material way without the prior written consent of
Participant. 
 6.9 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or
multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in Section 6.2 and the Plan, this Agreement shall be binding upon and inure to the
benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto. 
 6.10 Limitations
Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the Shares, the Grant Notice and this Agreement shall be
subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule.
To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule. 
 6.11 Not a Contract of Employment. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or
any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever,
with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant. 
 6.12 Entire Agreement. The Plan, the Grant Notice and this Agreement (including any exhibit hereto) constitute the entire agreement of the parties and supersede in their entirety all prior
undertakings and agreements of the Company and Participant with respect to the subject matter hereof. 
 6.13
Section 409A. This Award is not intended to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive
guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, “Section 409A”). However, 

  
 A-6

 
notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines that this Award (or any portion thereof) may be subject to
Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this
Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for this Award either to be exempt
from the application of Section 409A or to comply with the requirements of Section 409A. 
 6.14 Agreement
Severable. In the event that any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the
remaining provisions of the Grant Notice or this Agreement. 
 6.15 Limitation on Participant’s Rights.
Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the
Plan nor any underlying program, in and of itself, has any assets. Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Award.

 6.16 Counterparts. The Grant Notice may be executed in one or more counterparts, including by way of any electronic
signature, subject to Applicable Law, each of which shall be deemed an original and all of which together shall constitute one instrument. 
 6.17 Broker-Assisted Sales. In the event of any broker-assisted sale of shares of Stock in connection with the payment of withholding taxes as provided in Section 4.3(a)(iii) or
Section 4.3(a)(v): (A) any shares of Stock to be sold through a broker-assisted sale will be sold on the day the tax withholding obligation arises or as soon thereafter as practicable; (B) such shares of Stock may be sold as part of a
block trade with other participants in the Plan in which all participants receive an average price; (C) Participant will be responsible for all broker’s fees and other costs of sale, and Participant agrees to indemnify and hold the Company
harmless from any losses, costs, damages, or expenses relating to any such sale; (D) to the extent the proceeds of such sale exceed the applicable tax withholding obligation, the Company agrees to pay such excess in cash to Participant as soon
as reasonably practicable; (E) Participant acknowledges that the Company or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale may not be sufficient to satisfy the
applicable tax withholding obligation; and (F) in the event the proceeds of such sale are insufficient to satisfy the applicable tax withholding obligation, Participant agrees to pay immediately upon demand to the Company or its Subsidiary with
respect to which the withholding obligation arises an amount in cash sufficient to satisfy any remaining portion of the Company’s or the applicable Subsidiary’s withholding obligation. 

* * * * * 

  
 A-7

 BIND THERAPEUTICS, INC. 

2013 INCENTIVE AWARD PLAN 
 RESTRICTED STOCK UNIT GRANT NOTICE 
 BIND Therapeutics, Inc., a Delaware
corporation (the “Company”), pursuant to its 2013 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”) the number of Restricted
Stock Units (the “RSUs”) set forth below. The RSUs are subject to the terms and conditions set forth in this Restricted Stock Unit Grant Notice (the “Grant Notice”) and the Restricted Stock Unit Agreement attached
hereto as Exhibit A (the “Agreement”) and the Plan, which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in the Grant Notice and the
Agreement. 
  

			
	 Participant:
	  	
		
	 Grant Date:
	  	
		
	 Number of RSUs:
	  	
		
	 Type of Shares Issuable:            
	  	Common Stock
		
	 Vesting Schedule:
	  	[To be specified in individual agreements]

 By Participant’s signature below, Participant agrees to be bound by the terms and conditions of the
Plan, the Agreement and the Grant Notice. Participant has reviewed the Agreement, the Plan and the Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Grant Notice and fully understands all
provisions of the Grant Notice, the Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Grant Notice or the
Agreement. 
  

									
	BIND THERAPEUTICS, INC.	 		 	PARTICIPANT
					
	 By:
	 	 	 		 	By:	 	 
	 Print Name: 
	 	 	 		 	Print Name: 	 	 
	 Title:
	 	 	 		 		 	

 EXHIBIT A 
 TO RESTRICTED STOCK UNIT GRANT NOTICE 
 RESTRICTED STOCK UNIT AGREEMENT

 Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to Participant the number of
RSUs set forth in the Grant Notice. 
 ARTICLE I. 
 GENERAL 
 1.1 Defined Terms. Capitalized terms not specifically
defined herein shall have the meanings specified in the Plan or the Grant Notice. 
 1.2 Incorporation of Terms of Plan.
The RSUs and the shares of Common Stock (“Stock”) issued to Participant hereunder (“Shares”) are subject to the terms and conditions set forth in this Agreement and the Plan, which is incorporated herein by
reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. 

ARTICLE II. 

AWARD OF RESTRICTED STOCK UNITS AND DIVIDEND EQUIVALENTS 
 2.1 Award of RSUs and Dividend Equivalents. 
 (a) In consideration of
Participant’s past and/or continued employment with or service to the Company or a Subsidiary and for other good and valuable consideration, effective as of the grant date set forth in the Grant Notice (the “Grant Date”), the
Company has granted to Participant the number of RSUs set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice, the Plan and this Agreement, subject to adjustment as provided in Section 12.2 of the Plan. Each
RSU represents the right to receive one Share or, at the option of the Company, an amount of cash as set forth in Section 2.3(b), in either case, at the times and subject to the conditions set forth herein. However, unless and until the RSUs
have vested, Participant will have no right to the payment of any Shares subject thereto. Prior to the actual delivery of any Shares, the RSUs will represent an unsecured obligation of the Company, payable only from the general assets of the
Company. 
 (b) The Company hereby grants to Participant an Award of Dividend Equivalents with respect to each RSU granted
pursuant to the Grant Notice for all ordinary cash dividends which are paid to all or substantially all holders of the outstanding shares of Stock between the Grant Date and the date when the applicable RSU is distributed or paid to Participant or
is forfeited or expires. The Dividend Equivalents for each RSU shall be equal to the amount of cash which is paid as a dividend on one share of Stock. All such Dividend Equivalents shall be credited to Participant and be deemed to be reinvested in
additional RSUs as of the date of payment of any such dividend based on the Fair Market Value of a share of Stock on such date. Each additional RSU which results from such deemed reinvestment of Dividend Equivalents granted hereunder shall be
subject to the same vesting, distribution or payment, adjustment and other provisions which apply to the underlying RSU to which such additional RSU relates. 

  
 A-1

 2.2 Vesting of RSUs and Dividend Equivalents. 

(a) Subject to Participant’s continued employment with or service to the Company or a Subsidiary on each applicable vesting date and
subject to the terms of this Agreement, the RSUs shall vest in such amounts and at such times as are set forth in the Grant Notice. Each additional RSU which results from deemed reinvestments of Dividend Equivalents pursuant to Section 2.1(b)
hereof shall vest whenever the underlying RSU to which such additional RSU relates vests. 
 (b) In the event Participant incurs
a Termination of Service, except as may be otherwise provided by the Administrator or as set forth in a written agreement between Participant and the Company, Participant shall immediately forfeit any and all RSUs and Dividend Equivalents granted
under this Agreement which have not vested or do not vest on or prior to the date on which such Termination of Service occurs, and Participant’s rights in any such RSUs and Dividend Equivalents which are not so vested shall lapse and expire.

 2.3 Distribution or Payment of RSUs. 
 (a) Participant’s RSUs shall be distributed in Shares (either in book-entry form or otherwise) or, at the option of the Company, paid in an amount of cash as set forth in Section 2.3(b), in
either case, as soon as administratively practicable following the vesting of the applicable RSU pursuant to Section 2.2, and, in any event, within sixty (60) days following such vesting. Notwithstanding the foregoing, the Company may
delay a distribution or payment in settlement of RSUs if it reasonably determines that such payment or distribution will violate Federal securities laws or any other Applicable Law, provided that such distribution or payment shall be made at
the earliest date at which the Company reasonably determines that the making of such distribution or payment will not cause such violation, as required by Treasury Regulation Section 1.409A-2(b)(7)(ii), and provided further that no
payment or distribution shall be delayed under this Section 2.3(a) if such delay will result in a violation of Section 409A of the Code. 
 (b) In the event that the Company elects to make payment of Participant’s RSUs in cash, the amount of cash payable with respect to each RSU shall be equal to the Fair Market Value of a Share on the
day immediately preceding the applicable distribution or payment date set forth in Section 2.3(a). All distributions made in Shares shall be made by the Company in the form of whole Shares, and any fractional share shall be distributed in cash
in an amount equal to the value of such fractional share determined based on the Fair Market Value as of the date immediately preceding the date of such distribution. 
 2.4 Conditions to Issuance of Certificates. The Company shall not be required to issue or deliver any certificate or certificates for any Shares prior to the fulfillment of all of the following
conditions: (A) the admission of the Shares to listing on all stock exchanges on which such Shares are then listed, (B) the completion of any registration or other qualification of the Shares under any state or federal law or under rulings
or regulations of the Securities and Exchange Commission or other governmental regulatory body, which the Administrator shall, in its absolute discretion, deem necessary or advisable, and (C) the obtaining of any approval or other clearance
from any state or federal governmental agency that the Administrator shall, in its absolute discretion, determine to be necessary or advisable. 

  
 A-2

 2.5 Tax Withholding. Notwithstanding any other provision of this Agreement:

 (a) The Company and its Subsidiaries have the authority to deduct or withhold, or require Participant to remit to the Company
or the applicable Subsidiary, an amount sufficient to satisfy applicable federal, state, local and foreign taxes (including the employee portion of any FICA obligation) required by law to be withheld with respect to any taxable event arising
pursuant to this Agreement. The Company and its Subsidiaries may withhold or Participant may make such payment in one or more of the forms specified below: 
 (i) by cash or check made payable to the Company or the Subsidiary with respect to which the withholding obligation arises; 
 (ii) by the deduction of such amount from other compensation payable to Participant; 
 (iii) with respect to any withholding taxes arising in connection with the distribution of the RSUs, with the consent of the Administrator, by requesting that the Company and its Subsidiaries withhold a
net number of vested shares of Stock otherwise issuable pursuant to the RSUs having a then current Fair Market Value not exceeding the amount necessary to satisfy the withholding obligation of the Company and its Subsidiaries based on the minimum
applicable statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes; 
 (iv) with
respect to any withholding taxes arising in connection with the distribution of the RSUs, with the consent of the Administrator, by tendering to the Company vested shares of Stock having a then current Fair Market Value not exceeding the amount
necessary to satisfy the withholding obligation of the Company and its Subsidiaries based on the minimum applicable statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes; 

(v) with respect to any withholding taxes arising in connection with the distribution of the RSUs, through the delivery of a notice that
Participant has placed a market sell order with a broker acceptable to the Company with respect to shares of Stock then issuable to Participant pursuant to the RSUs, and that the broker has been directed to pay a sufficient portion of the net
proceeds of the sale to the Company or the Subsidiary with respect to which the withholding obligation arises in satisfaction of such withholding taxes; provided that payment of such proceeds is then made to the Company or the applicable
Subsidiary at such time as may be required by the Administrator, but in any event not later than the settlement of such sale; or 
 (vi) in any combination of the foregoing. 
 (b) With respect to any withholding
taxes arising in connection with the RSUs, in the event Participant fails to provide timely payment of all sums required pursuant to Section 2.5(a), the Company shall have the right and option, but not the obligation, to treat such failure as
an election by Participant to satisfy all or any portion of Participant’s required payment obligation pursuant to Section 2.5(a)(ii) or Section 2.5(a)(iii) above, or any combination of the foregoing as the Company may determine to be
appropriate. The Company shall not be obligated to deliver any certificate representing shares of Stock issuable with respect to the RSUs to Participant or his or her legal representative unless and until Participant or his or her legal
representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable with respect to the taxable income of Participant resulting from the vesting or settlement of the RSUs or any other
taxable event related to the RSUs. 
 (c) In the event any tax withholding obligation arising in connection with the RSUs will
be satisfied under Section 2.5(a)(iii), then the Company may elect to instruct any brokerage firm determined acceptable to the Company for such purpose to sell on Participant’s behalf a whole number of shares from those shares of Stock
then issuable to Participant pursuant to the RSUs as the Company 

  
 A-3

 
determines to be appropriate to generate cash proceeds sufficient to satisfy the tax withholding obligation and to remit the proceeds of such sale to the Company or the Subsidiary with respect to
which the withholding obligation arises. Participant’s acceptance of this Award constitutes Participant’s instruction and authorization to the Company and such brokerage firm to complete the transactions described in this
Section 2.5(c), including the transactions described in the previous sentence, as applicable. The Company may refuse to issue any shares of Stock in settlement of the RSUs to Participant until the foregoing tax withholding obligations are
satisfied, provided that no payment shall be delayed under this Section 2.5(c) if such delay will result in a violation of Section 409A of the Code. 
 (d) Participant is ultimately liable and responsible for all taxes owed in connection with the RSUs, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding
obligations that arise in connection with the RSUs. Neither the Company nor any Subsidiary makes any representation or undertaking regarding the treatment of any tax withholding in connection with the awarding, vesting or payment of the RSUs or the
subsequent sale of Shares. The Company and the Subsidiaries do not commit and are under no obligation to structure the RSUs to reduce or eliminate Participant’s tax liability. 

2.6 Rights as Stockholder. Neither Participant nor any person claiming under or through Participant will have any of the rights or
privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares (which may be in book-entry form) will have been issued and recorded on the records of the Company or
its transfer agents or registrars, and delivered to Participant (including through electronic delivery to a brokerage account). Except as otherwise provided herein, after such issuance, recordation and delivery, Participant will have all the rights
of a stockholder of the Company with respect to such Shares, including, without limitation, the right to receipt of dividends and distributions on such Shares. 
 ARTICLE III. 
 OTHER PROVISIONS 

3.1 Administration. The Administrator shall have the power to interpret the Plan, the Grant Notice and this Agreement and to adopt
such rules for the administration, interpretation and application of the Plan, the Grant Notice and this Agreement as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and
determinations made by the Administrator will be final and binding upon Participant, the Company and all other interested persons. To the extent allowable pursuant to Applicable Law, no member of the Committee or the Board will be personally liable
for any action, determination or interpretation made with respect to the Plan, the Grant Notice or this Agreement. 
 3.2
RSUs Not Transferable. The RSUs may not be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution, unless and until the Shares underlying the RSUs have been issued, and all restrictions
applicable to such Shares have lapsed. No RSUs or any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of Participant or his or her successors in interest or shall be subject to disposition by
transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings
(including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. 

3.3 Adjustments. The Administrator may accelerate the vesting of all or a portion of the RSUs in such circumstances as it, in its
sole discretion, may determine. Participant acknowledges that the RSUs and the Shares subject to the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan, including
Section 12.2 of the Plan. 

  
 A-4

 3.4 Notices. Any notice to be given under the terms of this Agreement to the Company
shall be addressed to the Company in care of the Secretary of the Company at the Company’s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant’s last address reflected on the
Company’s records. By a notice given pursuant to this Section 3.4, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly given when sent via email or when sent by
certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. 
 3.5 Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. 

3.6 Governing Law. The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and
performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. 

3.7 Conformity to Securities Laws. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to
conform to the extent necessary with all Applicable Laws, including, without limitation, the provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated thereunder by the Securities and Exchange
Commission, and state securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted, only in such a manner as to conform to Applicable Law. To the extent permitted by
Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to Applicable Law. 
 3.8
Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the
Board, provided that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of
Participant. 
 3.9 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or
multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in Section 3.2 and the Plan, this Agreement shall be binding upon and inure to the
benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto. 
 3.10 Limitations
Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the RSUs (including RSUs which result from the deemed
reinvestment of Dividend Equivalents), the Dividend Equivalents, the Grant Notice and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any
amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable
exemptive rule. 

  
 A-5

 3.11 Not a Contract of Employment. Nothing in this Agreement or in the Plan shall
confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby
expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and
Participant. 
 3.12 Entire Agreement. The Plan, the Grant Notice and this Agreement (including any exhibit hereto)
constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof. 

3.13 Section 409A. This Award is not intended to constitute “nonqualified deferred compensation” within the meaning
of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof,
“Section 409A”). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines that this Award (or any portion thereof) may be subject to Section 409A,
the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt
other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for this Award either to be exempt from the application of
Section 409A or to comply with the requirements of Section 409A. 
 3.14 Agreement Severable. In the event that
any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of the Grant
Notice or this Agreement. 
 3.15 Limitation on Participant’s Rights. Participation in the Plan confers no rights or
interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of
itself, has any assets. Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the RSUs and Dividend Equivalents. 

3.16 Counterparts. The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature,
subject to Applicable Law, each of which shall be deemed an original and all of which together shall constitute one instrument. 

3.17 Broker-Assisted Sales. In the event of any broker-assisted sale of shares of Stock in connection with the payment of
withholding taxes as provided in Section 2.5(a)(iii) or Section 2.5(a)(v): (A) any shares of Stock to be sold through a broker-assisted sale will be sold on the day the tax withholding obligation arises or as soon thereafter as
practicable; (B) such shares of Stock may be sold as part of a block trade with other participants in the Plan in which all participants receive an average price; (C) Participant will be responsible for all broker’s fees and other
costs of sale, and Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale; (D) to the extent the proceeds of such sale exceed the applicable tax withholding
obligation, the Company agrees to pay such excess in cash to Participant as soon as reasonably practicable; (E) Participant acknowledges that the Company or its designee is under no obligation to arrange for such sale at any particular price,
and that the proceeds of any such sale may not be sufficient to satisfy the applicable tax withholding obligation; and (F) in the event the proceeds of such sale are insufficient to satisfy the applicable tax withholding obligation, Participant
agrees to pay immediately upon demand to the Company or its Subsidiary with respect to which the withholding obligation arises an amount in cash sufficient to satisfy any remaining portion of the Company’s or the applicable Subsidiary’s
withholding obligation. 
 * * * * * 

  
 A-6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}]]